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ABSTRACT
The new field of ‘omics’ has spawned the development of metaproteomics, an approach
that has the ability to identify and decipher the metabolic functions of a proteome
derived from a microbial community that is largely uncultivable. With the development
and availabilities of high throughput proteomics, high performance liquid
chromatography coupled to mass spectrometry (MS) has been leading the field for
metaproteomics. MS-based metaproteomics has been successful in its’ investigations
of complex microbial communities from soils to the human body.
Like the environment, the human body is host to a multitude of microorganisms
that reside within the skin, oral cavity, vagina, and gastrointestinal tract, referred to as
the human microbiome. The human microbiome is made up of trillions of bacteria that
outnumber human genes by several orders of magnitude. These microbes are
essential for human survival with a significant dependence on the microbes to encode
and carryout metabolic functions that humans have not evolved on their own. Recently,
metaproteomics has emerged as the primary technology to understand the metabolic
functional signature of the human microbiome.
Using a newly developed integrated approach that combines metagenomics and
metaproteomics, we attempted to address the following questions: i) do humans share a
core functional microbiome and ii) how do microbial communities change in response to
disease. This resulted in a comprehensive identification and characterization of the
metaproteome from two healthy human gut microbiomes. These analyses have
resulted in an extended application to characterize how Crohn’s disease affects the
functional signature of the microbiota.
Contrary to measuring highly complex and representative gut metaproteomes is
a less complex, controlled human-derived microbial community present in the gut of
gnotobiotic mice. This human gut model system enhanced the capability to directly
monitor fundamental interactions between two dominant phyla, Bacteroides and
Firmicutes, in gut microbiomes colonized with two or more phylotypes. These analyses
revealed membership abundance and functional differences between phylotypes when
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present in either a binary or 12-member consortia. This dissertation aims to
characterize host microbial interactions and develop MS-based methods that can
provide a better understanding of the human gut microbiota composition and function
using both approaches.
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Chapter One
Characterization of human host-microbiome interactions at the molecular level
with metaproteomics approaches
Part of the introduction is adapted from the ‘proteomics and metaproteomics’
chapter in ‘The Human Microbiome’ book (CABI with editor Dr. Julian Marchesi)
written by Alison R Erickson (2012 release date).
1.1: Introduction
In a natural ecosystem, microbes do not exist in isolation, but rather in populations and
communities in which competition and cooperation are essential to shaping the
composition and function of a microbial community. To understand microbial community
composition, structure, function, and evolution, research has focused on development of
approaches to advance beyond single pure-culture laboratory experiments to in situ
analyses of environmental microbial populations and communities, since single
microbial isolates in lab cultures do not accurately capture the complexities of microbial
interactions in environmental communities. An organism cultivated in the laboratory
may not represent or reflect its true activity and physiology in a natural environment
where conditions such as resource competition and predation are widespread[1]. In
addition, estimates suggest that ~90% of the microorganisms inhabiting the
environment are not cultivable[2,3]. As a result, intensive research efforts have focused
on improving methodologies for cloning, sequencing, and annotating whole genomes
from heterogeneous microbial environments. For many complex environmental
communities, metagenomics (genomic sequencing and analysis of uncultured microbes
[4]) has provided insight into the genetic diversity, evolution, and metabolic potential of
uncultivable microorganisms[5,6,7,8] otherwise not possible with traditional laboratory
techniques.
With the emergence of metagenomics, extensive research has focused on
sequencing and characterization of environmental microbial communities collected from
extreme ecosystems, such as the Acid Mine Drainage[9] and hydrothermal systems[10],
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the ocean[11,12], soils[13], and more recently the human body[14]. The human body is
one example of a unique ecosystem where microbes and the human host live in
symbiosis (Figure 1.1), in which the microbial cells outnumber human cells by 10-fold.
Our collective microbial counterpart inhabits multiple body sites (e.g., skin, vagina, oral
and gastrointestinal tract) and is referred to as the human microbiome. Although the
human microbiome is made up of thousands of bacterial species (Figure 1.2), ~20-60%
of the bacteria inhabiting the human-associated microbiome cannot be
cultured[15,16,17,18,19]. For example, ~50% of the human oral microbiome is
estimated to be non-cultivable[20]. However, with the increasing availability and
quantity of human microbiota-associated metagenomic sequence data[21,22,23,24,25],
we can begin to study and understand the human microbiome in both healthy and
disease conditions. This sequence data has already increased our knowledge of the
human microbiota gene content and variability and paved the way for systems biology
(‘omic’) type studies, in particular making metaproteomics, a comprehensive community
proteome analysis, feasible [26]. These whole community genomic sequences currently
serve as the foundation for metaproteomics in the human microbiome (Figure 1.3) and
enable the identification of hundreds to thousands of proteins. However, the dogma
that DNA and RNA are equivalent is no longer considered accurate, as suggested by Li
et al., mandating that the primarily focus cannot only be on DNA, but RNA as a separate
entity, since its alterations induce changes in the final end product, the proteins[27].
Although metagenomic sequencing unveils the collective functional ‘potential’ of a
microbial community, this prediction is not directly related to the ‘actual’ host-microbial
functional signature where protein information provides a deeper look at the molecular
activities. Because metagenomics only captures the complete reportiore of genome
capacity, it will be the integration of metaproteomics and/or metatranscriptomics with
metagenomics that can serve as a powerful tool to study and collectively characterize
the functional and metabolic signatures of the complex human microbiome.
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Host%& Colonic%&
genotype& ﬂora&
Diet&

Figure 1.1: An interconnected landscape of host genetics, microbiota, and external
factors such as diet regulate the stability of the unique human ecosystem where
microbes and the human host live in symbiosis.

Figure 1.2: Microbial density in the gastrointestinal tract[26].
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Human
Microbiome
Metagenomics
Metatranscriptomics
Metaproteomics
Metabolomics
Interactomics
Figure 1.3: Integration and interconnectivity of metaproteomics with other ‘omic’
disciplines, with metagenomics as the primary foundation for all other ‘omics.’
Metagenomics provides DNA information, metatranscriptomics provides RNA
information, metaproteomics provide protein-level information, metabolomics provides
information about small-molecule metabolites, and interactomics provides information
about all interactions between proteins and other molecules.
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1.2: Microbial Community Functional Analysis
Proteomics, the identification and cataloguing of the entire suite of proteins translated in
an organelle, organism(s), or tissue, has begun to rise in significance in the ‘postgenomic era’, since proteomics reveals the final gene products that are inscribed in the
genome “dictionary.” It is the proteins, not genes, that are the active enzymatic and
metabolic players, and their complex network interactions and pathways that are
responsible for the complexity of humans and their microorganisms’ phenotype[28] in
the human microbiome. For example, the specific order and arrangement of genes in
the genome does not provide any information about the structures and functions of
protein complexes. Studies have shown that proteins rarely function on their own, but
rather usually exist in multi-component complexes and function with remarkable
specificity[29,30]. Protein-protein interactions and post-translation modifications and
are also very important and are not revealed by genomes or metagenomes. Therefore,
to understand the human microbiome, one has to not only identify and characterize the
gene content, but identify how its complete suite of proteins actually function in vivo,
which can not be revealed through metagenomics.
To enable comprehensive functional analysis, high-throughput sequencing
approaches (of transcripts and/or peptides) with high accuracy, sensitivity, and
reproducibility are necessary to study the complex and diverse human microbiota.
Microbial community functionality can be measured with either metaproteomics or
metatranscriptomics, which is the sequencing of community mRNA. Recent
developments in microbial sequencing technologies from microarrays to RNA-seq have
yielded a tremendous increase in the throughput, accuracy, and sequence coverage
(number and length of reads) of microbial transcriptomes and metatranscriptomes.
Metatranscriptomics has shown to be successful in the analysis of environmental
communities[31,32,33,34,35,36] and recently was applied to the analysis of the human
gastrointestinal microbiome[37,38,39,40,41]. In comparison, proteomics has also
advanced from two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and
single protein measurement platforms to MS-based proteomics and metaproteomics.
The first large-scale metaproteome characterizations of microbial communities from a
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static snapshot in time include the low-diversity Acid Mine Drainage (AMD)[42,43],
wastewater sludge[44], as well as the more complex ecosystems such as the
ocean[45,46] and the human gastrointestinal[26,47] and salivary[48,49] microbiome.
These omics’ studies have demonstrated the experimental capabilities and feasibility of
applying metatranscriptomics and metaproteomics to complex environmental
communities, including the human microbiome. Unlike traditional laboratory techniques,
both technologies are valuable resources that can be used to characterize the
functionality of uncultivable microorganisms and how it relates back to the genomic and
taxonomic diversity in microbial communities derived from complex natural
environments. While both ‘omic’ technologies are viable, there are advantages and
disadvantages to selectively use one over the other to understand microbial
functionality, as outlined below.
With respect to metatranscriptomics, there are several challenges when working
with bacterial RNA. For example, the half-life is short and fraction of obtainable
bacterial mRNA is limited. Compared to eukaryotic mRNA, most bacterial mRNA do not
have 3’ poly-A tails[50], which complicates isolation and purification from other noncoding RNA types when bacterial RNA preps consist of ~50-80% of rRNA and
tRNA[51]. Although several studies have begun to identify methods to remove or
deplete these contaminating RNA species[52,53,54,55], this comes at the risk of
potentially altering or disrupting the true composition and nature of the environmental
community transcriptome. Similarly, technical challenges exist with for metaproteomics.
Protein extraction from natural environments can be i) biased for high or low-abundance
members within a community and ii) inefficient when exposed to complex sample
matrices such as humic compounds commonly found in soils and sediment. The
separation and resolution of thousands of proteins from a consortium of microorganisms
can prove difficult with liquid chromotraphy (LC) timescales and current MS platforms.
Additionally, the vast dynamic range and complexity of microorganisms and proteins
within a consortium (e.g., 10-100 trillion microorganisms inhabiting the human
gastrointestinal tract) can hinder the ability to comprehensively identify the proteome of
all members of a microbial community. While both technologies have their limitations,
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using either or both metatranscriptomics and metaproteomics, is still highly valuable in
providing insight into the functional profile and physiological responses of a natural
microbial community under various and extreme environmental conditions, which is not
possible with metagenomics.
At this point in time, metaproteomics is better suited for understanding the actual
functional signature of the microbiota, as it directly measures and determines the
phenotype of the cells being studied. Metatranscriptomics (mRNA abundance) does not
always provide a direct correlative link to protein activity[56], since the final gene
products (proteins) can can be constitutively expressed and post-transcriptionally
modified. Additionally, mRNA abundance is an unreliable estimator for the
corresponding proteins’ abundance[57,58,59]. Therefore, protein expression should not
be directly predicted from mRNA expression data. Unlike metatranscriptomics,
metaproteomics directly provides measurement information about protein abundances,
turnover, post-translation modifications, and protein-protein interactions not possible
with metatransciptomics. We will focus on proteomics and metaproteomics in the
human microbiome from this point on.
1.3: Metaproteomics of Microbial Communities
Shotgun proteomics is a term commonly used to represent a variety of experimental
(2D-PAGE and LC) and analytical methodologies (mass spectrometry) that identify the
composite set of expressed gene products (proteins/proteome) collected from cells of a
microorganism, organ, or tissue. Similarly but distinct, metaproteomics, as first defined
by Wilmes and Bond, is identification of the suite of proteins that are derived directly
from an environmental consortia that can contain a mixture of several microorganisms,
and that cannot be binned into species or organism types[60]. Like shotgun DNA
sequencing, shotgun proteomics consists of digesting proteins into peptides, which can
be more easily separated by gel electrophoresis and/or liquid chromatography prior to
analysis via mass spectrometry. Traditionally, shotgun proteomics has been used to
catalogue all proteins from a single prokaryote (e.g., E. coli) or eukaryotic organism
(e.g., S. cerevisiae) grown in culture under variable, but controlled, growth conditions to
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evaluate the phenotypic changes as reflected by the measured proteome. Meanwhile,
developments in high resolution mass spectrometry, LC-based separation, and genomic
sequencing led to the viability of community proteomics of natural environmental
samples (metaproteomics) as first demonstrated by the large-scale proteome
measurements of the microorganisms inhabiting the AMD[42]. From this point on,
shotgun proteomics was also no longer restricted to using cultivable organisms or
artificially created mixtures of known proteins in culture. With the current state and
adaptation of MS, metaproteomics has transitioned from low complexity communities
consisting of few dominant organisms[5], to much more complex ecosystems such as
soil with 103 – 106 taxa per gram of soil[28,61], human gut microbiome with 500-3,000
bacteria species[62], and the oral microbiome with 500-700 bacteria
species[18,20,63,64,65].
In an attempt to identify the entire protein complement of a microbial community,
shotgun MS-based proteomics has been the most effective and comprehensive tool to
date. This involves the generation and identification of thousands of peptides in a single
sample. Protein identifications are generated by matching experimental tandem mass
spectra (MS/MS) against a peptide sequence database(s) using well-established
programs, such as SEQUEST, Mascot, and X!Tandem, to identify peptides (peptidespectrum matching)[66,67,68]. The accurate interpretation and assignment of MS/MS
spectra is the first step in the informatics data processing pipeline, called database
searching (discussed further in chapter two). Therefore, a relevant genome or
metagenome (protein database) is the necessary starting point to infer biological
meaning from complex environmental metaproteomes. Hence, the depth and quality of
DNA sequencing have a significant impact on protein database searching. Relative to
single microbial isolates, the complexity and sequence diversity (strain- and specieslevel variation) and reduced coverage of community metagenomic sequences can pose
many challenges for metaproteomics. As additional metagenomes are acquired and the
sequencing technologies and depth of coverage improve, this will correlate with an
increase in protein identification and deeper proteome coverage of complex, human
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microbial community metaproteomes using a metagenome(s) as the foundation for MS
peptide-spectrum matching.
1.4: Human microbiome
Like other environmental microbial communities, the human microbiome is a complex
and dynamic system that plays an important role in many aspects of human physiology.
The human microbiome (i.e., the host of our microbial symbionts) not only consists of
microbes living outside the body, but internally within the oral cavity, gastrointestinal
tract, and vagina. Together, these microbes (microbiota) outnumber the human somatic
and germ cells by 10:1 (Figure 1.4). A deep understanding of human genetic and
physiologic diversity requires characterization of our microbiome by focusing on factors
that influence its assembly, stability, functions, and functional variations. The Human
Microbiome Project (HMP) is currently focused on generation of large datasets
describing the microbial lineages and genes present in our gut communities. A central
challenge will be to move beyond compositional information and develop ways of
determining how these communities operate to influence human health as well as
disease predisposition.

Figure 1.4: The complex healthy human gut microbiome (mixture of human, bacteria,
and digested food components) and microbial diversity in human feces. Micrograph
courtesy of Janet Jansson, LBNL.
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Fortunately, with the advent of the HMP[14,69], a multitude of human-habitat
associated microbial metagenomes have been sequenced and are publically available
for researchers to use for additional investigations to help improve our understanding of
the human microbiome. In addition, a number of human-derived microbial reference
genomes[70] have been sequenced and are publically available; however, the vast
majority of microorganisms have yet to be cultured. Currently, >1,000 microbial
reference genomes collected from various sites of the human body including the mouth,
skin, gut, and vagina are publically available. Therefore, when a metagenome is not
available or representative for a particular sample, the human-derived microbial
reference genomes could be used as a substitute for a metagenome(s).
Metaproteomics can also take advantage of these metagenomes and human-derived
reference genomes for protein database searches against relevant human proteome
samples. While metagenomic predicted protein sequence database searches provide
highly relevant proteome information, it can be difficult to unambiguously assign
microbial species/strain information to many proteins. The reference genomes can be
used to overcome this by providing definitive species/protein identifications, which can
be used separately or as a complement to metagenomic predicted protein database
searches[71]. Several common experimental, analytical, and informatics workflows
suitable for MS-based proteomics will be explored in more detail with respect to their
applicability and challenges with the human gut microbiome.
The objective of this dissertation research is a comprehensive and mechanistic
understanding of the microbial functional signature in the gut microbiome. To achieve
this goal, it was necessary to begin with a lower complexity, synthetic gut microbiome
and then progress to a more realistic and complex human gut microbiome. Challenges
are present in both approaches, but both approaches provide different information that
will eventually contribute to an overall larger understanding of how the human gut,
normal or diseased, functions with our microbial counterparts. For both approaches,
liquid chromatography coupled with tandem mass spectrometry will be used to
characterize the gut microbial community proteomes of human twins and gnotobiotic
mice.
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1.4.1: Shotgun proteomics of a model human gut microbiome
It has become clear that the human gut manages to function in symbiosis with an
indefinite number of microorganisms which are necessary for normal gut function. For a
less complex, systematic approach, gnotobiotic mice were used as a model system due
to the ability to control what microbial flora is present in the gut. Collaborator Dr. Jeffrey
Gordon (Washington University, St. Louis, MO) has sequenced a multitude of genomes
from members of the two dominant phyla present in the normal distal human gut
microbiota: the Firmicutes and the Bacteroidetes[62,72]. To explore the interactions
between the Bacteroidetes and Firmicutes in vivo, adult germ-free mice were colonized
by the Gordon group with either: two, seven, or twelve human-derived microorganisms.
For example, to examine the fundamental interactions between these two phyla in gut
biomes, germ-free mice were colonized with either B. thetaiotaomicron or E. rectale, or
both (chapter 3). These gnotobiotic mice provided a novel model system in which to
study not only microbial mono- versus bi-association, but up to twelve microbial
inhabitants at a single point in time. The overall goal of this initial two-member
community study was to demonstrate proteomic measurements on gut microbiomes
from gnotobiotic mice. With increasing complexity, the goal was to (i) improve
experimental and informatics applications to resolve closely-related species within a
low-complexity system (chapter 4) and (ii) elucidate information about the functional
activities of these low complexity microbial systems under various dietary conditions
(chapter 5). The results presented in chapters 3, 4, and 5 emphasize the value of
combining gnotobiotics with high resolution proteomics as a strategy for developing the
experimental and computational pipeline needed to characterize gene expression in
more complex, human body habitat-associated microbial communities.
1.4.2: Metaproteomics of the human gut microbiome
The composition and stability of the gut microbiota can be disrupted by external factors
influencing the likelihood of developing inflammatory bowel diseases (IBD) and the
propensity for obesity. IBD can be divided into two disease categories: Ulcerative
Colitis and Crohn’s Disease. Crohn’s is a chronic, relapsing, immunologically mediated
	
  

11	
  

disorder that can have severe physical consequences. The current hypothesis is that
this disease is due to an overly aggressive immune response to a subset of commensal
enteric bacteria. Studies to date on IBD have suggested that the disorder may be
caused by a combination of bacteria and host susceptibility. Until recently, no study has
reported the use of advanced integrated systems biology techniques such as
metagenomics and metaproteomics, for the characterization of the natural microflora in
Crohn’s patients.
A non-targeted MS-based approach is ideal for studying complex communities
based on its ability to directly measure expressed proteins from complex environmental
matrices. This approach was applied to elucidate the differences and functional
activities of commensal microbiota between monozygotic concordant (genetically
identical twins with the same trait) and discordant (genetically identical twins, but differ
phenotypically for a trait) human twins with and without Crohn’s disease with a focus on
biological inference (chapter 6 and 8) in addition to method development (chapter 7).
1.5: Metaproteomics informatics for the gut microbiome
A challenge in MS-based proteomics is “protein inference” and the ability to accurately
assign a peptide to the protein from which it originated. This peptide-protein
assignment is often complicated by homology between proteins of different microbial
strains/species found in environmental communities. In a protein database containing
multiple bacterial reference genomes, gene redundancy between multiple
strains/species belonging to the same genera can make it difficult to accurately assign a
unique peptide to a MS/MS spectrum. Erickson et al. published a method whereby i)
only matched metagenomic derived protein databases were searched against the same
samples’ tandem mass spectra (multiple metagenomes are not concatenated into one
FASTA protein database) and ii) for proteins identified across multiple samples used for
comparison, a clustering approach was used to cluster identified proteins with peptides
that have >80% sequence identity to reduce the level of peptide and protein
redundancy[71]. For the human gut microbiome, Cantarel et al., Erickson et al. and
Roojers et al. suggest that if a matched metagenome is available, it should be used as
	
  

12	
  

the protein database for the same metaproteome sample to comprehensively identify
many MS/MS spectra without massive redundancy. If a matched metagenome is not
available, a synthetic metagenome can be created by concatenating available
metagenomes with relevance to the body site of interest, as proposed by Verberkmoes
et al. and/or use some combination of the publically available human-derived reference
genomes from the human microbiome project (HMP)[73].
Although matched metagenomes are highly desirable for several reasons, the
human-derived bacterial reference genomes have sufficient sequencing coverage
where the protein sequences are full length. Metagenomic sequencing of
environmental samples are not often sequenced to a sufficient depth to contain the
complete gene repertoire; as a result, the predicted genes are often fragmented,
resulting in incomplete protein sequences in a database. However, because many of
the genomic sequences captured from an environmental sample do not map to any
available reference genome, relying solely on reference genomes for metaproteomic
protein identification limits the proteins identified to only those in found in sequenced
organisms, which is a very small proportion of the total bacteria that is cultivable from
the HM. Additionally, the human microbiome is estimated to contain trillions of bacterial
cells and thousands of bacterial species, many of which are uncharacterized. Because
the majority of these bacteria have not been sequenced, their proteomes are likewise
undecipherable. As a result, these ‘unknown’ bacteria and proteins (hypotheticals)
cannot be assigned to MS/MS spectra with a protein database that contains only a
collection of known sequenced reference isolate genomes. Additionally, the humanderived reference genomes do not have any disease-representation or individual
sequence/strain variations, whereas a matched metagenome is usually derived from the
same human individual sample that may be associated with some disease (e.g., ileal
Crohns disease or gingivitis). An approach that uses either a metagenome or
genome/metagenome database search strategy will be able to capture the presence of
these unknown microorganisms/proteins and sequence variations which can more
accurately represent and reflect the entire metaproteome of the human microbiota being
studied. Finally, careful attention should be given to using only reference isolate
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genomes, because unidentified and uncharacterized microorganisms and their proteins
are equally important in revealing the function of the human microbiome.
In conclusion, the quality of environmental protein databases, whether it be a
matched or relevant metagenome(s) or a collection of reference genomes, and
database searching is a critical step and in many MS-based studies it is the bottleneck
in the informatics workflow and metaproteomics pipeline. With the exponential increase
in size, availability, and complexity of metagenomic sequence data from the human
microbiome[25], metaproteomics investigators will be severely affected and hindered by
the quality of the metagenomes in terms of obtaining full length contigs (incomplete
protein encoding genes) and subsequently the accuracy of annotation, degree of
technological sequencing errors, and impractical size of databases to generate reverse
databases and accurately predict false discovery rates (FDRs) using traditional
methods. There is a strong need for a new database search engine that is compatible
with large environmental protein databases that takes into account many of the
complications described above. Additionally, new informatics workflows that may
include a combination of both protein database searching and de novo peptide
sequencing may prove to be highly beneficial for covering the range of both known
(database predicted proteins; chapter 7) and assist in revealing the unknown proteins
that may not be sequenced (ie, due to low abundance) and/or are missed in the
assembly of metagenomic sequence reads.
1.6: The future of metaproteomics in the HM
While metaproteomics has advanced significantly beyond low resolution twodimensional gel electrophoresis (2DE), many obstacles still remain. Not only is
metaproteomics heavily reliant upon mass spectrometry technologies, but also on the
foundation of protein database searching, the metagenomes. To improve protein
identification using MS-based proteomics, we will need the quality (e.g., sequence
lengths, assembly and annotation) of metagenomic-predicted protein databases to
improve in parallel. However, given the error rates in genomic sequencing,
technologies that rely solely on database searching with genomes and/or metagenomes
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may not be as effective or desired in the future, but some alternative(s) and/or a
combination of methodologies that will provide for metaproteomics to achieve a deeper
and wider level of proteome coverage in the human microbiome. The initial lack of
metagenomic information hindered many environmental community studies from
performing comprehensive and reliable protein identification. However, investigators
are now readily sequencing environmental communities (ie, cost of sequencing has
decreased with the simultaneous improvement of DNA sequencing techologies such as
Illumina) where they can also be used for matched and/or relevant metagenomic–
predicted protein database searches. With large-scale DNA sequencing efforts,
metaproteomics-based functional analyses will simultaneously improve for protein
identification in microbial communities inhabiting the human microbiome.
In order to cope with the large and increasing quantities of sequence data that
has been acquired by large-scale sequencing efforts in the human microbiome,
metaproteomics will equally require advanced technology and vast informatics
resources to manage and preserve its significance within the ‘omics’ field. However,
given the advancement and cost of sequencing technologies, the scientific community is
driving towards smaller and smaller sequence read lengths from Sanger (~1,000bp) to
454 (~500bp) and now Illumina (75-100bp), which could potentially impede the
advancement of metaproteomics by limiting the ability to achieve full length protein
sequences in communities. While the sequencing depth of coverage and error rate is
equally important for metagenomics and metaproteomics, the lack of full-length protein
sequences can be equally if not more detrimental to protein identification and biological
inference. Revolutionary tools and integrated ‘omic’ studies are highly sought after to
enable the study of the web of events rather than a static snapshot of the activities
taking place in the human microbiome.
Future MS-specific developments include the optimization of up-front cellular
lysis and protein extraction methods in addition to the development of new highthroughput hybrid mass spectrometers capable of higher resolution and mass accuracy.
While protein extraction methods are straightforward when applied to culture-based
microorganisms, these methods are not always efficient or non-biased for the in situ
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extraction of proteins from complex environmental matrices. As seen with soil and
sediment samples, efficient cell lysis and extraction can be technically challenging.
However, as investigators continue to adapt and improve lysis and extraction protocols
for environmental samples[74] (chapter 4), protein identification will benefit significantly
by increasing the accessibility, depth, and coverage of proteins contained in
complicated environmental matrices such as human feces. Additionally, a direct cell
lysis and protein extraction method of samples collected from the human microbiome
may prove to be more efficient and/or representative of the microbial community
compared to indirect methods that enrich for microorganisms. To characterize the
metaproteome of the human microbiota one step further would incorporate the analysis
of post-translational modifications and strain-level variants in addition to
protoegenomics, where we can use metaproteomics and identified peptides to refine
metagenomes and gene predictions to assist in the identification of false starts/stops,
misassembled contigs, gene boundaries, and incorrect protein annotations. However,
in order to accurately assess and correct these critical issues with high confidence, the
acquirement of and use of high mass accurate mass spectrometric data is vital. High
mass accurate mass spectrometers that are capable of discriminating all amino acids
will be essential to filter and control for false positives as the size and redundancy
increases with higher complexity environmental communities such as those in soil and
the human microbiome.
As described above, protein redundancy and peptide degeneracy is a challenge
and scales substantially with environmental communities such as the human gut. Due
to the level of protein redundancy found in higher complexity microbial communities, it is
difficult to assign and suggest that one species/strain is uniquely responsible for a
specific function within the community using MS/MS spectral abundance. With current
informatics workflows, it is often challenging to identify 1) to which proteins the
measured peptides originated from, 2) to which organisms the identified proteins belong
to, and 3) to estimate an accurate peptide or protein false discovery rate[75,76]. Even
with the use of high mass accuracy, the available informatics algorithms are not capable
of differentiating and classifying peptides that are not only shared amongst multiple
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proteins, but between species and strains regardless of the database type (reference
genomes and/or a matched or relevant metagenome) that is used for complex
environmental communities. While many algorithms assign and differentiate unique
from non-unique (shared) peptide identifications, a large portion of the peptide
identifications are non-unique, complicating the accuracy of biological inference in
environmental communities. Adaptations of either the available informatics workflows
or the generation of new algorithms may prove to be more effective, accurate, and
computationally higher throughput due to the sizes of metagenomic-derived protein
databases for dealing with peptide and protein redundancy on a large-scale with
environmental communities.
Other challenges that remain include the ability to assess the “complete” or entire
bacterial functionality of the human microbiome due to i) the biological dynamic range of
low abundant proteins and on a broader level, microbial species/strains with variable
abundance in the same sample and ii) dynamic range limitations of the mass
spectrometer instrumentation. With improvements in peptide separations (LC) and
technological developments over the past couple of years, the dynamic ranges have
increased by 1-2 orders of magnitude[77]. Technological developments have increased
ion transmission and speed while delivering ultra-high resolution and accurate mass
data as seen in the LTQ-Velos and LTQ-Oribtrap Velos[78] that have provided new
capabilities to achieve deeper coverage of less abundant proteins. More recently, the
Orbitrap Elite was released with a novel high-field mass analyzer that increases the
speed, sensitivity, and dynamic range of complex proteome samples. Nevertheless, in
spite of these partially solved challenges, metaproteomics is already providing
remarkable insight into the functional activities of the gut and oral microbiota with
technological advancements that will provide unrivaled capabilities for future
metaproteomics analyses of the human microbiome.
With increasing large-scale DNA sequencing efforts, metagenomics will drive the
emerging field of metatranscriptomics and metaproteomics in the human microbiome.
With innovation and new developments emerging in MS-based proteomics, the scientific
community will have access to many more capabilities to study the metaproteome of the
	
  

17	
  

human microbiome. For example, it is anticipated that proteomics will be capable of
identifying all isoforms and modifications (e.g., PTMs) on a large scale in the future. To
achieve this, not only will shotgun proteomics (bottom-up) continue to prevail in its
applications, but also higher-throughput top-down analysis of proteins will emerge as a
necessity. It is the combination of both approaches, with advancement of all areas
within mass spectrometry-based proteomics including technology and informatics
workflows, which may serve as the revolutionary tool to fully characterize environmental
community metaproteomes in the human microbiome.
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1.7: Scope of the dissertation
This dissertation encompasses a set of experimental and informatics methods and
advancements that have enabled biological inference of the highly complex and diverse
human gut microbiome. As described above, the human gut microbiome is highly
complex and diverse with thousands of microbial species. Therefore, to
comprehensively identify and characterize the metaproteome of each microbial member
inhabiting the gut can be challenging as described throughout this dissertation. Chapter
2 will provide a detailed experimental and methodological overview and platform for
successful applications of MS-based proteomics to microbial communities collected
from complex gut-related sample matrices (ceca and feces). As described in chapter 2,
different approaches have been proposed and described as viable methods to
effectively characterize the proteomes of gnotobiotic mice and metaproteomes of
human individuals. An approach that focuses on a less complex and carefully designed
gut microbiota allows for the focused study of human-derived microbial structure,
cooperation, competition and adaptation in vivo as described in chapters 3-5. Chapter 3
will introduce the first application of MS-based proteomics to a human-derived microbial
community in gnotobiotic mice. In this chapter, we define the interactions between two
members of the Firmicutes and the Bacteroidetes that are commonly represented in the
human gut microbiota. The functional differences between B. thetaiotaomicron and E.
rectale are revealed through an integrated approach of genomics, transcriptomics and
proteomics. This chapter lays the framework for comparing and developing new
methods to increase protein identifications and coverage of individual microbes within a
defined consortium as described in chapter 4. Chapter 4 will describe and compare
several up-front sample processes for the lysis and extraction of proteins from a higher
complexity, 7-member microbial community composed of only phylotypes belonging to
Bacteroidetes. Chapter 5 will use the previous two chapters as a guide for both
experimental applications and biological inference of a 12-member microbial
consortium. This chapter will not only focus on characterizing the community proteome
as a single entity, but each individual species and their responses to diet perturbations.
In contrast to chapters 3-5, an approach that directly measures the expressed
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metaproteome of a highly complex gut microbiome derived from feces can more
accurately represent the diversity and abundances of a human gut microbiome as
described in chapters 6-8. Chapter 6 will introduce the first application of high
throughput MS-based metaproteomics to human gut microbiomes. This chapter
specifically describes the capabilities of the first LC-MS application to healthy gut
microbiomes collected from adult feces and establishes a baseline for the biological
inference of healthy metaproteomes. This work lays the groundwork for developing new
integrated informatics workflows to increase the identification and coverage of
metaproteomes using a variety of metagenomic sequencing and assembly strategies as
described in chapter 7. Chapter 7 will deliver a new integrated
metagenomic/metaproteomic approach that uses metagenomic sequence reads as a
database to search against matched tandem MS/MS spectra collected from a healthy
human twin pair. Using the new methodology and informatics workflow discussed in
chapter 7, chapter 8 will highlight the benefits of this method with increased protein,
peptide, and spectra identifications in both healthy and diseased gut microbiomes.
Compared to the previous two chapters, this chapter highlights the significant
improvements and capabilities of MS-based metaproteomics in the revelation of a core
gut microbiome in addition to the shared and functional differences in healthy and
diseased (Crohn’s disease) metaproteomes. Finally, chapter 9 will summarize the
experimental, technological and informatics methods that served as the platform to
permit in-depth biological inference of complex human-gut microbial metaproteomes of
healthy and disease.
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Chapter Two
Development of an integrated experimental/computational omics platform for
human gut microbiome research
Part of the introduction is adapted from the ‘proteomics and metaproteomics’
chapter in ‘The Human Microbiome’ book (CABI with editor Dr. Julian Marchesi)
written by Alison R Erickson (2012 release date).
2.1: Introduction
Metaproteomics has advanced from the protein identification in low-complexity
ecosystems (AMD)[42] to highly complex microbial communities inhabiting the soil,
ocean, and the human microbiome (HM). The capability to identify hundreds to
thousands of proteins in the HM is predicated on experimental optimization of sample
collection and lysis/preparation methods, high throughput liquid chromatographic
separation coupled to tandem mass spectrometry (MS/MS), and integration with
genomics and metagenomics to perform sequence database searching (Figure 2.1).
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Figure 2.1: Experimental design for human gut microbiome sample collection and
integrated metagenomic / metaproteomic MS characterization.
The collection of microbial cells and extraction of proteins from the human gutassociated microbiota is the one of the most important steps in the experimental design
of MS-based proteomics to insure accurate representation of the collective microbiota
that is sampled and sufficient biomass for all downstream processes and MS analysis.
The primary goals for MS-based community proteomics are: efficient sample
processing, peptide separation, high sequence coverage of proteins and the proteome,
and coverage of high and low abundant organisms (dynamic range). Presently, a
multitude of sample processing methods for microbial cell lysis, protein extraction,
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denaturation and digestion, and purification are available to perform error-prone tandem
mass spectrometry. In general, there are two general methods for microbial cell lysis
where a sample is collected for proteomics and either i) derived, processed, and lysed
directly (in situ) from the source (i.e., feces, tissue biopsy) where both microbial and
human cells are included (direct approach) or ii) the collected sample is enriched for
microbial cells to eliminate all human proteins and contaminants via centrifugation
(ultra- or differential centrifugation; indirect approach). Currently there is no widely
accepted or approved method suggesting that either the direct or indirect approach is
better or worse than the other for metaproteomics of HM related samples, and this will
be a key focus of part of the research under this dissertation.
Mass spectrometry is the most comprehensive tool available for large-scale
proteomics[79] and metaproteomics for several reasons. MS is high-throughput,
reproducible, unbiased, and highly versatile, with applications to a variety of sample
types ranging from solids, gases, small molecules, to peptides and proteins (single,
mixtures, or communities). MS can provide high detection sensitivity, resolution, and
mass accuracy, unlike traditional methods of Western blotting. In addition, MS can be
coupled with separation techniques to increase the dynamic range of higher complexity
samples. A multitude of mass spectrometers are increasingly available and range
based on their i) ionization source, ii) mass analyzer, and iii) data processing and ion
detection source. The first component in the proteome measurement is the ionization
source for proteins and peptides to be analyzed by MS. This can be accomplished with
two primary ionization methods: matrix-assisted laser desorption ionization (MALDI)[80]
and electrospray ionization (ESI)[81]. The second critical component is the mass
analyzer, which sorts and measures ions based on their mass-to-charge ratios (m/z).
The most common mass analyzers include 1) trapping mass spectrometers: Ion trap,
Orbitrap, and Fourier transform-ion cyclotron resonance (FT-ICR) that use dynamic
electrostatic or magnetic confinement, 2) ion-beam mass spectrometers: quadrupoles
(Q) and time-of-flight (TOF) that utilize spatial resolution. Ion traps are generally most
suited for bottom-up proteomics and LC-MS/MS of complex proteomes and mixtures.
FT-ICR instruments are generally suited for top-down proteomics and PTM identification
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due to its wide m/z range, high resolution (500,000 FWHM) and accuracy (< 1 ppm),
however, the scan rate is much slower compared to the linear ion trap. The widely used
triple quadrupole (QqQ) instrument contains a series of three quadrupoles (Q) that
allows for selected/multiple ion reaction monitoring (SRM and MRM). Most
investigators use the QqQ platform for targeted proteomics investigation rather than
comprehensive proteome identification and coverage. Finally, TOF mass analyzers can
be used for either top-down or bottom-up proteomics with high duty cycle, unlimited
mass range, and low cost, however, low resolution limits its general application. Novel
hybrid instruments integrating more than one mass analyzer (e.g., LTQ-FT-ICR, LTQOrbitrap, and QqTOF) have evolved from single mass analyzer instruments to combine
multiple features (Figure 2.2) to provide more superior, faster, and robust measurement
possibilities. For example, the newest revolution is the novel dual-pressure linear ion
trap mass spectrometers LTQ Velos and LTQ-Orbitrap Velos with increased ion
transmission, more efficient isolation and dissociation, greater resolution, and faster
scan rates (compared to the LTQ-XL)[78]. For complex metaproteomes, this instrument
permits higher acquisition rates while simultaneously isolating more low-abundant
peptides and proteins.

Figure 2.2: Schematic of the hybrid LTQ-Orbitrap[82]. The Orbitrap performs high
resolution full MS scans and the linear trapping quadrupole performs MS/MS.
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For the technical reasons described previously, mass spectrometry is an
unparalleled analytical tool that has shown to be successful in its application to human
microbiome-related samples. Briefly, several studies have applied a variety of MS
platforms to the human gut and oral microbiome, such as the work by Klaassens et al.
to use MALDI-TOF mass spectrometry to analyze the infants’ gastrointestinal tryptic
peptides[47]. While this study established the role of MS and metaproteomics in the
human microbiome, it was very limited in protein and proteome coverage, with 55
excised protein spots and only one identified microbial protein with 91% identity to
Bifidiobacterium. The lack of identifications may have been a result of the experimental
technique (i.e., low resolution 2D gels), MS platform, and lack of peptide separation.
VerBerkmoes et al. and Erickson et al. applied 2D-ESI-LC-MS/MS on a LTQ-Orbitrap
mass spectrometer, specifically exploiting its’ high mass accuracy capabilities to acquire
low false discovery rates of peptides and proteins in these complex microbial
communities[26,71]. Similarly, Rooijers et al. used an LTQ-Orbitrap mass
spectrometer, but did not focus on high mass accurate identifications for their analyses
of the human gut microbiota[83]. Hongwei and Rudeny et al. both used an LTQ mass
spectrometer without the Orbitrap for all MS analysis on human whole saliva[48,84].
Grant et al. used a 7 T LTQ FT mass spectrometer for the analysis of human GCF to
study the oral microbiome[49]. LC-ESI-MS/MS and hybrid mass spectrometers are the
technology of choice for high-throughput peptide and protein identification[78] featuring
greater sensitivity, acquisition rates, and resolution to accurately and comprehensively
identify and characterize complex metaproteomes as those in the human microbiome.
While up-front sample collection, preparation, and selection of the most
appropriate MS platform are important for complex human microbiota samples, the final
post-MS/MS steps are critical for data interpretation and biological inference. Finally,
the last step in the shotgun proteomics methodology and pipeline is informatics. Protein
identifications are generated by matching MS/MS spectra against a sequence
database(s) to identify the most accurate peptide-spectrum matches (Figure 2.3). The
correct interpretation and assignment of such MS/MS spectra to peptides is the major
step in the informatics data processing pipeline, called database searching. This step is
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not only heavily reliant upon MS/MS quality, but the quality and accuracy of a sequence
database. A ‘sequence database’ is a FASTA formatted file that contains the entire
theoretical proteome and sequences that are predicted from a genome (e.g, bacterial
isolate) or metagenome (e.g., microbial community). Thus, we are limited to only
matching spectra to the peptides that are found in the sequence database, hence,
mutated or alternatively spliced genes, and post-translationally modified peptides will
not be identified. Although having a sequenced genome or metagenome for the exact
same biological (protein) sample is extremely valuable for MS-based peptide-spectrum
matching, a metagenome is of higher complexity compared to a single genome. The
simplicity of peptide-spectrum matching with, for example, a well-characterized bacterial
genome (e.g., E. coli), via MS database searching is not as straightforward with a
metagenome(s). The traditional isolate/genome-based approaches and methodology
for DNA sequencing, assembling, and predicting genes, thus, proteins for well-studied
model organisms, although routine and widely accepted, may not provide the most
expansive and reliable gene sequences for increasing both protein identifications and
proteome coverage via MS-based proteomics for community samples.
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Figure 2.3: Mass spectrometry protein database searching workflow.
For each of the methodological steps and parameters described previously, this
dissertation will focus on using a variety of sample processing methods (indirect and
direct), hybrid ion trapping mass spectrometers (LTQ-Orbitrap), and protein database
searching to optimize and examine the metaproteomes to provide an unprecedented
molecular level glimpse into the complex human gut microbiome of both human
individuals and gnotobiotic mice.
2.2: Reagents and solvents
All salts, chemical reagents (i.e., guanidine HCl, urea, acetic acid, dithiothreitol (DTT),
sodium dodecyl sulfate (SDS)) were acquired from Sigma Chemical Co. (St. Louis, MO)
and were used as supplied without further purification. Modified sequencing grade
trypsin (Promega, Madison, WI) was used for all protein digestions. HPLC-grade water
and acetonitrile were obtained from Burdick & Jackson (Muskegon, MI), and 99% formic
acid was purchased from EM Science (Darmstadt, Germany).
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2.3: Sample collection
The selection of host subjects and body sites is a critical step for representing the
collective metaproteome of the human microbiota. The majority of subjects that have
been selected to represent the metaproteome of the HM include human, but also
gnotobiotic mice that have been colonized with human-derived microbes to control for
and monitor a less complex, but representative human gastrointestinal microbiota[37].
The use of culture-independent techniques for the collection of cells representative of a
specific microbial metaproteome niche(s) within the human microbiome can be
challenging for several reasons. The invasiveness, quantity, quality, and preservation
of sample collection is important for maintaining an intact, native proteome that has not
been altered or disrupted such that biological and technical variation is minimal. For
example, biological variation would occur if the proteome were not treated (lysed and
denatured) immediately upon removal from freezing temperatures where the proteome
would begin experience changes as a result of active endogenous proteases.
Therefore, minimization of both technical (LC-MS/MS-related) and biological variation
will provide for more accurate biological inference relative to the microbiota, sampling
subject, and site. Sampling sites have included feces and ceca to represent the human
gastrointestinal microbiome[26,37,47,71,83] where microbial cells are typically
separated and enriched from the raw human fecal material to remove exfoliated human
epithelial cells, interfering food debris and other contaminating compounds. Klassens et
al. was one of the first to apply metaproteomics to processed human fecal samples
(infant). Klassens and colleagues used mechanical homogenization with glass beads
and centrifugation to enrich for microbial cells and remove debris. Proteins were then
extracted via bead beating. A second, more comprehensive study was performed on
adult human fecal samples described from Verberkmoes et al. where healthy human
feces was processed with a five-cycle differential centrifugation method published by
Apajalahti et al.[85]. Microbial cells were lysed and proteins extracted via a small-scale
microbial biomass protocol[86]. This protocol was also adapted by Mahowold et al. for
gnotobiotic mice (chapter 3) and by Erickson et al. for healthy and diseased human
subjects (chapter 8).
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2.3.1: Gnotobiotic mice
Gnotobiotic mice were used as a human model system to control the microbial diversity
of the microbiota present in the gut. A collaborator, Dr. Jeffrey Gordon and his research
group at the Washington University in St. Louis performed all microbial inoculations and
cultivations of the gnotobiotic mice (Figure 2.4). Dr. Gordon has sequenced genomes
from several members of the two dominant phyla present in the normal distal human gut
microbiota: the Firmicutes and the Bacteroidetes. To explore the interactions between
the Bacteroidetes and Firmicutes in vivo, adult germ-free male mice were gavaged with
a mixture of sequenced human-derived microorgansims, ranging from a binary mixture
of two bacteria (binary community), seven-members, and finally, a twelve-member
community. qPCR analysis of both feces and cecal contents indicated that at the time
of sacrifice, the microbial species had colonized the distal gut of recipient mice. Unlike
the binary communities containing two evolutionarily distinct microbes (Bacteroides
thetaiotaomicron and Eubatcterium rectale), a second set of adult germ-free mice were
colonized with 7 sequenced human gut-derived microbes belonging to the same phyla,
Bacteroidetes. After comparing the proteomes of these binary communities to the
proteomes acquired from the 7-member communities, the focus shifted to sample
processing optimization to better suite “cecum” and feces. The traditional method of cell
lysis was not as efficient for lysing cecal material nor did it provide a thorough sampling
of the individual microbes’ proteome. Thus, the initial goals for the 7-member
community study were to achieve deeper and wider coverage of the ceca proteome
prior to in depth biological analyses. Lastly, with the improvements and accumulation of
an advanced mass spectrometer (LTQ-Orbitrap Velos), Dr. Gordon scaled up the
complexity of the microbial consortium to twelve human gut-derived microorganisms
consisting of the same seven phylotypes used in the 7-member consortium in addition
to four Firmicutes and one Actinobacteria.
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Figure 2.4: Gnotobiotic mouse isolator used to rear pups to adulthood (figure courtesty
of Dr. Jeffrey Gordon at Wash. Univ.).
Adult male germ-free mice belonging to the NMRI inbred strain were colonized
via gavage with of either 108 Colony Forming Units (CFU) of B. thetaiotaomicron VPI5483 or a log-phase culture of E. rectale, or both. All mice were fed a standard diet rich
in complex plant polysaccharides. Organisms were present in equivalent numbers in
the inoculum. Distinct microbial samples were obtained from the distal gut (cecum) of
eight gnotobiotic mice provided by Dr. Jeffrey Gordon and Michael Mahowald. Two
mice were not colonized with any bacteria (germ-free control); two were colonized only
with B. thetaiotaomicron; two were colonized with a mixture of both B. thetaiotaomicron
and E. rectale; and the last two were colonized only with E. rectale.
Dr. Gordon’s group provided a total of seven cecal samples for the 7-member
community proteomics experiments. The C57BL/6 mice, labeled as 2, 3, 5, and 7-10,
were gavaged with an equal inoculum of the following species: Bacteroides caccae, B.
ovatus, B. uniformis, B. WH2, B. thetaiotaomicron, B. vulgatus, and Parabacteroides
distasonis and fed a standard BK diet ab libitum. The total microbial does was ~ 8.7 x
107 corresponding to 1.2-1.3x107 CFUs/microbe.
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Dr. Gordon’s group provided a 12-member community of gut-derived
microorganisms consisting of the same seven phylotypes used in the 7-member
consortium (Bacteroides caccae, B. ovatus, B. uniformis, B. WH2, B. thetaiotaomicron,
B. vulgatus, and Parabacteroides distasonis) in addition to four Firmicutes (Dorea
longicatenta, Ruminococcus obeum, Clostridium spiroforme, and C. scindens) and one
Actinobacteria (Collinsella aerofaciens). This 12-member consortium was selected for a
diet oscillation study in fourteen gnotobiotic mice where ORNL only received the ceca
belonging to four mice. There are two treatment groups for which two mice consumed a
high fat and simple sugar diet (termed ‘western’ diet) and the other two other mice
consumed a standard high-protein BK diet.
2.3.2: Human gut swedish twin cohort
Human fecal samples from normal, concordant, and discordant human twins with and
without Crohn’s Disease were provided by a collaborator, Dr. Janet Jansson (Lawrence
Berkeley National Lab). The purpose of these studies is to apply proteogenomic
techniques to understand the physiology of complex microbial communities in
concordant and discordant twins with Crohn’s disease. Highly representative, complex
gut microbiomes were extracted from bulk human fecal samples (estimated >1011
bacteria cells/g of feces) from a total of 6 monozygotic twin pairs (Table 2.1) including: 1
set of healthy twins (6a and 6b), 1 set of concordant twins with Crohn’s disease
inflammation localized in the colon (CCD; 9a and 9b), 2 sets of concordant twins with
Crohn’s disease inflammation localized in the ileum (ICD; 10a and 10b, 15a and 15b)
and 2 sets of ICD discordant twins (16a and 16b, 18a and 18b, ICD and healthy
respectively), via differential centrifugation[85] to obtain enriched microbial pellets. The
resulting bacterial cell pellets were immediately frozen at –70°C and shipped overnight
to the Oak Ridge National Laboratory (ORNL).
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Table 2.1: Twin cohort sample descriptions and details for all subjects, healthy, ileal Crohn’s disease (ICD), and colonic
Crohn’s disease (CCD).
Sample ID Birth year
6a
1951
6b
1951
9a
1947
9b
1947
10a
1962
10b
1962
15a
1953
15b
1953
16a
1954
16b
1954
18a
1953
18b
1953

Phenotype
Sex NOD2 Status Gastro-enteritis Age at diagnosis
Surgery (year)
Healthy
F
nd
Yes
Healthy
F
nd
No
CCD, Non-stricturing, Non-penetrating M
No
41
wt
CCD, Non-stricturing, Non-penetrating M
wt
No
40
ICD, Stricturing
Yes
23
ileal res + right hemi (1985)
F
wt
ICD, Stricturing
F
wt
Yes
24
ileocec res (1986)
ICD, Non stricturing, Non-penetrating
No
23
ileal res (1980)
M
snp 8 m/w
ICD, Non-stricturing, Non-penetrating M
snp 8 m/w
No
23
ileocec res (1976)
ICD, Penetrating
No
20
ileal res + right hemi (1974)
F
wt
Healthy Co-twin
F
wt
No
ICD, Non-stricturing, Non-penetrating M
No
20
ileal res + right hemi (1973)
wt
Healthy Co-twin
M
wt
No
-

Abbreviations: ileal res, ileal resection; right hemi, right sided hemicolectomy; ileocec res, ileocecal resection; nd, no data; wt, wildtype
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2.4: MS-Based Sample Preparation
There are several major steps in MS-based shotgun proteomics that follow in the order
of i), separation and/or in situ lysis of the bacteria from the environmental matrix and, ii)
extraction, denaturation, and digestion of proteins into peptides and, iii) separation and
fragmentation of peptides in a mass spectrometer and, iv) peptide-spectrum matching
(PSM) (Figure 2.5). Several protocols are available and complement the delicate
intricacies (e.g., quantity biomass, complexity of sample matrix, and diversity of
community membership) that come with processing samples collected from the
environment for metaproteomics. Widely accepted methods for the cellular lysis and
extraction of proteins from complex microbial communities for metaproteomics analysis
include a thermally assisted detergent-based cellular lysis (sodium dodecyl sulfate,
SDS) method[74], a small-scale microbial biomass experimental approach[86],
sonication[87,88], freeze-thaw cycles[89], French press[60] and published methods
described above for HM-related metaproteome samples.
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Figure 2.5: General MS-based proteomics experimental, analytical, and informatics
pipeline.
Available and tested cellular lysis buffers include detergents (e.g., SDS, CHAPS,
and Triton X-100), chaotropes (urea and guanidine), acid-labile surfactants (PPS silent
surfactant) and many other commercially available buffers to disrupt bacterial cells with
or without physical or mechanical disruption prior to protein extraction. Several
precautions must be taken if a detergent is selected due to interference with binding,
elution, and ionization of peptides during tandem MS experiments. To eliminate
contamination and interference with detergents and mass spectrometers, several
metaproteomics studies[26,42,86,90] selected to use an indirect extraction approach
and chaotropes (ie, guanidine) to enrich and lyse microbial cells and denature proteins.
These methods were also dependent upon the type of peptide separation that would be
applied following protein denaturation and digestion, that is, an online 2D-LC separation
rather than 2D-PAGE. For the third and fourth major steps, protocols for protein
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denaturation and digestion of microbial environmental metaproteomes range where
several methods include protein precipitation (ie, trichloroacetic acid (TCA) or ethanol)
prior to denaturation and digestion to concentrate proteins away from contaminants (ie,
small molecules and interfering environmental-related compounds) that were not
eliminated further upstream with indirect extraction methods by centrifugation. Chourey
et al. has shown that protein precipitation (TCA) was beneficial in eliminating humic
compounds and other interfering substances commonly found in soil
metaproteomes[74] and could be also improve protein purification for other complex
environmental matrices such as human feces. Protein digestion is one of the most
critical steps because it involves the reduction of intact proteins to peptides that are
suitable for MS analysis (10-20 amino acids), which relies heavily upon sufficient lysis
and solubilization of all cells in order for proteases (e.g., trypsin) to access the entire
surface area of proteins for effective digestion. The final selection of one method
should be based on the available starting biomass quantity and environmental sample
type and quality (matrix type (ie, degree of exopolysaccharides and interfering humic
and phenolic compounds) and feasibility for purification).
Although many of the described protocols are suitable for a variety of samples,
there are potential biases that range with: i) the indirect (enrichment) approach and its’
efficiency of bacterial extraction via density and differential centrifugation, ii) presence of
other organisms (e.g., fungi, protozoa, and eukaryotes), iii) lysis of bacteria with certain
properties (i.e., gram negative versus positive), iv) extraction of proteins with diverse
properties (i.e., cytosolic versus membrane proteins and fractions) directly from natural
environments, and v) the efficiency of digestion has not all been resolved for complex
samples collected from the HM. There are many challenges that stem from processing
environmental communities for efficient recovery of proteins including those mentioned
above in addition to contamination with other interfering compounds imbedded in the
surrounding matrix if they are not eliminated prior to MS analysis and bias in the
quantitative and qualitative recovery of proteins.
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2.4.1: Gnotobiotic mice and human twin cohort
The gnotobiotic mouse gut microbial communities were treated differently for each
study. Similar to the human twin cohort studies, the binary community cecal contents
were processed via a single tube cell lysis method[86] and proteins digested into
peptides with trypsin. All eight samples were coded and mass spectrometry
measurements conducted in a blinded fashion. Each of the individual cecal contents
collected for the 7-member community were processed differently for method
comparisons and development and is described in more detail under chapter 4. Using
the results from chapter 4, the 12-member microbial community cecal contents were
solubilized in SDS lysis buffer and lysed mechanically by sonication and heat.
Following a TCA precipitation, the precipitates were resolubilized and reduced in 8M
urea and DTT and digested with trypsin.
The bacterial cell pellets (~100mg) that were extracted from bulk human fecal
samples were lysed; proteins were denatured and reduced, and digested into peptides
with trypsin using the protocol developed by Thompson et al.[86]. These samples were
used throughout chapters 6-8.
2.5: Liquid Chromatography
Complex biological samples often contain thousands to hundreds of thousands of
proteins and can be a challenge in terms of total comprehensive intact protein
identification. Therefore, proteins and proteomes are generally digested into smaller
products (peptides) that are technically easier to separate, measure, and identify
compared to intact proteins. However, following proteolytic digestion, a complex
environmental sample can contain hundreds of thousands to millions of peptides.
Therefore, complex peptide digests are fractionated by either a one or multiple
chromatographic dimensions or electrophoretic steps to reduce the complexity of
peptides analyzed at a single time point by mass spectrometry (Figure 2.1).
Since the use of and coupling of two-dimensional gel electrophoresis (2DE),
SDS-PAGE, and mass spectrometry with environmental communities[60,91], the
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scientific community has moved towards using other gel-less alternatives, such as,
higher throughput protein and peptide separation via LC coupled to mass
spectrometers. This transition has enabled the high resolution identification of a few
thousands of proteins from cultured bacteria (e.g., R. palustris[92]) to an environmental
microbial community[42]. For LC-MS, either a single-dimensional (1D) or orthogonal
two-dimensional chromatographic system could be used to separate proteins or
peptides online or offline[93], however, complex mixtures can overwhelm the capacity of
a single dimension. Therefore, a “multi-dimensional” separation is better suited for
complex mixtures and it is the current standard for large-scale proteomics consisting of
two- or three-step peptide fractionation. Yates and colleagues founded the technique
that is referred to as “multidimensional protein identification technology” (MudPIT)
where orthogonal 2D chromatography is used to separate complex peptide mixtures
prior to MS analysis[94,95,96]. The most popular MudPIT setup consists of i) strong
cation exchange (SCX) chromatography followed by ii) reversed-phase (RP)
chromatography to achieve peptide separation prior to MS/MS[96]. SCX
chromatography serves as the primary dimension that separates peptides based on
charge where it has an increased loading capacity compared to RP which separates
peptides by their hydrophobicity while simultaneously eliminating any salts in the
sample. Compared to 2DE and 1D-LC, the MudPIT technique has the advantage of
being higher throughput, higher resolution and reproducible with both the
chromatography and identified proteins, and it is unbiased to a range of proteins with
variable and extreme pIs, MW, location (membrane or cytosol) and abundance.
In the human microbiome, both separation technologies have been applied in a
variety of ways. Klaassens et al. demonstrated for the first time that 2D-PAGE and
protein identification via matrix-assisted laser desorption (MALDI)-time of flight (TOF)
mass spectrometry was applicable to study the metaproteome of the gut microbiome in
human infants using infant fecal material[47]. On the contrary, LC-MS-based
proteomics was first demonstrated in the adult human gastrointestinal
microbiome[26,71] with the application of 2D-(SCX-RP)-LC-MS/MS to human fecal
material. Rooijers et al., on the other hand, used gel electrophoresis for protein
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separation followed by in gel protein digestions[83]. The tryptic peptides were then
separated via 1D-(RP)-LC coupled to electrospray MS/MS on a Thermo LTQ-Orbitrap.
For the oral microbiome, Hongwei et al. separated tryptic peptides via a 3-step
fractionation method[84]. First, peptides were separated by isoelectric focusing (IEF)
using a free-flow electrophoresis system (FFE) and fractionated into a 96-microtiter
plate. Each pI fraction was subjected to preliminary MS/MS to identify fractions with the
highest complexity of peptides to be characterized and separated further. For the final
selected IEF fractions, the peptide fractions were purified (to remove high MW
polymers) and fractionated by SCX (second fractionation step) using a step-gradient.
The SCX peptide fractions were then desalted, concentrated, and loaded onto and
separated on a RP column (third fractionation step) where peptides were directly eluted
and analyzed by ESI-MS/MS on a thermo LTQ linear ion trap. Similarly, Rudney et al.
adapted the same protocol[84] to focus on the metaproteomics analysis of the bacterial
component, taxonomy and metabolic activity, of the human oral microbiome using
human whole saliva. Grant et al. also investigated the oral microbiome in healthy
humans using gingival crevicular fluid (GCF) and a non-invasive gingivitis model that is
used to study the inflammatory response as a result of increasing bacteria over 21
days[49]. GCF samples were pooled and treated with dithiothreitol, heat, and
proteolytically digested with trypsin prior to quantitative labeling with iTRAQ (discussed
in further detail under ‘quantitative proteomics in the HM’). iTRAQ labeled samples
were separated and fractions collected offline using SCX-HPLC. The fractions were
vacuum centrifuged, desalted, and peptides acidified with formic acid prior to LCMS/MS. Lastly, tryptic labeled peptides were separated online using 1D-(RP)-LC and
eluted directly into a thermo LTQ-FT mass spectrometer. In conclusion,
metaproteomics can be applied to complex samples collected from the human
microbiota using a variety of separation technologies as described (2DE, 1D- or 2D-LC,
and/or multiple fractionation steps online or offline). In my opinion, an approach that
uses a “multidimensional” separation approach (e.g., MudPIT) will provide the most
comprehensive and representative coverage of peptides and proteins from the human
microbiome.
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2.5.1: Gnotobiotic mice and human twin cohort
For all gnotobiotic mouse (chapters 3-6) and human twin (chapters 6-8) studies, the
microbial proteins were extracted and processed for 2D-LC-MS/MS using an Ultimate
HPLC system (Dionex, Sunnyvale, CA) coupled to a LTQ, LTQ-Orbitrap, or LTQOrbitrap Velos (Thermo Fisher Scientific, San Jose, CA). At a flow rate of ~100 µL/min
(set on the Ultimate pump), the peptide mixtures of all twelve samples were separated
across a split-phase column (packed in-house with SCX and C18 reverse-phase
chromatographic resins) that was connected to a 15-cm C18 analytical column by a 12
step, multidimensional high-pressure liquid chromatographic elution consisting of eleven
salt pulses (0-500 mM ammonium acetate) followed by a 2 hour reverse-phase gradient
from 100% solvent A (A: 95% H2O, 5% acetonitrile, 0.1% formic acid) to 50% solvent B
(B: 30% H2O, 70% acetonitrile, 0.1% formic acid). The last salt pulse was followed with
a gradient from 100% solvent A to 100% solvent B. During a single chromatographic
separation (~22-24 hr run), mass spectral data acquisition was performed in datadependent mode under the control of Xcalibur software (version 2.0.7; Thermo Fisher
Scientific).
2.6: Mass spectrometric measurements
As described previously under 2.1, the selection of a mass spectrometer is important
and dependent upon several factors including: (i) the proposed biological questions (ie,
comprehensive characterization or targeted analysis of a subset of proteins) and (ii) the
type and complexity of the biological sample (single or mixture of proteins or
environmental sample; dynamic range of proteins). A linear ion trap mass spectrometer
would be best suited for a comprehensive characterization of a proteome whereas a
QqQ platform is preferred for targeted proteomics investigation. Due to the complexity
of the samples (i.e., microbial communities) used in both the human microbiome and
gnotobiotic mice, and the desire to comprehensively characterize the proteomes, ion
trap mass spectrometers and hybrid mass spectrometers are ideally best suited for
these bottom up studies due to their rapid scan time, resolution, and mass accuracy.
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2.6.1: Gnotobiotic mice and human twin cohort
All cecal and fecal samples were analyzed in technical duplicates using a twodimensional (2D) nano-LC MS/MS system with a split-phase column (RP-SCX)[97] on a
LTQ-XL, LTQ-Orbitrap (Figure 2.2), or LTQ-Orbitrap Velos (Thermo Fisher Scientific)
with 22 hr runs per sample (LC as previously described). The mass spectrometer
settings were as follows: one full MS scan was acquire in the Orbitrap (m/z 400-1,700)
at 30k resolution followed by five or ten data-dependent MS/MS in the LTQ at 35%
normalized collision energy. Two microscans were averaged for both full and MS/MS
scans and centroid data were collected for all scans, with dynamic exclusion enabled at
1.
2.7: Proteome informatics
Comparative and quantitative proteomics is the evaluation of how similar and/or
different environmental conditions affect protein expression and abundance. Following
the acquisition of qualitative and in many studies quantitative proteome MS data,
bioinformatics tools, such as DTASelect[98] and software packages, such as
Scaffold[99,100,101] sort and filter through these massive MS datasets to provide the
best quality peptide-spectrum matches (PSM) and their corresponding protein
identifications.
As described previously, protein database searching, an informatics workflow
that deduces the amino acids of a peptide sequence and assigns it to a corresponding
tandem mass spectrum (MS/MS) (Figure 2.3), has been widely adopted by MS-based
proteomics for the high throughput identification of proteins. Database search engines,
such as SEQUEST[66], Mascot[67], and Xtandem![68], assign peptide sequences to
MS/MS spectra by correlating the experimentally identified peptide to a theoretical
peptide sequence derived in silico from a known FASTA formatted protein database.
The peptide sequences with the highest correlation scores are reported in the final
output. As a result, the protein database informatics platform is high throughput and
applicable to range of protein complexity, from a single or mixture of proteins to a
complex environmental community metaproteome. The alternative approach to assign
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MS/MS is de novo peptide sequencing where no prior knowledge of proteins or a
protein database is required.
2.7.1: PSM and database searching
For the first informatics platform, protein database searches, mass spectrometers first
collect precursor ions (intact peptide ions; MS scan) that are selected for fragmentation
by collision with inert gas (e.g., collisional induced dissociation; CID) into fragment ions
(amino acids; MS/MS scan). In total, three to ten of the most abundant precursor ions
(MS) are selected for MS/MS generating thousands of MS/MS during one experiment
(2-24hrs) that represent fragmented peptides of a samples’ protein(s). It is the quantity,
quality (signal versus noise), and complexity of these MS/MS that necessitates the need
for informatics workflows that can sort, filter, and confidently assign PSMs with high
accuracy at a computationally reasonable speed. Currently, there are several opensource and commercial tandem mass spectrometry database search engines that are
widely available. The freely open-source search engines include X!Tandem[68],
OMSSA[102], Myrimatch[103]. The commercially available search engines Mascot[67],
from Matrix Science, and SEQUEST[66], from Thermo Fisher Scientific, have become
the most widely used and are referred to as the golden standards. However, each
database search algorithm has its advantages and disadvantages in terms of spectral
filtering, scoring, configuration, compatible formats, and speed/performance. Several of
these factors are dependent on the quality and relevance of the protein database to the
measured sample and its’ proteome. For example, if a high quality experimentally
identified PSM cannot be assigned to a protein because it is missing in the protein
database, these high quality PSMs will go unidentified. As demonstrated by Cantarel et
al. with the human gut microbiome, up to several thousands of high-quality MS/MS may
not be identified as a result of the database even with having a matched
metagenome(s)[76]. Therefore, the quality and selection of a protein database and/or
metagenomes(s) is a critical component of the protein database search informatics
workflow. Additionally, the larger and all-inclusive protein sequence database(s) will
often take longer to search hindering the performance of several search engines and
increase the number of false positive-identifications.
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Currently, there are many ways of estimating error associated with peptide
identifications. Until the field of proteomics comes to a conclusion on the proper way of
reporting proteomic data, different versions will exist. For these large-scale studies,
false discovery rates were used in order to differentiate between true and false peptide
identifications. The overall false discovery rate (FDR) was estimated using the formula:
FDR= 2[nrev/(nrev + nreal)]*100 where nrev is the number of peptides identified from the
reverse database and nreal is the number of peptides identified from the real
database[96].
2.7.1.1: Gnotobiotic mice and human twin cohort
All MS/MS spectra were searched with the SEQUEST algorithm[66] [(enzyme type,
trypsin; Parent Mass Tolerance, 3.0; Fragment Ion Tolerance, 0.5; up to 4 missed
cleavages allowed (internal lysine and arginine residues), and fully tryptic peptides only
(both ends of the peptide must have arisen from a trypsin specific cut, except N and Ctermini of proteins)] and filtered with DTASelect/Contrast[98] at the peptide level [Xcorrs
of at least 1.8 (+1), 2.5 (+2) 3.5 (+3) and deltCN of either 0.08 or 0.0]. Only proteins
identified with two fully tryptic peptides from the MS runs were considered for further
biological study. Monoisotopic theoretical masses for all peptides identified by
SEQUEST were generated and compared to observed masses. Observed high
resolution masses were extracted from .raw files from the full scan preceding best
identified spectra; parts per million (ppm) calculations were made comparing each
identified peptides’ observed and theoretical mass. When quality MS/MS spectra didn’t
have an observed mass (low intensity) due to an unassignable charge state for the
precursor ion, a mass of 0 was reported and ppm was calculated as infinity.
Detailed database descriptions and search strategies can be found for each of
the following chapters under their “experimental methods.” The FDRs were also
calculated for the majority of experiments and are described in more detail for each
chapter.
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2.7.2: De novo peptide sequencing in the microbiome
As mentioned, the second alternative workflow for protein identification from tandem
mass spectra is de novo peptide sequencing[104,105,106]. Protein identification via
database searching will not be able to identify peptides that are not in the database.
Additionally, with the use of high mass resolution and mass accuracy MS data, de novo
peptide sequencing can be used for the identification of amino acid polymorphisms and
post-translation modifications (PTMs). De novo sequencing calculates the mass
difference between two peaks in a single mass spectrum and if the difference
corresponds to an amino acids’ mass, the algorithm is able to assume that the two
peaks are adjacent fragment ions in the peptide sequence. However, to assess this
mass difference, differentiate signal versus noise, and identify a specific amino acid with
high accuracy, investigators need high mass accuracy MS/MS data to eliminate the
degree of interference. Several de novo sequencing algorithms are currently available
and include PepNovo[105,107], DirecTag[108], PEAKS[109], MSNovo[110] and
Vonode[111]. As described by Cantarel et al., the first de novo peptide sequencing
application (high confidence sequence tags found by both PEAKS and PepNovo) to the
human gut microbiome, conservative de novo sequencing can be highly beneficial for its
revelation of novel peptides that were not identified using a database search engine
(SEQUEST) and increase in protein discovery[76]. Additional details and results are
described in chapter 7.
2.8 Summary
The experimental and analytical methods described above provides a robust, highthroughput, and highly reproducible platform for the application of MS-based proteomics
to characterize complex human gut microbiomes collected from gnotobiotic mice ceca
and human feces. Each step of the general MS-based proteomics workflow: i), sample
collection, ii) MS-based sample preparation, iii) liquid chromatography, iv) MS/MS
measurement and, v) peptide-spectrum matching is important and intended to provide a
solid foundation for optimum identification and coverage of human gut metaproteomes.
This workflow results in the assignment of hundreds of thousands of spectra and the
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identification of thousands of proteins and peptides with a deeper characterization and
understanding of the gut microbiota as highlighted in the following analyses.
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Chapter Three
Characterizing a model human gut microbiota composed of members of its two
dominant bacterial phyla
Portions of the included text are adapted from:
Michael A. Mahowald, Federico E. Rey, Henning Seedorf, Peter J. Turnbaugh,
Robert S. Fulton, Aye Wollam, Neha Shah, Chunyan Wang, Vincent Magrini,
Richard K. Wilson, Brandi L. Cantarel, Pedro M. Coutinho, Bernard Henrissat,
Lara W. Crock, Alison Russell, Nathan C. Verberkmoes, Robert L. Hettich, and
Jeffrey I. Gordon. “Characterizing a model human gut microbiota composed of
members of its two dominant bacterial phyla.” PNAS, 2009, volume 106, issue
14, pages 5859-5864.
Alison R. Erickson’s contributions include experimental preparation of ceca samples for
proteomics and all experimental LC-MS/MS measurements and analysis.
3.1: Introduction
The adult human gut houses a bacterial community containing trillions of members
comprising thousands of species-level phylogenetic types (phylotypes). Cultureindependent surveys of this community have revealed remarkable interpersonal
variations in strain- and species-level phylotypes, and two commonly abundant bacterial
phyla, the Firmicutes and the Bacteroidetes[112]. This phylum-level composition is not a
unique feature of humans: a global survey of the guts of 59 other mammalian species
showed a similar phylum level pattern[113].
Comparative analysis of five sequenced human gut Bacteroidetes revealed that
each genome contains a large repertoire of genes involved in acquisition and
metabolism of polysaccharides: this repertoire includes (i) up to hundreds of glycoside
hydrolases (GHs) and polysaccharide lyases (PLs); (ii) myriad paralogs of SusC and
SusD, outer membrane proteins involved in recognition and import of specific
carbohydrate structures[114]; and (iii) a large array of environmental sensors and
regulators[115]. These genes are assembled in similarly organized, selectively
regulated polysaccharide utilization loci (PULs) that encode functions necessary to
detect, bind, degrade and import carbohydrate species encountered in the gut habitat –
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either from the diet or from host glycans associated with mucus and the surfaces of
epithelial cells[116,117,118]. Studies of gnotobiotic colonized with human gut-derived
Bacteroides thetaiotaomicron alone have demonstrated that this organism can vary its
pattern of expression of PULs as a function of diet: e.g., during the transition from
mother’s milk to a polysaccharide-rich chow consumed when mice are weaned[116], or
when adult mice are switched from a diet rich in plant polysaccharides to a diet devoid
of these glycans and replete with simple sugars (under the latter conditions, the
organism forages on host glycans)[117,118].
Our previous functional genomic studies of the responses of B. thetaiotaomicron
to co-colonization of the guts of gnotobiotic mice with Bifidobacterium longum, an
Actinobacterium found in the guts of adults and infants, or with Lactobacillus casei, a
Firmicute present in a number of fermented dairy products, have shown that B.
thetaiotaomicron responds to the presence of these other microbes by modifying
expression of its PULs in ways that expand the breadth of its carbohydrate foraging
activities[119].
These observations underscore the notion that gut microbes may live at the
intersection of two forms of selective pressure: bottom-up selection, where fierce
competition between members of a community that approaches a population density of
1011-1012organisms/ml of colonic contents drives phylotypes to assume distinct
functional roles; and top-down selection, where the host selects for functional
redundancy to insure against the failure of bioreactor functions that could prove highly
deleterious[120,121].
The content, genomic arrangement and functional properties of PULs in
sequenced gut Bacteroidetes illustrate the specialization and functional redundancy
within members of this phylum. They also emphasize how the combined metabolic
activities of members of the microbiota undoubtedly result in interactions that are both
very dynamic and overwhelmingly complex (at least to the human observer), involving
multiple potential pathways for the processing of substrates (including the order of
substrate processing), varying patterns of physical partitioning of microbes relative to
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substrates within the ecosystem, plus various schemes for utilization of products of
bacterial metabolism. Such a system likely provides multiple options for processing of a
given metabolite, and for the types of bacteria that can be involved in these activities.
All of this means that the task of defining the interactions of members of the
human gut microbiota is daunting, as is the task of identifying general principles that
govern the operation of this system. In the present study, we have taken a reductionist
approach to begin to define interactions between members of the Firmicutes and the
Bacteroidetes that are commonly represented in the human gut microbiota. In the
human colon, Clostridium cluster XIVa is one of two abundantly represented clusters of
Firmicutes. Therefore, we have generated the initial two complete genome sequences
for members of the genus Eubacterium in Clostridium cluster XIVa, (the human gutderived E. rectale strain ATCC 33656 and E. eligens strain ATCC 27750) and compared
them with the draft sequences of 25 other sequenced human gut bacteria belonging to
the Firmicutes and the Bacteroidetes. The interactions between E. rectale and B.
thetaiotaomicron were then characterized by performing whole genome transcriptional
profiling of each species after colonization of gnotobiotic mice with each organism
alone, or in combination under three dietary conditions. Transcriptional data collected by
Wash. Univ. were verified by mass spectrometry of cecal proteins collected by ORNL,
plus biochemical assays of carbohydrate metabolism. Lastly, we examined colonization
and interactions between these microbes from a host perspective; to do so, we
performed whole genome transcriptional analysis of colonic RNA prepared from mice
that were germ-free or colonized with one or both species. Our results illustrate how
members of the dominant gut bacterial phyla are able to adapt their substrate utilization
in response to one another and to host dietary changes, and how host physiology can
be affected by changes in microbiota composition.
3.2: Experimental Methods
3.2.1: Genome comparisons
All nucleotide sequences from all contigs of completed genome assemblies containing
both capillary sequencing and pyrosequencer data, produced as part of the HGMI, were
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downloaded from the Washington University Genome Sequencing Center’s website
(http://genome.wustl.edu/pub/organism/Microbes/Human_Gut_Microbiome/) on
September 27, 2007. The finished genome sequences of B. thetaiotaomicron VPI5482, Bacteroides vulgatus ATCC 8482, and B. fragilis NCTC9343 were obtained from
GenBank.
For comparison purposes, protein-coding genes were identified in all genomes
using YACOP[122]. Each proteome was assigned InterPro numbers and GO terms
using InterProScan release 16.1. Statistical comparisons between genomes were
carried out, as described previously[115] using perl scripts that are available upon
request from the authors.
3.2.2: GeneChip analysis
Previously described methods were used to isolate RNA from a 100-300 mg aliquot of
frozen cecal contents, synthesize cDNA, and to biotinylate and hybridize the cDNAs to a
custom bacterial GeneChip[123]. The only modification was that in RNA isolation
protocol 0.1mm zirconia/silica beads (Biospec Products, Bartlesville, OK) were used for
lysis of bacterial cells in a bead beater (Biospec; 4 min run at highest speed). Genes in
a given bacterial species that were differentially expressed in mono- versus
biassociation experiments were identified using CyberT (default parameters) following
probe masking and scaling with the MAS5 algorithm (Affymetrix; for details about the
methods used to create the mask, see the Methods section of Supplementary
Information).
RNA was purified from proximal colon using Mini RNeasy kit (Qiagen) with oncolumn DNase digestion. Biotinylated cRNA targets were prepared from each sample
(n=4/treatment group). cRNA was hybridized to Affymetrix Mouse Genome Mo430 2
GeneChips, and the resulting data sets analyzed using Probe Logarithmic Error
Intensity Estimate method (PLIER+16). Fold-changes and p-values were calculated
using Cyber-t. Significance was defined by maintaining a FDR <1% using BenjaminiHochberg correction[124].
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3.2.3: Proteomic methods
Cecal contents were processed via a single tube cell lysis and protein digestion method
as follows. Briefly, the cell pellet was re-suspended in 6M Guanidine/10 mM DTT,
heated at 60°C for 1h, followed by an overnight incubation at 37°C to lyse cells and
denature proteins. The guanidine concentration was diluted to 1 M with 50mM
Tris/10mM CaCl2 (pH 7.8), and sequencing grade trypsin (Promega, Madison, WI) was
added (1:100; wt/wt). Digestions were run overnight at 37°C. Fresh trypsin was then
added followed by additional 4h incubation at 37°C. The complex peptide solution was
subsequently de-salted (Sep-Pak C18 solid phase extraction; Waters, Milford, MA),
concentrated, filtered, aliquoted and frozen at -80°C. All eight samples were coded and
mass spectrometry measurements conducted in a blinded fashion.
Cecal samples were analyzed in technical triplicates using a two-dimensional
(2D) nano-LC MS/MS system with a split-phase column (SCX-RP)[97] on a linear ion
trap (Thermo Fisher Scientific) with each sample consuming a 22 hr run as detailed
elsewhere[92,125]. The linear ion trap (LTQ) settings were as follows: dynamic
exclusion set at one; and five data-dependent MS/MS. Two microscans were averaged
for both full and MS/MS scans and centroid data were collected for all scans. All
MS/MS spectra were searched with the SEQUEST algorithm[66] against a database
containing the entire mouse genome, plus the B. thetaiotaomicron, E. rectale, rice, and
yeast genomes (common contaminants such as keratin and trypsin were also included).
To find potential food proteins, yeast and rice databases were included. The breakdown
of each database component can be found in Table 3.1. The SEQUEST settings were
as follows: enzyme type, trypsin; Parent Mass Tolerance, 3.0; Fragment Ion Tolerance,
0.5; up to 4 missed cleavages allowed (internal lysine and arginine residues), and fully
tryptic peptides only (i.e., both ends of the peptide must have arisen from a trypsinspecific cut, except the N- and C-termini of proteins). All datasets were filtered at the
individual run level with DTASelect (22) [Xcorrs of at least 1.8 (+1 ions), 2.5 (+2 ions)
3.5 (+3 ions)]. Only proteins identified with two fully tryptic peptides were considered.
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Table 3.1: Protein sequence database components for binary microbial community
SEQUEST database searches.
Database
B. thetaiotaomicron
E. rectale
M. musculus
Rice
Yeast
contaminants

Proteins Size (MB)

4,958
3,188
34,966
66,710
6,345
36

2.3
1.36
19.2
36
3.33
0.02

For this study, false-positive rates (FPR) were used to estimate the error
associated with peptide identifications. The overall FPR was estimated using the
formula: FPR = 2[nrev/(nrev + nreal)]*100 where nrev is the number of peptides identified
from the reverse database and nreal is the number of peptides identified from the real
database[96]. Reverse and shuffled databases were created in order to calculate
FPRs[96,126]. A reverse database was created by precisely reversing each protein
entry (i.e., N-terminus became C-terminus in each case) and then appended these
reversed sequences onto the original database. Two runs - samples 705, Run 1 and
710, Run 2 - were randomly selected for estimating a FPR. The observed FPR rates
were 0.55% and 0.31% respectively for these two runs. An additional database was
created by randomly shuffling the amino acids of each protein rather than simply
reversing the N-terminus and C-terminus. A FPR was estimated using a similar formula
as that described above except that the number of identified reverse peptides was
replaced with the number of shuffled peptides. A FPR was estimated for both samples,
705, Run 1 (0.45%) and 710, Run2 (0.31%) and was similar to the rate determined by
the reverse database method. Datasets for calculating FPR rates are available on the
website mentioned above.
In addition to differentiating between true and false peptide identifications with
FPRs, label-free quantitation methods were used to estimate relative protein
abundance. Several protein quantitation methods are currently available and routinely
performed for shotgun proteomics analyses. To estimate relative protein abundance in
complex protein mixtures and communities, spectral counts and normalized spectral
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abundance factors (NSAF)[127] are commonly used. Spectral counting is based on the
theory that the more abundant peptides are typically sampled more frequently, resulting
in higher spectral counts. Liu et al. has shown that spectral copy number provides a
more accurate correlation to protein abundance than peptide count and %
coverage[128]. NSAF, on the other hand, is based on spectral counts, but takes into
account protein size and the total number of spectra from a run, thus normalizing the
relative protein abundance between samples[127].
3.3: Results and Discussion
3.3.1: Comparative genomic studies of human gut-associated Firmicutes and
Bacteroidetes
Wash. Univ. produced finished genome sequences for Eubacterium rectale, which
contains a single 3,449,685 bp chromosome encoding 3,627 predicted proteins, and
Eubacterium eligens which contains a 2,144,190 bp chromosome specifying 2,071
predicted proteins, plus two plasmids. We also analyzed 25 recently sequenced gut
genomes, including (i) 9 sequenced human gut-derived Bacteroidetes [includes the
finished genomes of B. thetaiotaomicron, B. fragilis, B. vulgatus, and Parabacteroides
distasonis, plus deep draft assemblies of the B. caccae, B. ovatus, B. uniformis, B.
stercoris and P. merdae genomes generated as part of the human gut microbiome
initiative (HGMI; http://genome.wustl.edu/hgm/HGM_frontpage.cgi], and (ii) 16 other
human gut Firmicutes where deep draft assemblies were available through the HGMI.
We classified the predicted proteins in these two genomes using Gene Ontology (GO)
terms generated via Interproscan, as well as according to the scheme incorporated into
the Carbohydrate Active Enzymes (CAZy) database [www.cazy.org;[129], and then
applied a binomial test to identify functional categories of genes that are either over- or
under-represented between the Firmicutes and Bacteroidetes phyla. This analysis
emphasized among other things that the Firmicutes, including E. rectale and E. eligens,
have significantly fewer polysaccharide-degrading enzymes and more ABC transporters
and PTS systems than the Bacteroidetes[130]. We subsequently chose E. rectale and
B. thetaiotaomicron as representatives of these two phyla for further characterization of
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their niches in vivo, because of their prominence in culture-independent surveys of the
distal human gut microbiota[62,131], the pattern of representation of carbohydrate
active enzymes in their glycobiomes and E. rectale’s ability to generate butyrate as a
major end product of fermentation[132,133]. These choices set the stage for an
‘arranged marriage’ between a Firmicute and a Bacteroidetes, hosted by formerly germfree mice.
3.3.2: Functional genomic analyses of the minimal human gut microbiome
3.3.2.1: Creating a “minimal human gut microbiota” in gnotobiotic mice - Young
adult male germ-free mice belonging to the NMRI inbred strain were colonized with B.
thetaiotaomicron or E. rectale alone (monoassociations) or co-colonized with both
species (biassociation). 10-14 d after inoculation by gavage, both species colonized the
ceca of recipient mice, fed a standard chow diet rich in complex plant polysaccharides,
to high levels (n=4-5 mice/treatment group in each of 3 independent experiments).
Moreover, cecal levels of colonization for both organisms were not significantly different
between mono- and biassociated animals.
3.3.2.2: B. thetaiotaomicron’s response to E. rectale - A custom, multispecies,
human gut microbiome Affymetrix GeneChip was designed and used to compare the
transcriptional profile of each bacterial species when it was the sole inhabitant of the
cecum, and when it co-existed together with the other species. A significant number of
B. thetaiotaomicron genes located in PULs exhibited differences in their expression
upon E. rectale colonization [55 of 106; p<10-15 (cumulative hypergeometric test). Of
these 55 genes, 51 (93%) were upregulated.
As noted in the Introduction, two previous studies from our lab examined
changes in B. thetaiotaomicron’s transcriptome in the ceca of monoassociated
gnotobiotic mice when they were switched from a diet rich in plant polysaccharides to a
glucose-sucrose chow[117], or in suckling mice consuming mother’s milk as they
transitioned to a standard chow diet[116]. In both situations, in the absence of dietary
plant polysaccharides, B. thetaiotaomicron adaptively forages on host glycans. The
genes upregulated in B. thetaiotaomicron upon co-colonization with E. rectale have a
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significant overlap with those noted in these two previous datasets (p<10-14, cumulative
hypergeometric test). In addition, they involve several of the genes upregulated during
growth on minimal medium containing porcine mucosal glycans as the sole carbon
source[118]. For example, in co-colonized mice and in vitro, B. thetaiotaomicron
upregulates several genes (BT3787-BT3792; BT3774-BT3777) used in degrading αmannosidic linkages, a component of host N-glycans as well as the diet. (Note that E.
rectale is unable to grow in defined medium containing α -mannan or mannose as the
sole carbon sources). B. thetaiotaomicron also upregulates expression of its starch
utilization system (Sus) PUL in the presence of E. rectale (BT3698-3704). This wellcharacterized PUL is essential for degradation of starch molecules containing ≥6
glucose units[134].
Thus, it appears that B. thetaiotaomicron adapts to the presence of E. rectale by
upregulating expression of a variety of PULs so that it can broaden its niche and
degrade an increased variety of glycan substrates, including those derived from the host
that E. rectale is unable to access. There are a number of reasons why the capacity to
access host glycans likely represents an important trait underpinning microbiota function
and stability: (i) glycans in the mucus gel are abundant and are a consistently
represented source of nutrients; (ii) mucus could serve as a microhabitat for
Bacteroidetes spp. to embed in (and adhere to via SusD paralogs), thereby avoiding
washout from the ecosystem; and (iii) the products of polysaccharide
digestion/fermentation generated by Bacteroidetes spp. could be shared with other
members of the microbiota that are also embedded in mucus[118].
3.3.2.3: E. rectale’s response to B. thetaiotaomicron - E. rectale’s response to B.
thetaiotaomicron in the mouse cecum stands in marked contrast to B.
thetaiotaomicron’s response to E. rectale. Carbohydrate metabolism genes, particularly
GHs, are significantly overrepresented among the E. rectale genes that are
downregulated in the presence of B. thetaiotaomicron compared to monoassociation;
i.e., 12 of E. rectale’s predicted 51 GHs have significantly reduced expression while only
two are upregulated. The two upregulated GH genes (EUBREC_1072, a 6-P-bglucosidase and EUBREC_3687, a cellobiose phosphorylase) are predicted to break
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down cellobiose. Three simple sugar transport systems with predicted specificity for
cellobiose, galactoside, and arabinose/lactose (EUBREC_3689, EUBREC_0479, and
EUBREC_1075-6, respectively) are among the most strongly upregulated genes.
Phosphoenolpyruvate carboxykinase (EUBREC_2002) is also induced with cocolonization (GeneChip data verified by qRT-PCR assays in 2 independent experiments
involving 3-4 mice/treatment group). This enzyme catalyzes an energy conserving
reaction that produces oxaloacetate from phosphoenolpyruvate. In a subsequent
transaminase reaction, oxaloacetate can be converted to aspartate, linking this
branching of the glycolytic pathway with amino acid biosynthesis.
Additional data support the notion that E. rectale is better able to access nutrients
in the presence of B. thetaiotaomicron. For example, a number of peptide and amino
acid transporters in E. rectale are upregulated, as are the central carbon and nitrogen
regulatory genes CodY (EUBREC_1812), glutamate synthase (EUBREC_1829) and
glutamine synthetase (EUBREC_2543) (note that these genes are also upregulated
during growth in tryptone glucose medium).
3.3.2.4: Changes in E. rectale’s fermentative pathways - E. rectale possesses genes
(EUBEC733-737; EUBEC1017) for the production of butyrate that show high similarity
to genes from other Clostridia. This pathway involves condensation of two molecules of
acetylCoA to form butyrate and is accompanied by oxidation of NADH to NAD+.
Transcriptional and high resolution proteomic analyses (see below) disclosed that the
enzymes involved in production of butyrate are among the most highly expressed in
cecal extracts prepared from mono- and biassociated mice containing E. rectale.
In vitro studies have shown that in the presence of carbohydrates, E. rectale
consumes large amounts of acetate for butyrate production[133]. Several observations
indicate that E. rectale utilizes B. thetaiotaomicron-derived acetate to generate
increased amounts of butyrate in the ceca of our gnotobiotic mice. First, E. rectale
upregulates a phosphate acetyltransferase (EUBREC_1443; EC 2.3.1.8) - one of two
enzymes involved in the interconversion of acetyl-CoA and acetate. Second, cecal
acetate levels are significantly lower in co-colonized mice compared to B.
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thetaiotaomicron monoassociated animals. Third, although cecal butyrate levels are
similar in E. rectale mono- and biassociated animals, expression of mouse Mct-1,
encoding a monocarboxylate transporter whose inducer and preferred substrate is
butyrate[135], is significantly higher in the distal gut of mice containing both E. rectale
and B. thetaiotaomicron versus E. rectale alone (p<0.05). The cecal concentrations of
butyrate we observed are similar to those known to upregulate Mct-1 in colonic
epithelial cell lines[135]. Higher levels of acetate (i.e. those encountered in B.
thetaiotaomicron monoassociated mice) were insufficient to induce any change in Mct-1
expression compared to germ-free controls.
The last enzyme in E. rectale’s butyrate production pathway, butyrylCoA
dehydrogenase/electron transfer flavoprotein (Bcd/Etf) complex (EUBREC_0735-0737;
EC 1.3.99.2), offers a recently discovered additional pathway for energy conservation,
via a bifurcation of electrons from NADH to crotonylCoA and ferredoxin[136]. Reduced
ferredoxin, in turn, can be reoxidized via hydrogenases, or via the membrane-bound
oxidoreductase, Rnf, which generates sodium-motive force. The upregulation and high
level of expression of these key metabolic genes when E. rectale encounters B.
thetaiotomicron indicates that E. rectale not only employs this pathway to generate
energy, but to also accommodate the increased demand for NAD+ in the glycolytic
pathway. Consistent with these observations, we found that the NAD+/NADH ratio in
cecal contents was significantly increased with co-colonization. A high NAD+/NADH
ratio promotes high rates of glycolysis, since NAD+ is a required cofactor and may
represent an adaptation by E. rectale to increased nutrient uptake.
The pathway for acetate metabolism observed in this simplified model human gut
community composed of B. thetaiotaomicron and E. rectale differs markedly from what
is seen in mice that harbor B. thetaiotaomicron and the principal human gut
methanogenic archaeon, Methanobrevibacter smithii. When B. thetaiotaomicron
encounters M. smithii in the ceca of gnotobiotic mice, there is increased production of
acetate by B. thetaiotaomicron, no diversion to butyrate (and no induction of Mct-1;
[123] and B. Samuel and J. Gordon, unpublished observations), increased serum
acetate levels, and increased adiposity compared to B. thetaiotaomicron mono	
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associated controls. In contrast, serum acetate levels and host adiposity (as measured
by fat pad to body weight ratios) are not significantly different between B.
thetaiotaomicron monoassociated and B. thetaiotaomicron-E. rectale co-colonized
animals (n=4-5 animals/group; n=3 independent experiments; data not shown).
3.3.2.5: Colonic transcriptional changes evoked by E. rectale-B. thetaiotaomicron
co-colonization – We subsequently used Affymetrix Mouse 430 2 GeneChips to
compare patterns of gene expression in the proximal colons of mice that were either
germ-free, monoassociated with E.rectale or B. thetaiotaomicron, or co-colonized with
both organisms (n=4 mice per group; total of 16 GeneChip datasets). In contrast to the
small number of genes whose expression was significantly changed (1.5-fold cut off,
<1%FDR) after colonization with either bacterium alone relative to germ-free controls,
co-colonization produced significant alterations in the expression of 508 host genes.
Expression of many of these genes also changed with monoassociation with either
organism, and in the same direction as seen after co-colonization, but in most cases the
changes evoked by B. thetaiotaomicron or E. rectale alone did not achieve statistical
significance. Unsupervised hierarchical clustering of average expression intensity
values derived from each of the four sets of GeneChips, revealed that the E.rectale
monoassociation and E.rectale-B.thetaiotaomicron bi-association profiles clustered
separate from the germ-free and B. thetaiotaomicron monoassociation datasets.
Ingenuity Pathway Analysis (www.ingenuity.com) disclosed that the list of 508
host genes affected by co-colonization was significantly enriched in functions related to
cellular growth and proliferation (156 genes), as well as cell death (142 genes). A
number of components of the canonical wnt/β catenin pathway known to be critically
involved in controlling self-renewal of the colonic epithelium were present in this list.
Many of the changes observed in biassociated mice are likely to be related to the
increased influx of butyrate, generated by E. rectale, into colonic cells. Butyrate, a
histone deacetylase inhibitor that evokes pronounced transcriptional changes in
different types of cultured epithelial cell line[137,138,139,140], is the preferred energy
substrate for colonic enterocytes[141]. While transcriptional changes caused by
butyrate differ depending upon the cell lineage, state of cellular differentiation, and
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cellular energy status[139,140,142,143] in vitro and in vivo studies have shown that it
affects expression of genes involved in proliferation, differentiation and
apoptosis[137,142].
As mentioned above, as part of its adaptation to the presence of E. rectale, B.
thetaiotaomicron upregulates a number of genes involved in the harvest of host glycans.
Included among these B. thetaiotaomicron genes are components of a fucose utilization
operon linked to the production of a bacterial signal that induces synthesis of intestinal
mucosal fucosylated glycans, and also catabolism of fucose from O-glycans[144].
GeneChip profiling of colonic gene expression disclosed that co-colonization results in
increased expression of Fut2 (α-1,2 fucosyltransferase), Fut4 (α-1,3fucosyltransferase), plus nine other genes involved in the synthesis of mucosal glycans
(glycosphingolipids and O-glycans). By increasing host production of glycans, B.
thetaiotaomicron can benefit itself, and through its metabolic products, E. rectale.
3.3.2.6: E. rectale’s colonization levels and production of butyrate are affected by
host diet - In a final series of experiments, we assessed how E. rectale and B.
thetaiotaomicron were affected by changes in host diet. Groups of age- and gendermatched co-colonized mice were fed one of three diets that varied primarily in their
carbohydrate and fat content: (i) the standard low-fat, plant polysaccharide-rich diet
used for the experiments described above (abbreviated ‘LF/PP’ for low-fat/plant
polysaccharide), (ii) a high-fat, ‘high-sugar’ Western-type diet (abbreviated HF/HS) that
contained sucrose, maltodextrin, corn starch as well as complex polysaccharides
(primarily cellulose) that were not digestible by B. thetaiotaomicron or E. rectale, and (iii)
a control diet that was similar to (ii) except that the fat content was 4-fold lower (‘LF/HS’
for low-fat, high-sugar; n=5 mice per group). Whereas B. thetaiotaomicron’s colonization
levels were similar in all three diets, colonization of E. rectale was significantly reduced
(five-fold) in mice fed either the LF/HS or HF/HS diets (p<0.01, heteroscedastic t-test).
Whole-genome transcriptional profiling of both organisms showed that relative to
the standard polysaccharide-rich chow diet (LF/PP), both the Western style HF/HS diet
and its LF/HS control produced a significant upregulation of B. thetaiotaomicron PULs
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involved in harvesting and degrading host polysaccharides, and a downregulation of
several PULs involved in the degradation of dietary plant polysaccharides. E. rectale’s
response to the HF/HS and LF/HS diets was to downregulate several of its GHs as well
as a number of its sugar transporters. Moreover, levels of butyrate were five-fold lower
in co-colonized mice fed these compared to the standard chow LF/PS diet [0.496
±0.0051 µmol/g wet weight cecal contents; (LF/PP) vs. 0.095±0.002 (HF/HS) vs
0.080±0.008 (LF/HS) (p<0.05 ANOVA)].
These dietary manipulations lend further support to the view that B.
thetaiotaomicron functions in this model two-member human microbiota to process
complex dietary plant polysaccharides and to distribute to the products of digestion to E.
rectale which, in turn, synthesizes butyrate. The response of E. rectale to the HF/HS
and LF/HS diets can be explained by the fact that this Firmicute does not have
predicted GHs and PLs that can process host glycans. In addition, it could not utilize
most of the sugars we tested that are derived from mucosal polysaccharides. Finally,
the host possesses enzymes in its glycobiome that can directly process the simple
sugars present in these two diets. Indeed, human subjects that are fed diets deficient in
complex polysaccharides harbor lower levels of butyrate-producing gut bacteria,
including members of the E. rectale-containing clade[145]. Our simplified gnotobiotic
model of the microbiota underscores the functional implications of diet-associated
changes in the representation of this clade, not only as they relate to the operations of
the microbiota itself but also potentially as they relate to butyrate-mediated changes in
gut epithelial homeostasis.
3.3.3: Proteomic studies of this simplified two-component model of the human
gut microbiome
Model communities such as the one described above, constructed in gnotobiotic mice,
where microbiome gene content is precisely known and transcriptional data are
obtained under conditions where potentially confounding host variables such as diet and
host genotype can be constrained, provide a way to test the efficacy of mass
spectrometric methods for characterizing gut microbial community proteomes.
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Therefore, we assayed luminal contents, collected from the ceca of 8 gnotobiotic mice
fed the standard polysaccharide-rich LF/PP diet: (germ-free, monoassociated, and cocolonized; n=2 mice/treatment group representing two independent biological
experiments).
The measured proteomes had high reproducibility in terms of total number of
proteins observed and spectra matching to each species. A total of ~6,300-21,000
spectra were identified per sample and differ based on inoculations. For a complete list
of the total number of identified spectra, peptides and proteins per sample and run, see
Table 3.2. Interestingly, the total number of identified spectra was, for the most part,
distinct and unique to each bacterial species. Unlike B. thetaiotaomicron and E. rectale,
the number of identified spectra belonging to mouse was redundant: thus, a higher
number of spectra were non-unique spectra. The difference is evident when the total
spectra counts are compared to unique spectra counts only. The total average spectra
count identified in the control (germ-free) mouse was 10,767 for sample 700 and 11,
221 for sample 799. The total average unique spectra count, however, decreased to
4,394 and 4,168. Therefore, the majority of identified mouse peptides are not unique
within the database. The total number of unique spectra counts per species and run
can be found in Table 3.3. The two co-colonized mice (710 and 810) had a total of ~
77% unique spectra belonging to B. thetaiotaomicron, 20% unique spectra belong to E.
rectale, and only 3% of the two species’ combined spectra counts were non-unique.
This suggests that the majority of identified proteins belonging to B. thetaiotaomicron
and E. rectale are true unique identifications and these species can be easily
differentiated by proteomics. These values were calculated by summing the total
number of unique spectra per species per run, followed by an average per species
across all runs (Table 3.3).
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Table 3.2: High resolution proteomic analyses of cecal contents from gnotobiotic mice –
total proteins, peptides, and spectra for each sample.
Sample
700 Run 1
700 Run 2
700 Run 4
705 Run 1
705 Run 2
705 Run 3
710 Run 2
710 Run 3
710 Run 4
715 Run 1
715 Run 2
715 Run 5
799 Run 1
799 Run 2
799 Run 3
806 Run 1
806 Run 2
806 Run 3
810 Run 1
810 Run 2
810 Run 3
817 Run 1
817 Run 2
817 Run 3

	
  

Protein IDs Peptide IDs Spectra

716
702
596
1526
1538
1513
1335
1482
1612
914
894
945
571
471
449
1407
1424
1358
1409
1509
1431
837
791
881

3505
3448
2965
11515
11534
9577
9270
9256
10484
6388
6241
6040
2809
2355
2213
9366
9400
8867
7798
8505
7658
4779
4519
4880

7561
7067
7019
21228
20051
17119
17910
16839
17635
12243
12257
11358
6338
6575
6995
18071
18915
15864
14102
14659
14217
10294
10346
10829

Species Inoculation
None (control)

B. thetaiotaomicron

B. thetaiotaomicron +and+ E. rectale

E. rectale

None (control)

B. thetaiotaomicron

B. thetaiotaomicron +and+ E. rectale

E. rectale

60	
  

Table 3.3: High resolution proteomic analyses of cecal contents from gnotobiotic mice –
breakdown of unique spectral counts for all species in the database for Sample Set 1
and 2.
Sample Set 1
Sample ID:

700 Run1 700 Run2 700 Run4 705 Run1 705 Run2 705 Run3 710 Run2 710 Run 3 710 Run4 715 Run1 715 Run2 715 Run5

B. thetaiotaomicron
E. rectale
M. musculus
Rice
Yeast
contams
Total:

9
36
4591
232
13
40
4921

8
23
4377
254
8
32
4702

6
31
4216
269
13
30
4565

17329
22
2324
171
2
37
19885

16455
15
2122
142
4
33
18771

14149
6
1852
105
5
19
16136

10723
3596
1911
69
9
30
16338

10104
3494
1827
46
4
24
15499

10596
3843
1847
45
16
26
16373

7
6817
3426
121
23
30
10424

23
6790
3438
112
12
35
10410

2
6294
3317
98
8
27
9746

Sample Set 2
Sample ID:
B. thetaiotaomicron
E. rectale
M. musculus
Rice
Yeast
contams
Total:

	
  

799 Run1 799 Run2 799 Run3 806 Run1 806 Run2 806 Run3 810 Run1 810 Run2 810 Run3 817 Run1 817 Run2 817 Run3

0
4
3949
272
14
15
4254

0
1
4250
226
12
13
4502

0
2
4306
243
7
15
4573

14403
6
2318
56
4
5
16792

15034
11
2384
113
0
0
17542

12693
5
1932
34
4
4
14672

9115
1600
2260
62
5
7
13049

9562
1736
2183
114
9
6
13610

8933
1658
2366
107
5
8
13077

4
4749
3582
140
16
3
8494

4
4686
3739
113
11
7
8560

3
5068
3743
135
3
5
8957
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Table 3.4 provides a summary of our analyses, including the percentage of
mRNAs called ‘Present’ in the GeneChip datasets for which there was an identified
protein product. These data suggest that RNA and protein identifications are not always
correlative. While both datasets provide valuable insight into the two microbes function
in the gut, there are differences for which many mRNAs were identified, but were not
present or identified in the final protein product. The most abundant identified products
from both microbes included ribosomal proteins, elongation factors, chaperones, and
proteins involved in energy metabolism. Many conserved hypothetical and pure
hypothetical proteins were identified, as well as 10 genes in B. thetaiotaomicron whose
presence had not been predicted in our initial annotation of the finished genome.
Together, the results provide validation of experimental and computational procedures
used for proteomic assays of a model gut microbiota, and also illustrate some of the
benefits in obtaining this type of information.
Table 3.4: Summary of proteins detected by mass spectrometry of the cecal contents of
gnotobiotic mice.
E.&rectale
B.&thetaiotaomicron
Mono$association Bi$association Total Mono$association Bi$association
Detected&by&MS/MS
661
453
680
1608
1367
Detected&by&GeneChip
2139
2010
2150
3798
3865
GeneChip2/&MS/MS+
7
7
8
40
21
MS/MS2&/GeneChip+& a
1608
1638
1603
2280
2569
a
Positive:is:defined:as:having:a:‘Present’:call:in:≥75%:of:GeneChips.

Total
1687
3995
23
2357

3.4: Prospectus
These studies of a model two component human gut microbiota created in gnotobiotic
mice support a view of the Bacteroidetes, whose genomes contain a disproportionately
large number of glycan-degrading enzymes compared to sequenced Firmicutes, as
responding to increasing diversity by modulating expression of their vast array of
polysaccharide utilization loci. B. thetaiotaomicron responds to the presence of E.
rectale by upregulating a variety of loci specific for host-derived mucin glycans that E.
rectale is unable to utilize. E. rectale, which like other Firmicutes has a more specialized
capacity for glycan degradation, broadly downregulates its available GHs in the
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presence of B. thetaiotaomicron, even though it does not grow efficiently in the absence
of carbohydrates. It also becomes more selective in its harvest of sugars and its
transcriptional profile suggests improved access to other nutrients (e.g. there is a
generalized upregulation of amino acid biosynthetic genes as well as a set of nutrient
transporters that can harvest peptides).
We have previously used gnotobiotic mice to show that the efficiency of
fermentation of dietary polysaccharides to short chain fatty acids by B. thetaiotaomicron
increases in the presence of M. smithii [123]. Co-colonization increases the density of
colonization of the distal gut by both organisms, increases production of formate and
acetate by B. thetaiotaomicron and allows M. smithii to use H2 and formate to produce
methane, thereby preventing the build-up of these fermentation end-products (and
NADH) in the gut bioreactor, and improving the efficiency of carbohydrate
metabolism[123]. Removal of H2 by this methanogenic archaeon allows B.
thetaiotaomicron to regenerate NAD+, which can then be used for glycolysis. This
situation constitutes a mutualism, in which both members show a clear benefit. The
present study, characterizing the co-colonization with B. thetaiotaomicron and E.
rectale, describes a more nuanced interaction where both species colonize to similar
levels if carbohydrate substrates are readily available. Moreover, certain aspects of
bacterial-host mutualism become more apparent with co-colonization, including
increased microbial production and host transport of butyrate, and increased host
production and microbial consumption of mucosal glycans: this mutualism is likely vital
for the co-existence of these species.
It seems likely that as the complexity of the gut community increases,
interactions between B. thetaiotaomicron and E. rectale will either be subsumed or
magnified by other ‘similar’ phylogenetic types (as defined by their 16S rRNA sequence
and/or by their glycobiomes). Synthesizing model human gut microbiotas of increasing
complexity in gnotobiotic mice using sequenced members of our intestinal communities
should be very useful for exploring two ecologic concepts: (i) the neutral theory of
community assembly which posits that most species will share the same general niche
(profession), and thus are likely to be functionally redundant[146], and (ii) the idea that
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both bottom-up selection, where fierce competition between members of the microbiota
drives phylotypes to assume distinct functional roles, and top-down selection, where the
host selects for functional redundancy to insure against failure of bioreactor functions,
operate in our guts.
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Chapter 4
Optimization of a cellular lysis/mass spectrometric proteome characterization
approach for a model 7-member gut microbial community in gnotobiotic mice
Alison R. Erickson, Nathan P. McNulty, Nathan C. VerBerkmoes, Jeffrey I. Gordon, and
Robert L. Hettich
4.1: Introduction
Mass-spectrometry (MS)-based proteomics has become very powerful in providing
comprehensive and unbiased characterization of proteins and proteomes. With the
onset of multidimensional protein separations interfaced to high-performance tandem
mass spectrometry, this experimental approach can handle substantial protein or
peptide complexity and simultaneously achieve protein identification[95]. However, the
complexity and ‘dynamic range’ of microbial proteomes containing thousands of
bacterial species have hindered the ability to identify whole community proteomes, as
compared to traditional single bacterial isolates (e.g., E. coli).
The ‘standard’ shotgun proteomics strategy includes cellular lysis (with or without
fractionation), protein denaturation and digestion, peptide separation via LC and
identification via tandem mass spectrometry (MS/MS). While much optimization has
been invested in LC-MS/MS, experimental methods involving sample preparation (i.e.,
cellular fractionation and lysis), peptide separation (i.e., gel electrophoresis and LC),
and MS/MS are equally important to enhance overall protein identifications in MS-based
shotgun proteomics of complex microbial samples (i.e., soil, ocean, feces).
Environmental microbial samples pose several challenges not characteristic of
laboratory –based systems, such as increased dynamic range (abundance) of microbial
species and proteins, and interferences derived from the environmental matrix. In
general, there are two options available where a microbial community sample is either i)
derived, processed, and lysed directly (in situ) from the source (i.e., feces, cecum,
tissue) with both bacterial and host cells included (‘direct approach’) or ii) enriched for
bacterial cells to eliminate all host proteins and contaminants via centrifugation
(‘indirect’ approach). Environmental matrices can be problematic for the ‘direct’ lysis
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and protein extraction approach[89] without any pre-fractionation or enrichment (i.e.,
differential centrifugation) of bacterial cells due to inference with downstream processes
and analysis (i.e., peptide signal suppression)[74]. Widely accepted protocols for cell
lysis and extraction of proteins from complex microbial communities for proteomic
analysis include a thermally assisted detergent-based cellular lysis (sodium dodecyl
sulfate, SDS) method[74], a small-scale microbial biomass experimental approach[86],
sonication[87,88], freeze-thaw cycles[89], and French press[60]. Available and tested
lysis buffers include detergents (e.g., SDS, CHAPS, and Triton X-100), chaotropes
(urea and guanidine), acid-labile surfactants (PPS silent surfactant) and many other
commercially available buffers to disrupt bacterial cells with or without physical or
mechanical disruption prior to protein extraction. Several precautions should be taken if
a detergent is selected due to their interference with binding, elution, and ionization of
peptides during tandem MS experiments. To eliminate contamination and interference
of detergents with mass spectrometers, several proteomics studies[26,42,43,86] opted
to use an ‘indirect’ approach and chaotropes (i.e., guanidine) to enrich and lyse
bacterial cells and denature proteins. In this study, we focused on comparing methods
that are used prior to proteolysis and LC-MS/MS with emphasis on identifying an
efficient in situ lysis and protein extraction method.
Due to the growing interest and desire to understand the human
microbiome[14,69], MS-based proteomics has begun to emerge as a key player in
understanding the functional signatures of the human gut and oral
microbiome[26,37,47,48,49,83]. Therefore, to achieve comprehensive proteome
coverage of samples collected from the human gut microbiota, optimization of
experimental MS-based methods for their direct application to complex community
samples (i.e., feces or ceca) would help increase protein identification and our
understanding of the host-microbiota functional signatures. A variety of methods
including one protein fractionation (ultracentrifugation) method, five bacterial lysis
methods, and protein (TCA) precipitation were evaluated to identify the best performing
method for MS-based analysis of human-derived gut microbiota in germ-free
(gnotobiotic) mice (Figure 4.1). A model human gut microbiota of seven bacterial
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species (B. WH2, B. ovatus, B. vulgatus, B. thetaiotaomicron, B. caccae, and
Parabacteroides distasonis) belonging to one of two dominant gut phyla, Bacteroides,
was inoculated in gnotobiotic mice to measure the proteomes of the microbial
community, in addition to each individual species. The method that provided the most
efficient lysis and higher peptide recovery, thus, increased protein identification would
be identified as the best overall performing method that could be applied in situ to any
future fecal or cecal samples.
1mL$cecal$material$containing$tubes$labeled:$$
2,$3,$7,$8,$9,$10$$
Part$1:$
Determine$Best$Lysis$
Method$

Freeze/Thaw$
#$3$

SonicaCon$
#$8$

HomogenizaConD$
Bead$BeaCng$
#$2$and$7$

Guanidine/Heat$ SDS/SonicaCon/Urea$
#$9$
#$10$

Part$2:$
Determine$whether$
FracConaCon$helps$

1. Preferred Lysis Method
2. Fractionation (# 7 only)

Part$3:$
Determine$whether$protein$
precipitaCon$helps$with$eliminaCng$
these$viscous$polysaccharides$&$
interfering$compounds$$

1. Preferred Lysis Method
2. Fractionation
3. Protein Precipitation (# 7 only)

Figure 4.1. Experimental design for method optimization of microbial and host cell lysis
and protein extraction of a model human-derived gut microbial community in gnotobiotic
mice.
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4.2: Experimental Methods
4.2.1: Sample collection
Dr. Jeffrey Gordon and Nate McNulty (Wash. Univ) provided a total of six ceca samples
for the 7-member community proteomics experiments. The C57BL/6 adult male germfree mouse cecum, labeled as either 2, 3, 7, 8, 9 and 10, were gavaged with an equal
inoculum of the following species: Bacteroides caccae, B. ovatus, B. uniformis, B. WH2,
B. thetaiotaomicron, B. vulgatus, and Parabacteroides distasonis and fed a standard BK
diet ab libitum. The total microbial does was ~ 8.7 x 107 corresponding to 1.2-1.3x107
CFUs/microbe. The cecum was harvested at 14 days post-gavage, frozen in liquid
nitrogen immediately, and shipped overnight on dry ice to ORNL.
4.2.2: Bacterial lysis and protein extraction
A total of five bacterial lysis methods were each performed on single mouse cecum (~1
mL). As described in Figure 4.1, the following widely-accepted bacterial lysis methods
were applied and varied with respect to each of their individual protocols: sonication (8),
freeze-thaw cycles (3), bead-beating (2 and 7), no physical disruption (9), and chemical
disruption via sodium dodecyl sulfate (SDS) (10) with a brief description of the protocols
to follow. Cecum 2 (bead-beating) was first solubilized with 1mL 6M guanidine in 0.1
mm zirconia/silica beads and beat using a RETSCH Mixer Mill MM 400 for a total of 2
minutes (30 second intervals with 2 minute break) at room temperature with a frequency
of 20Hz. The homogenized cecum was centrifuged for 5 minutes at 3,000 rpm to
remove excess debris and pellet all beads. The supernatant was removed and beads
washed with 6M Guanidine.
Cecum 7 (bead-beating) was treated using the same steps described above for
cecum 2; however, the cecum was solubilized in 50mM Tris/10mM CaCl2 instead of 6M
guanidine to allow for proper cell separation via ultracentrifugation. Following
homogenization, the collected supernatant was transferred to a glass test tube and
centrifuged at room temperature for 1 hour at 100,000x g using a Ti 40 fixed angle rotor
ultracentrifuge (Beckman Coulter). The supernatant (soluble fraction) was extracted
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away from the pellet (membrane fraction) and treated separately for protein
denaturation and digestion.
Cecum 3 (freeze-thaw lysis method) was initially frozen in liquid N2 for 1 minute
followed by 60°C treatment in a water for 1 minute and repeated for a total of three
cycles.
Cecum 8 (sonication only method) was initially solubilized in 6M Guanidine and
exposed to sonication for a total 5 minutes at 20% amplitude on ice.
Cecum 9 (no physical or chemical disruption) wa processed via single tube cell
lysis[86] and protein digestion. The cecum (~1mL) was suspended in 6M
Guanidine/10mM DTT at 60°C for 1 hour to lyse cells and denature proteins.
Lastly, cecum 10 was solubilized in 1mL SDS lysis buffer (4% w/v SDS, 100mM
Tris•HCl, pH 8.0, 10mM dithiothreitol (DTT)) and lysed mechanically by sonication
followed by incubation for 5 minutes at 95°C. Cells were centrifuged at 21,000 x g.
Following an overnight tricholoroacetic acid (TCA) precipitation, the TCA precipitates
(protein mixtures) were resolubilized in 500uL of 8M urea, 100mM Tris•HCl, pH 8.0, and
reduced by incubation at a final concentration of 10mM DTT for 1 hr at room
temperature. Samples were sonicated and an aliquot taken to determine the protein
concentration using a bicinchonic acid-(BCA) based protein assay kit (Pierce).
Approximately 3mg of protein was extracted were diluted with 100mM Tris•HCl, 10mM
CaCl2, pH 8.0 to a final urea concentration below 4M. Proteolytic digestions were
initiated with sequencing grade trypsin (1/100, w/w; Promega) overnight at room
temperature. A second aliquot of trypsin was added (1/100) and diluted with 100mM
Tris•HCl, pH 8.0 to a final urea concentration below 2M. Following a 4 hr incubation at
room temperature, samples were reduced to a final concentration of 10mM DTT. The
peptides were acidified (protonated) in 200mM NaCl, 0.1% formic acid, filtered, and
concentrated with a 10k molecular weight cutoff spin column (Sartorius). A total of
~100mg of peptides were used for each LC-MS/MS experiment.
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For ceca 3, 8, and 9 the lysed cecum (~1mL) was centrifuged at room
temperature for 10 minutes at 3,000 rpm to pellet all debris and any small contaminating
molecules. An aliquot was taken from all six ceca to determine the protein
concentration using a BCA (Pierce). A total concentration of 3mg protein was extracted
for protein denaturation in 6M Guanidine and proteolytic digestions as follow. For ceca
2, 3, 7, 8, and 9 protein extractions, the guanidine concentration was diluted from 6M to
1M with 50mM Tris buffer/10mM CaCl2 and proteolytic digestions initiated with
sequencing grade trypsin (1/100, w/w; Promega) overnight at 37°C to digest proteins
into peptides. A second aliquot of trypsin was added (1/100) and incubated for 4 hours
at room temperature. Samples were reduced to a final concentration of 10mM DTT.
The complex peptide solution was desalted via C18 solid phase extraction, concentrated
and filtered (0.45um filter). For each LC-MS/MS analyses below, ~100mg of the total
peptide sample was used for LC-MS/MS.
4.2.3: LC-MS/MS analysis
Peptides were loaded onto a two-dimensional (C18 and SCX) 15cm length column
packed in-house and separated with a 12 step, multidimensional high-pressure liquid
chromatographic elution method using an Ultimate HPLC system (Dionex, Sunnyvale,
CA) consisting of eleven salt pulses followed by a 2 hr reverse-phase gradient from
100% solvent A (A: 95% H2O, 5% acetonitrile, 0.1% formic acid) to 50% solvent B (B:
30% H2O, 70% acetonitrile, 0.1% formic acid). The HPLC system was coupled on-line
with an LTQ-Orbitrap XL (Thermo Fischer Scientific) via the Proxeon nanospray source.
Full MS scans were acquired in the Orbitrap mass analyzer (from 400-1700 m/z) with
resolution 30,000 followed by five data dependent tandem MS/MS scans in the LTQ
with normalized collision energy of 35%. For all sequencing events, dynamic exclusion
was enabled.
4.2.4: Data analyses and informatics
All MS/MS spectra were searched with the SEQUEST v 0.27 algorithm[66] and filtered
with DTASelect/Contrast[98] at the peptide level [Xcorrs of at least 1.8 (+1), 2.5 (+2),
3.5 (+3)] with a deltCN 0.08. Only proteins identified with two fully tryptic peptides from
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the 22 hr runs were considered for further biological inference. Tandem MS/MS spectra
were searched against a protein sequence database (Table 4.1) containing the 7
relevant Bacteroides species (B. WH2, B. ovatus, B. vulgatus, B. thetaiotaomicron, B.
caccae, and Parabacteroides distasonis) in addition to 8 distractor (non-relevant)
species, the host (mouse) genome, diet components (rice and yeast), and common
contaminants.
Table 4.1: Protein sequence database composition for the 7-member database
searches. Bolded genome names are relevant microbes that were gavaged in the
gnotobiotic mice.
Genome
Bacteroides caccae
Bacteroides ovatus
Bacteroides thetaiotaomicron
Bacteroides uniformis
Bacteroides vulgatus
Bacteroides WH2
Collinsella aerofaciens
Clostridium scindens
Clostridium spiroforme
Dorea longicatena
Eubacterium rectale
Faecalibacterium prausnitzii_M212
Parabacteroides distasonis
Ruminococcus obeum
Ruminococcus torques
Mouse
Yeast
Rice
Common contams

	
  

Proteins Size (MB)
3855
1.772
5536
2.536
4778
2.376
4663
1.952
4065
1.932
5244
2.656
2367
0.996
3995
1.528
2465
1.016
2970
1.18
3631
1.42
3493
1.368
3850
1.86
4175
1.536
2875
1.124
34966
19.2
6345
3.33
66710
36
36
0.02
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4.3: Results and Discussion
4.3.1: General MS-based proteome metrics
As first demonstrated in chapter 3, MS-based proteomics for the human gut microbiome
in gnotobiotic mice has proven successful and applicable to in vivo gut-derived
ecosystems[37]. However, with increasing complexity and diversity of the microbial
community(s) membership, traditional up-front sample processing methods were
evaluated and optimized for increased depth and coverage of proteomes derived in situ
from cecum. All MS experiments were performed in duplicate for each method and
demonstrated high technical reproducibility, with an R2 ≥ 0.9184 for all six ceca
samples. Using general MS-based proteomics metrics (i.e., assigned spectra and
protein identifications), a comparison of all six samples and methods suggest that
fractionation via ultracentrifugation and protein precipitation (TCA) of the soluble fraction
provided the greatest identification of non-redundant spectra, peptides and proteins
(Table 4.2). Thus, the approach used for the ‘soluble fraction’ significantly improved
the quantity of protein and peptide identifications with a 2.72X gain in protein
identifications from, on average, 411 to 1,118 proteins and 2.925X gain in peptide
identifications from, on average, 1,907 to 5,578 peptides per run. Therefore, from this
point on, we will only focus on using the protein precipitated soluble fraction to represent
the soluble fraction of sample and method #7.

	
  

72	
  

Table 4.2: Proteome sample metrics of total non-redundant protein, peptide and spectra
counts per method.
Sample
7 (membrane)

7 (soluble)

10
8
3
2
9

Run Proteins Peptides Spectra PPMs (%)
1
2
4
5
1
2
1
2
1
2
1
2
3
4
2
3

3159
3149
1188
1047
424
398
3204
2931
2207
2079
2062
2178
1826
1834
1832
1728

11675
11607
5961
5194
1935
1879
11162
9986
6874
6422
6470
6845
5416
5448
5908
5573

23901
23338
14789
13220
10331
10709
20265
21976
16730
17107
16641
16467
11951
11380
13404
14175

86.88
86.99
88.91
88.94
87.7
88.6
89.51
89.63
85.6
85.79
85.45
86.29
86.55
87.43
85.57
86.88

Method
Bead-beating; Ultracentrifugation;
Guanidine
Bead-beating; Ultracentrifugation; TCA;
Guanidine
Bead-beating, Ultracentrifugation;
Guanidine
Boiling SDS; TCA; Urea
Sonication, Guanidine
Freeze-Thaw, Guanidine
Bead-beating, Guanidine
Guanidine only

The results found in Table 4.2 demonstrate that method #7, ultracentrifugation
and protein precipitation performed the best based on overall MS-based metrics with a
total sum of, on average, 4,272 proteins (3,154 membrane and 1,118 soluble proteins
per run). However, these numbers can be misleading due to insufficient fraction purity
and degree of protein overlap between the two fractions. As described further below
(Figure 4.2), a total of 3,118 and 521 proteins are unique to the membrane and soluble
(protein precipitation) fractions, respectively, with 1,248 shared proteins for a total of
4,887 non-redundant proteins. Although method #7 (ultracentrifugation) significantly
out-performs method #2 (without ultracentrifugation) and all other methods, a gain of
only 521 proteins were uniquely identified from the soluble TCA fraction. Following
closely is the second best performing lysis method #10 with, on average, 3,068
proteins, 10,574 peptides, and 21,121 spectra per run. Of the physical disruption
techniques (methods 2, 3 and 8), 8 and 3 (sonication and freeze-thaw, respectively)
performed the best followed by #9 and #2 (guanidine only and bead-beating,
respectively) which provided the least assigned spectra, peptide and protein
identifications. Because an equal quantity of tandem MS/MS spectra were acquired for
each method and MS run, the variation in assigned spectra is not a reflection of the
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technical (mass spectrometer) variability, but rather a reflection of the lysis and protein
extraction method.

Figure 4.2: A comparison of identified proteins that are shared (1,248) between and
unique to the membrane (left circle; 3,118 proteins) and soluble (TCA; right circle; 521
proteins) fractions for method 7 only. A total of 4,366 and 1,769 non-redundant proteins
were indentified in the membrane and soluble (TCA) fraction, respectively.
4.3.2: Protein-level comparison
A four-way protein comparison of methods: 2 (bead-beating), 3 (freeze-thaw), 8
(sonication), and 9 (no physical disruption) identified 1,972 shared proteins (~61-73% of
all protein identifications) across all four methods, with 6-9% of all identified proteins
unique to only one method (Figure 4.3). A three-way protein comparison of methods
containing physical disruption only (2, 3, and 8) identified 2,292 shared proteins (81%,
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73%, and 71%, respectively, of all identified proteins) (Figure 4.4). These two
comparisons suggest that the methods 2, 3, 8, and 9 do not vary significantly from one
another, since the majority of identified proteins are similar in one or more methods (i.e.,
only 6-9% of all identified proteins are unique to a single method). On the other hand,
these methods (with and without physical disruption) vary significantly from a method
that uses a combination of chemical lysis (SDS) and physical disruption (sonication)
simultaneously to lyse microbial and host cells, where only ≤ 48% of all identified
proteins are shared with methods 2, 3, 8, and 9 and ≥ 30% are unique to method 10
only (data not shown).

Figure 4.3: A four-way comparison of identified proteins from four different methods: 2
(bead-beating), 3 (freeze-thaw), 8 (sonication), and 9 (no physical disruption).

	
  

75	
  

Figure 4.4: A three-way comparison of identified proteins from three methods
containing physical disruption only (2, 3, and 8).
For method 7, on average, 3,154 proteins were identified in the membrane
fraction per run (Table 4.1) with a total of 4,366 non-redundant proteins across both
runs. On the other hand, an average of 1,118 and 411 proteins were identified per run
for the soluble fraction with and without protein precipitation, respectively, for a total of
1,769 and 676 non-redundant identified proteins. As mentioned previously, a
comparison of both fractions from method 7 indicated that 3,118 proteins were uniquely
identified in the membrane fraction, as compared to 521 in the soluble fraction, with
1,248 proteins shared between the two fractions. Therefore, a total of 4,887 proteins
were identified for method 7 (both membrane and soluble TCA fraction shared and
unique proteins summed).
Based on total spectra, peptides, and proteins identified, method # 7 (with protein
precipitation) is the best overall performing method, with a total of 4,887 non-redundant
proteins, followed by method # 10 with 4,495 non-redundant proteins. Of all proteins
identified, a two-way comparison of methods 7 and 10 indicate that 3,506 proteins are
shared (72 and 78% of all identified proteins, respectively) with 1,381 and 989 proteins
unique to methods 7 (28%) and 10 (22%), respectively (Figure 4.5). While a significant
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portion of identified proteins were found using both methods, method # 7 had ~40%
more unique proteins relative to method 10. Although method # 7 has out-performed
the other four lysis methods, we wanted to determine whether any potential biases
existed on a functional level as a result of each lysis and extraction method. Functional
comparisons will be explored in more detail below.

Figure 4.5: A comparison of identified proteins that are shared (3,506 proteins) between
and unique to method 7 (membrane and soluble fractions combined; left circle) and 10
(right circle).
4.3.3: Comparison of methods based on protein-species assignments
Due to the differences in lysis methods (i.e., chemical or physical), we wanted to
evaluate whether any of the methods were biased and preferentially lyse one or more
specific bacterial species within the 7-member consortium. For example, does any
method preferentially lyse one particular species better than another or enrich for
proteins with specific functional roles, such as outer membrane receptor proteins? A
comparison of identified protein counts per species (Figure 4.6) suggested that the
majority of proteins were derived from B. WH2 and B. thetaiotaomicron for all methods,
with the exception of method 9 (guanidine only) and the soluble fractions (# 7).
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Contrary to the majority of methods, B. thetaiotaomicron was one of the least abundant
microbes in method # 9. These results may suggest that additional chemical (SDS)
and/or physical (i.e., sonication) disruption is necessary for the complete lysis of all
Bacteroides. Interestingly, M. musculus was the most abundant contributor based on
protein counts followed by B. WH2 in both soluble fractions contrary to the membrane
fraction for method 7.
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Figure 4.6: Distribution of identified protein counts for all relelvant database
components (microbial and host) for all 7 cecal samples.
Due to protein sequence redundancy between the seven-closely related
Bacteroides phylotypes, a similar comparison was performed with only unique peptides
(Figure 4.7) and total spectra counts (Figure 4.8) to determine whether similar trends
were observed. The distribution of unique peptides also suggest that B. WH2 and B.
thetaiotaomicron are the most abundant microbial species for all methods, including
method 9 (guanidine only), with the exception of both soluble fractions (# 7). In
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agreement with the protein count distribution, M. musculus was the most abundant
based on unique peptide and spectra counts, followed by B. WH2 for both soluble
fractions. While the spectra counts distribution agrees with the protein and unique
peptide distribution, slightly more spectra were assigned to B. thetaiotaomicron relative
to B. WH2 for the majority of methods (exception are the soluble fractions).
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Figure 4.7: Distribution of unique peptide counts for all relevant database components
(microbial and host) for all 7 cecal samples.
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Figure 4.8: Distribution of total assigned spectra counts for all relevant database
components (microbial and host) for all 7 cecal samples.
Why the soluble fractions contain significantly more host-related (M. musculus)
proteins, peptides, and assigned spectra relative to the membrane fraction and other
methods (Figure 4.6-4.8) is unclear. Although the unique peptide and protein counts
agree with the majority of identifications belonging to B. WH2 and B. thetaiotaomicron
for most of the methods, we have yet to determine why these two microbes dominate
the community proteome relative to the other five species belonging to Bacteroides. It
may be that B. WH2 and B. thetaiotaomicron contain significantly more ‘unique’
peptides in the genome (predicted proteome) relative to the other microbes; hence,
more unique peptides were identified for these two species. Alternatively, there may be
a biological (non-technical) difference between these two species relative to the other
members of the consortium. To assess whether a subset of proteins related to a
specific function are enriched in one method compared to the others, we classified the
identified proteins in Clusters of Orthologous Groups (COGs). Figure 4.9 indicated that
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we are not enriching for specific functional subsets of proteins with any particular
method. However, proteins classified with functions related to translation and metabolic
pathways commonly involved in the gastrointestinal tract were highly abundant across
all six methods. Therefore, while differences are evident between the types of COGs
present in the proteomes, there are insignificant biases in the methods’ enriching for
specific functional groups of proteins. Although method # 7 identified more proteins
relative to the other five methods, Figure 4.10 (A and B) suggests that methods 7 and
10 provide very similar results in terms of identified protein COGs. In conclusion, while
method # 7 has the overall best performance for proteome identification relative to the
other methods, method 10 may be equally sufficient in the in situ lysis of microbial
communities derived from the cecum of mice, with the advantage of less sample
handling, fewer surface exposures, less time-consuming, and does not require
additional expensive instrumentation (i.e., ultracentrifuge).
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Figure 4.9: COG classification of all identified proteins for all cecal samples.
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Figure 4.10: Distribution of identified proteins for (A) method 7 (membrane and soluble
TCA fraction combined) and (B) compared to method 10 based on COG categories.
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Figure 4.10 (B)
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4.4: Conclusions
The method that demonstrated the greatest performance for the lysis and extraction of
microbial and host (mouse) proteins from a model 7-member human microbial gut
community is bead-beating homogenization, ultracentrifugation, and protein
precipitation of the soluble fraction with a total of 4,887 non-redundant proteins.
Although this method performed the best based on overall MS-based proteome metrics,
the soluble fraction (TCA) only contributed 521 unique proteins. Method #10 (lysis via
SDS solubuilization and sonication) followed closely with a total of 4,495 non-redundant
proteins and may be more successful for some research groups whom do not have
access to an ultracentrifuge.
Based on the host and microbial protein, unique peptide, and spectra count
distributions per species, the abundance-levels were not evenly distributed among all
seven phylotypes of Bacteroides and the host, but rather skewed with a higher
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abundance of B. WH2 and B. thetaiotaomicron in all six methods with the exception of
the soluble fraction in method 7. We believe that this is not a reflection of technical or
instrumental variation, but is a result of the microbial community dynamics and
functional signature differences because the abundance-level trends are very similar
across all lysis and protein extraction methods. A classification of all microbial proteins
by general function (e.g., COG) suggests that all six methods provide very similar
functional trends with translation and metabolic pathways highly abundant across all
methods. Therefore, the five different methods described in this study are not biased
and do not preferentially lyse one species or functional group (COG) more efficiently
relative to others within the 7-member consortium.
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Chapter 5
Temporal profiling of a defined 12-member human gut microbial community in
gnotobiotic mice in response to changing diets
Alison R. Erickson, Nathan P. McNulty, Nathan C. VerBerkmoes, Jeffrey I. Gordon,
Robert L. Hettich
5.1: Introduction
The human gut microbiome is host to a large population of microbes that heavily rely
upon the host (human) and diet for maintenance and growth. It is the microbial
inhabitants that shape the establishment, diversity, and stability of the host-associated
microbial community. While the phylogenetic composition and membership differs
between human individuals[62], [112], gut microbiomes are functionally very
similar[112]. Although host genetics accounts for a small fraction of the variation
observed between human individuals[147] and mice[148], studies have indicated that
environmental conditions (e.g., diet) and stochastic factors affect the relative
abundances of microbes in the gut community of both humans and
mice[149,150,151,152]. As our diets have evolved over time, from a starch-rich diet to
high-starch plant and dairy foods)[153], the host and gut microbiota subsequently
adapted by competing for dietary substrates. For example, the modern Western diet,
low in complex carbohydrates but high in simple sugars and fat, has shown a relatively
higher abundance of Firmicutes[131,154] relative to other phyla. As a result, the host
selects for simple carbohydrates while the microbes consume and degrade complex
polysaccharides (e.g., starch). To understand the interrelationship between the host-gut
microbiota and diet, studies have focused on using gnotobiotic mice inoculated with a
defined quantity of sequenced human gut bacteria and monitored their response to diet
perturbations[155].
We have demonstrated effective proteomic methods for binary microbial
communities and optimized the MS-based sample preparation methodology such that
we are ready to scale up to more complex, interactive systems. Here, we used high
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resolution MS-based proteomics to evaluate the functional differences and estimate the
relative abundance of closely-related species within a defined microbial community in
gnotobiotic mice in response to diet perturbations. An in vivo model microbial
community was designed at Wash. Univ. to represent the diversity in the human gut and
was comprised of 12 human gut-derived phylotypes belonging to the Firmicutes,
Bacteroidetes, and Actinobacteria. The microbial consortium consisted of the same
seven phylotypes used in the 7-member consortium (Bacteroides caccae, B. ovatus, B.
uniformis, B. WH2, B. thetaiotaomicron, B. vulgatus, and Parabacteroides distasonis) in
addition to four Firmicutes (Dorea longicatenta, Ruminococcus obeum, Clostridium
spiroforme, and C. scindens) and one Actinobacteria (Collinsella aerofaciens). The
gnotobioic mice and their 12-member consortium were exposed to two diet oscillation
perturbations for which several mice initially consumed a high fat and simple sugar diet
(‘western’ diet) and others consumed a standard BK diet. Expression profiling of the 12member endpoint communities was performed using transcriptomics and MS-based
proteomics to explore community robustness and system-wide microbial responses in
the context of dietary disturbances. We wanted to gain insight into the communities’
establishment, assembly, and adaption prior to and after a change in diet (Figure 5.1).
Additionally, we wanted to investigate to what extent we can characterize the function of
entire defined communities with significant dynamic range between species at the level
of both transcription and protein expression.
There are several challenges associated with the 12-member consortium, (i) the
Actinobacteria and Firmicutes are not as abundant as the Bacteroides in these samples
(0.5-2.0% of the community), which complicates the ability to achieve complete
proteome coverage of the lesser abundant species and (ii) an increased number of
degenerate peptides (peptides that match to multiple proteins due to sequence overlap)
and protein redundancy. The GeneChip expression data was also used to compare the
protein abundance data to determine how well these methodologies agree and disagree
in their revelation of the microbiotas’ functional signature and differences in response to
diet.
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A challenge in mass spectrometry-based proteomics is the ability to accurately
assign a PSM to the protein from which it originated. When studying microbial
communities, this assignment is complicated by homology between proteins of different
microbial strains/species. In several environmental communities, the majority of
identified PSMs are non-unique, and spectral counting may not be sufficient to estimate
a protein’s abundance and concomitant phylogenetic origin. Thus, with increasing
complexity and microbial composition, differentiation of closely-related species
compared to species that are more evolutionarily divergent becomes challenging for
mass spectrometry. Although proteomics is not the preferred method to evaluate the
abundance of species or to differentiate between species, the use of either unique
peptide counts or total spectra counts with the total number of identified proteins (per
species) have been evaluated for their ability to differentiate and estimate the relative
abundance of each species on a proteome level.
5.2: Experimental Methods
Adult germ-free mice were gavaged with: Bacteroides thetaiotaomicron, B. caccae, B.
ovatus, B. uniformis, B. vulgatus, B. WH2, Parabacteroides distasonis, Clostridium
scindens, C. spiroforme, Ruminococcus obeum, Dorea longicatena, and Collinsella
aerofaciens. Proteins were extracted from the cecum of four gnotobiotic mice fed a diet
rich in plant polysaccharides (BK diet) or a ‘Western’ diet high in fat and sugars.
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Figure 5.1: Experimental setup and example of sample collection timepoints for hostmicrobial community diet oscillations. Fecal and cecal collections were used for
GeneChip expression experiments. Cecal collections were also used for MS
experiments.
5.2.1: Sample preparation
Cecal contents were collected from four mice and analyzed via nano-2D (strong cation
exchange – reverse phase)-LC-MS/MS on a hybrid LTQ – Orbitrap Velos mass
spectrometer (Thermo Fisher Scientific). Cecal contents were solubilized in 1mL SDS
lysis buffer (4% w/v SDS, 100mM Tris•HCl, pH 8.0, 10mM dithiothreitol (DTT)) and
lysed mechanically by sonication followed by incubation for 5min at 95°C. Cells were
centrifuged at 21,000xg. Following an overnight tricholoacetic acid (TCA) precipitation,
the TCA precipitates (protein mixtures) were resolubilized in 500uL of 8M urea, 100mM
Tris•HCl, pH 8.0, and reduced by incubation at a final concentration of 10mM DTT for 1
hr at room temperature. Samples were sonicated and an aliquot taken to determine the
protein concentration using the widely available bicinchonic acid-(BCA) based protein
	
  

88	
  

assay kit (Pierce). Samples were diluted with 100mM Tris•HCl, 10mM CaCl2, pH 8.0 to
a final urea concentration below 4M. Proteolytic digestions were initiated with
sequencing grade trypsin (1/100, w/w; Promega) overnight at room temperature. A
second aliquot of trypsin was added (1/100) and diluted with 100mM Tris•HCl, pH 8.0 to
a final urea concentration below 2M. Following a 4 hr incubation at room temperature,
samples were reduced to a final concentration of 10mM DTT. The peptides were
acidified (protonated) in 200mM NaCl, 0.1% formic acid, filtered, and concentrated with
a 10k molecular weight cutoff spin column (Sartorius).
5.2.2: LC-MS/MS data collection and analyses
Peptide mixtures were desalted and separated utilizing a split phase 2D-LC column
(SCX-C18) over a 12-step gradient with 22 hr runs per sample. All MS analyses were
performed in positive ion mode. One full MS scan was acquired in the Orbitrap Velos at
30K resolution followed by ten data-dependent MS/MS scans (m/z 400-1700) at 35%
normalized collision energy with dynamic exclusion enabled at 1. The data was
searched using SEQUEST against a database containing the following predicted
proteomes to be encoded by the genomes of the 12-member community: Bacteroides
caccae, B. ovatus, B. thetaiotaomicron, B. uniformis, B. vulgatus, B. WH2, Clostridium
scindens, C. spiroforme, Collinsella aerofaciens, Dorea longicatena, Parabacteroides
distasonis, and Ruminococcus obeum in addition to potential food components (e.g.,
rice and yeast) and common contaminants (e.g., keratins). Additionally, Eubacterium
rectale, Faecalibacterium prausnitzii M212 and R. torques were included as distractors
that were not expected to be present. The SEQUEST settings were the following:
enzyme type, trypsin; parent mass tolerance, 3.0; fragment mass tolerance, 0.5; up to 4
missed cleavages, and fully tryptic peptides only. All datasets were filtered with
DTASelect, parameters included: Xcorrs of 1.8, 2.5, and 3.5 for singly, doubly, and triply
charged precursor ions, minimum deltCN of 0.08, and a minimum requirement of two
fully tryptic peptides per protein. An in silico tryptic digested protein sequence database
was used to generate a theoretical peptidome of unique peptides within a mass range of
600-4,890Da and ≤1 miscleavages.
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Spectral normalization by community and individual species was generated with
the help of Chongle Pan in which the p value is calculated using the Mann–Whitney U
test (non-parametric version of t test). The spectral count difference is the difference
between the median spectral counts of the two diets. A protein is labeled as "UP"
regulated if the p value is less than 0.05 and the spectral count different is greater than
5 and equally for proteins are labeled as "DOWN.”
5.3: Results and Discussion
5.3.1: Overview of proteome metrics
The proteomes displayed high technical reproducibility in terms of total number of
assigned spectra per mouse with an R2 ≥ 0.9883 for all four mice. The BK-fed mice
proteomes were highly correlated with an R2 of 0.9059 for mouse 1 and 2, as compared
to the Western-fed mice with R2 0.7815 for mouse 9 and 12. This would suggest that
the variation in the western fed mice is a reflection of biological variability and is not a
result of technical deviation (i.e., mass spectrometer and HPLC effects). On average, a
total of 4,827 and 3,251 proteins were identified for the BK diet and Western diet,
respectively (Table 5.1). Of all proteins identified in the BK-fed mice, 4,220 proteins
were found across both mice (1 and 2) and all four MS runs. Of all identified proteins in
the Western-fed mice, ~2,658 proteins were identified across both mice (9 and 12) and
all four MS runs. However, when both diets are directly compared, only ~1,824
microbial and host proteins were identified across both diets where 2,322 proteins were
unique to the BK diet and 805 proteins unique to the western diet (Figure 5.2). Upon
accumulation of all identified proteins from both diets and all MS runs, ~2-20% of each
species’ genome was identified (Table 5.2) with the majority of proteins identified from
B. WH2 (20%) and the least from C. spiroforme (2%). Although the phylotypes
belonging to Bacteroides collectively had higher proteome coverage in terms of nonredundant protein identifications (>11%) compared to the Firmicutes and Actinobacteria
in this study (<8%), the range of abundance varies between the two different diets.
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Table 5.1: Overall MS metrics for the BK and western diet fed mice.

Figure 5.2: Comparison of shared and unique microbial and host identified proteins
across both diets with proteins unique to the BK diet (left; 2,322 proteins), shared
proteins (center; 1,824 proteins) and proteins unique to the Western diet (right; 805
proteins).
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Table 5.2: Relevant database components and % of each species’ genome identified via MS-based proteomics.

Relevant.Database.Components
Genome

Acroynmn Predicted.Proteins Identified.Proteins

Bacteroides+caccae
Bacteroides+ovatus
Bacteroides+thetaiotaomicron
Bacteroides+uniformis
Bacteroides+vulgatus
Bacteroides+WH2
Clostridium+scindens
Clostridium+spiroforme
Collinsella+aerofaciens
Dorea+longicatena
Parabacteroides+distasonis
Ruminococcus+obeum
Mus+musculus

BACCAC
BACOVA
BACTHE
BACUNI
BACVUL
BACWH2
CLOSCI
CLOSPI
COLAER
DORLON
PARDIS
RUMOBE
Mus

	
  

Community<wide.analysis.and.significantly.differential.proteins.with.preference.for.one.diet
BK.fed.mice
Western.diet.fed.mice

Total.Protein.Identifcations

3855
5536
4778
4663
4065
5244
3995
2465
2367
2970
3850
4175
34966

669
693
722
563
783
1025
220
39
154
114
414
325
881

%.of.Predicted.
Proteins.identified. Proteins.identified. #.of.statistically.
%.of.Total.Identified. %.of.Total.BK<Identified.
#.of.statistically.
%.of.Total.Identified. %.of.Total.Western<Identified.
Proteome.Identified
in.BK.diet
in.Western.diet differential.proteins Proteome.per.Species Proteome.per.Species differential.proteins Proteome.per.Species
Proteome.per.Species
17.35%
12.52%
15.11%
12.07%
19.26%
19.55%
5.51%
1.58%
6.51%
3.84%
10.75%
7.78%
2.52%

594
667
660
550
755
996
105
18
124
76
405
291
575

362
277
343
204
357
353
203
32
101
91
118
231
698

148
176
164
160
244
339
1
0
2
0
87
7
41

22%
25%
23%
28%
31%
33%
0%
0%
1%
0%
21%
2%
5%

25%
26%
25%
29%
32%
34%
1%
0%
2%
0%
21%
2%
7%

65
16
52
9
20
24
82
4
6
22
4
12
203

10%
2%
7%
2%
3%
2%
37%
10%
4%
19%
1%
4%
23%

18%
6%
15%
4%
6%
7%
40%
13%
6%
24%
3%
5%
29%
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5.3.2: Peptidome Comparisons
Several quantitative metrics were evaluated for their ability to differentiate and estimate
the abundance of closely-related and divergent microbial species within a defined
human gut consortium. Three quantitative methods that use spectra counts only,
spectra and protein counts, or unique peptides to estimate species abundance were
compared to GeneChip expression data from the same samples. All three quantitative
methods suggest the Bacteroides phylotypes are significantly more abundant in mice
consuming the plant polysaccharide-rich diet. More specifically, the unique peptide
quantitative metric indicated that B. caccae was significantly more abundant in the
western diet, in agreement with the GeneChip expression data. A phylotype’s
estimated abundance based on unique identified peptides, however, may be affected by
the proportion of unique predicted peptides assignable to that phylotype in the
database.
A method that estimates abundance via identified unique peptides may be biased
and skewed by the degree of predicted unique peptides in the sequence database. For
example, more unique peptides belonging to Bacteroides WH2 may be present because
there are more unique peptides in the database relative to the other species. To
address this potential bias, a “theoretical peptidome” was created for each species (12
relevant species and 3 unrelated distractor species) in the sequence database with an
in silico peptide digest that takes into account (i) tryptic miscleavages (0-4) and (ii) the
standard peptide mass range that can be experimentally detected. A “theoretical
peptidome” provides the ability to compare the identified peptidome (both unique and
non-unique peptides per species) to the predicted (theoretical) peptidome to determine
what percentage of each species is unique relative to all of the other species within the
entire consortium. By comparing the percentage of each species’ predicted unique
peptidome to the identified peptidome, you could determine whether (i) the closelyrelated species (i.e., Bacteroides) are contributing any unique peptides to the entire
predicted peptidome and (ii) whether the identified unique peptides are following the
same trends as the predicted peptidome.
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To generate a theoretical peptidome, several parameters (miscleavages and
peptide mass range) were first compared for the identified peptide results prior to their
application of the sequence database (15 microbial genomes, mouse, rice and yeast
genomes, and common contaminants) used in this study. The majority of
experimentally identified peptide sequences fell within 0-1 miscleavages (94%; Table
5.3) and a mass range of 600-4,890 Da. Based on this data, the theoretical peptidome
was generated in silico with the same filters for the entire protein sequence database at
≤1 miscleaveage.
Table 5.3: Proportion of total non-redundant identified peptides for all mice with 0, 1, 2,
3 or 4 miscleavages.

Although the mouse and diet genomes contributed the majority of unique
predicted peptides (20.44%-34.57%), all twelve phylotypes (including closely-related
species) contributed comparable percentages of unique peptides (~2-4%) to the entire
unique peptidome (Table 5.4) with B. WH2 containing the majority of unique predicted
peptides of the human-derived bacteria. Within each individual species, ~61-89% of all
predicted peptides are classified as “unique” (Table 5.4). This would suggest that
although there is significant genome sequence overlap, this is does not equate on a
peptide level since the majority of tryptic peptides are unique per species. Significantly,
89% of all peptides belonging to the single species (C. aerofaciens) of Actinobacteria
are unique, whereas only ~61-79% of peptides belonging to the majority of Bacteroides
are unique within this protein sequence database.
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Table 5.4: Distribution of total predicted peptides (unique and non-unique) for the
protein sequence database with ≤1 miscleavage.

Species

Sequence Database: 1 Miscleavage; Peptide Mass Range: 600-4,890 Da
% Total of Total % Unique of Total % Unique of Total
DB peptides
DB peptides
DB unique peptides #Proteins Size (MB)
Unique
% Unique
Total

Non-Unique

% Non-Unique

Rice

2,733,343

56.35%

2,117,393

43.65%

4,850,736

44.86%

Mouse

1,174,515

48.40%

1,252,078

51.60%

2,426,593

22.44%

Yeast

64,216

13.40%

414,911

86.60%

479,127

4.43%

B. WH2

71,238

20.96%

268,594

79.04%

339,832

3.14%

105,322

33.19%

211,964

66.81%

317,286

2.93%

29,795

12.83%

202,464

87.17%

232,259

2.15%

101,982

34.06%

197,434

65.94%

299,416

2.77%

B. vulgatus

58,625

23.66%

189,181

76.34%

247,806

2.29%

B. uniformis

70,619

30.25%

162,806

69.75%

233,425

2.16%

R. obeum

26,276

14.96%

149,371

85.04%

175,647

1.62%

C. scindens

32,174

18.16%

144,987

81.84%

177,161

1.64%

E. rectale

26,300

15.80%

140,179

84.20%

166,479

1.54%

B. caccae

87,509

39.39%

134,675

60.61%

222,184

2.05%

F. prausnitzii M212

20,667

14.55%

121,341

85.45%

142,008

1.31%

D. longicatena

29,210

20.72%

111,738

79.28%

140,948

1.30%

R. torques

25,607

18.95%

109,523

81.05%

135,130

1.25%

C. spiroforme

18,658

15.44%

102,145

84.56%

120,803

1.12%

C. aerofaciens

11,628

11.11%

93,021

88.89%

104,649

0.97%

Contaminants

1,026

43.24%

1,347

56.76%

2,373

0.02%

B. ovatus
P. distasonis
B. thetaiotaomicron

19.58%
11.58%
3.84%
2.48%
1.96%
1.87%
1.83%
1.75%
1.51%
1.38%
1.34%
1.30%
1.25%
1.12%
1.03%
1.01%
0.94%
0.86%
0.01%

34.57%
20.44%
6.77%
4.39%
3.46%
3.31%
3.22%
3.09%
2.66%
2.44%
2.37%
2.29%
2.20%
1.98%
1.82%
1.79%
1.67%
1.52%
0.02%

66,710

36.00

34,966

19.20

6,345

3.33

5,244

2.66

5,536

2.54

3,850

1.86

4,778

2.38

4,065

1.93

4,663

1.95

4,175

1.54

3,995

1.53

3,631

1.42

3,855

1.77

3,493

1.37

2,970

1.18

2,875

1.12

2,465

1.02

2,367

1.00

36

0.02

While B. WH2, B. ovatus, P. distasonis, and B. thetaiotaomicron are the most
abundant phylotypes based on the representation of unique predicted peptides in the
theoretical peptidome, experimental phylotype abundance estimated using unique
identified peptides did not follow this same trend (Figure 5.3). Instead, B. WH2, B.
vulgatus, R. obeum, B. caccae, and C. scindens are most abundant in the ‘Western’
diet. Although there is significant sequence overlap in the microbiota, less sequence
overlap exists on a peptidome level, suggesting that a unique peptide quantitative
metric, rather than spectra counts, can be used to quantitate the relative abundance of
species and proteins in microbial communities with varying ranges of diversity. In
addition, the expression data, provided by Jeff Gordon’s group, indicates that B. ovatus
and B. WH2 have a strong preference for the BK diet while B. caccae prefers the
western diet. Unlike the spectra and protein counts metric, the unique peptide counts’
distribution strongly supports the genechip expression data.
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Figure 5.3: Theoretical and experimental unique peptidome comparison per database
component (genome) for the BK and Western-fed mice. The % of unique peptides
(predicted or identified) out of the total (unique and non-unique) peptides plotted for
each database component.
Finally, the predicted unique peptidome was compared to the experimentally
identified unique peptidome distribution to identify which microbes are hurt most by
proteome overlap with the other community members. Although B. WH2 is the most
abundant species followed by B. ovatus, B. thetaiotaomicron, and B. vulgatus based on
predicted unique peptides, the western diet fed mice did not follow this same trend.
Comparing the ratio of identified unique peptides to total predicted unique peptides per
species, B. caccae and C. scindens continue to be the most abundant microbes in the
western diet fed mice and are more abundant than in the BK fed mice. Based on these
results, our unique peptide data is not skewed by the sequence database and this
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‘theoretical peptidome’ provides additional support for evaluating the relative distribution
and abundance of species using MS proteomic data.
5.3.3: Community-wide functional comparisons
To understand to what extent we can monitor shifts in the community proteome in
response to a diet change, we began by looking at the community as a one functional
entity. Within the community, all of the Bacteroides phylotypes are more abundant in
the BK diet compared to the Western diet, with the exception of B. caccae, which is
approximately proportional across all samples and runs, using the sum of normalized
spectra counts (Figure 5.4). C. scindens, on the other hand, is more abundant in the
Western-fed mice. This would suggest that although some species, e.g., C. scindens
are at very low abundance based on total proteome coverage, they still contribute
significantly to the pool of proteins and shift in response to diet. In addition, several
statistically differential abundant proteins were identified with higher abundance
(preference) for one diet relative to the other. Out of all the proteins identified within the
12-member consortium, ~21-33% of the Bacteroides phylotypes’ identified proteins
were identified with higher abundance in the BK diet relative to the western diet (p-value
≤0.03). Of the identified BK diet-only proteomes, B. WH2 and B. vulgatus expressed
the majority of differentially abundant proteins with a preference for the BK diet (34%
and 32%, respectively). On the other hand, ~40% and 29% of all proteins identified as
derived from C. scindens and Mus musculus, respectively, were significantly more
abundant in the Western-fed mice (Table 5.2) compared to the BK diet (1% and 5%,
respectively).
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Figure 5.4: Community-wide normalized spectra counts for the host and relevant
microbial proteins per MS run for both diets.
Classification of all identified microbial proteins by Clusters of Orthologous
Groups (COG) for the two diets indicate that proteins involved in critical gut-associated
functions, e.g., carbohydrate metabolism and energy production, are highly abundant
across all mice regardless of diet based on normalized spectra counts (technical
replicates average and biological replicates summed) (Figure 5.5). This would suggest
that the microbial community members are actively working together to carryout vital
metabolic functions necessary for host-microbiota gut homeostasis. Interesting, many
poorly characterized proteins (proteins with unknown function) are highly abundant
across both communities and diets, with ~800 and 400 hypothetical proteins identified in
the BK and Western-fed mice, respectively, suggesting that the gut microbiota encode
beneficial, yet many unknown functions across both communities. On the other hand,
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translation was less represented in the Western-fed mice and protein functions related
to cellular processes that include DNA replication, chromatin and nuclear structure, and
RNA processing were not active in either diet.
Western"Diet"

Chroma1n"structure"and"dynamics"
RNA"processing"and"modiﬁca1on"
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Func1on"Unknown"
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Figure 5.5: Classification of all differentially abundant proteins by COGs for both diets.
The classification of differentially abundant proteins by COGs suggests that
many of the over-abundant proteins are also involved in similar key functions in the BK
diet (carbohydrate and amino acid metabolism, and energy production (Figure 5.6));
however, translation-related proteins are statistically less abundant (down-regulated) in
the Western-diet relative to the BK diet (Figure 5.7). While translation is present and
active across all mice, many essential proteins associated with mRNA translation and
its machinery: aminoacyl tRNA synthetases, ribosomes, and translation initiation and
elongation factors are less abundant in the Western diet. Of the 13 over-abundant
aminoacyl tRNA synthetases identified, all 13 are derived from phylotypes belonging to
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Bacteroides. As a result of dietary protein deficiency or diet disturbances, protein
synthesis by Bacteroides phylotypes may be suppressed in the western diet because
they are growing slower since the diet does not contain the same level of nutrients that
are needed by these species. On the contrary, of the 19 translation-associated proteins
that are over-abundant in the Western diet, the majority (16) belong to C. scindens. Of
the 332 microbial proteins identified with over-abundance in the Western diet, 16% (82
proteins) are derived from C. scindens and 39% from M. musculus. These findings
suggest that the C. scindens and the host may be acting to provide one or several
unique protein functions in the Western-fed mice that are not acquired or significantly
active in the microbiota of the BK-fed mice. Further investigation of these individual
microbes (B. WH2 and C. scindens), their differences, and general role in the
community is provided under ‘species-level functional comparisons.’
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Figure 5.6: Statistically over-abundant proteins based on COG assignments in the BK
diet relative to the Western diet.
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Figure 5.7: Statistically over-abundant proteins based on COG assignments in the
Western diet relative to the BK diet.
While a similar number of proteins were identified and classified as ‘inorganic ion
metabolism’ for both diets (225 and 144 proteins for BK and Western diet, respectively),
the abundance of these proteins varies with higher abundance in the Western-fed mice.
The majority of proteins classified as involved in inorganic ion metabolism belongs to
phylotypes of Bacteroides and serve as outer membrane receptor proteins and
superoxide dismutase. Of those with significantly higher abundance for the Western
diet were outer membrane receptors of B. caccae with a preference for iron,
ferrienterochelin and colicins. On the contrary, B. WH2 identified outer membrane
receptors associated with iron transport were significantly more abundant in the BK-fed
mice. Although inorganic ion transport and metabolism is active and represented
across both communities, these results may suggest that B. caccae and B. WH2 may
be overcompensating or primarily responsible for iron transport relative to the other
Bacteroides phylotypes in the Western and BK-fed mice, respectively.
Due to protein sequence redundancy between closely-related species,
statistically high abundance microbial proteins were clustered (UCLUST v2.1.) via
sequence identity to group proteins with ≥97% sequence identity. Following clustering
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analysis of the statistically differentiated microbial proteins, the total number of overabundant proteins in the BK fed mice reduced from 1,330 proteins to 1,092 protein
clusters and from 332 proteins to 303 clusters in the Western fed mice. Many of these
protein clusters were related to similar functions described previously confirming a lack
of translation-related protein abundance when exposed to a western fed diet relative to
a high protein BK diet.
5.3.4: Species-level functional comparisons
While the community-wide analyses provide a broad functional understanding of the
microbiota collectively, in order to directly compare the abundance levels of specific
proteins of interest, it was necessary to evaluate the proteomes of each microbe within
the 12-member community individually. In addition, by using a species-level approach,
we can determine whether one species up- or down-regulates gene(s) in a specific
pathway in response to the host’s diet.
Based on the community-wide proteome analyses (Figure 5.4 and Figure 5.8)
and GeneChip expression data, B. WH2 has a strong preference for the BK diet.
However, why such significant abundance differences exist and the significant
functional role of B. WH2 in the BK-fed mice relative to the other microbial proteomes is
unclear. Of the 1,025 B. WH2 identified proteins, 269 were statistically differentiated,
with 199 significantly more abundant in the BK-fed mice. The majority of these proteins
(199) were classified with functions related to carbohydrate metabolism, amino acid
metabolism, translation or hypothetical proteins. On the other hand, the B. WH2
proteins that had a preference (up-regulated) for the Western diet were related to
inorganic ion transport, coenzyme transport, carbohydrate metabolism, and hypothetical
proteins. Coenzyme metabolism related proteins included an outer membrane
cobalamin receptor, 7-keto-8-aminopelargonate synthetase, and phosphoserine
aminotransferase that were significantly more abundant in the Western-fed mice (p
value<0.03 and difference of 52-84 spectra). Inorganic ion metabolism related proteins
include superoxide dismutase and outer membrane receptors for ferrienterochelin and
colicins (p value<0.03 and difference of 17-280 spectra).
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Figure 5.8: B. WH2 (only) total identified proteins’ distribution based on COG categories
for both diets.
Due to the significant abundance of B. WH2 relative to the other 12 phylotypes
(Figure 5.9 and Figure 5.10), is B. WH2 performing differently from the other
Bacteroides that might explain its dominance? After comparing each of the Bacteriodes
phylotypes individually for each diet, carbohydrate metabolism, outer membrane-related
proteins, and signal transduction were identified as being dominated by B. WH2
proteins while, for example, translation is relatively proportional amongst all of the
phylotypes (Figure 5.10). The proteomic data may suggest that B. WH2 expresses a
larger proportion of proteins that are involved in carbohydrate metabolism and signal
transduction relative to the other Bacteroides phylotypes in the BK diet. In addition, a
significant portion of B. WH2 identified proteins were annotated as ‘unknown function.’
In the Western-fed mice, B. WH2 identified proteins are not as functionally different from
the other Bacteroides phylotypes (Figure 5.11 and Figure 5.12) compared to the BK	
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fed mice. This may suggest that most members of the Bacteroides phylotypes are able

to cooperate and function individually with respect to the host and Western diet whereas

the BK-fed mice are heavily dependent upon B. WH2 to process certain biological

functions. Further investigation (ie, KEGG pathway analysis) would help reveal whether

B. WH2 is responsible for processing specific pathways within these broad functional

terms relative to the other phylotypes.
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Figure 5.9: Distribution of protein counts per COG category for each phylotype of

Bacteroides for the BK-fed mice.
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Figure 5.11: Distribution of protein counts per COG category for each phylotypes of

Bacteroides for the Western-fed mice.
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Figure 5.12: Distribution of protein counts per COG category for all 12 phylotypes for
the Western-fed mice.
Compared to BK-fed mice, C. scindens was identified with higher abundance in
the Western-fed mice (Figure 5.4 and Figure 5.13). A significant portion of the
Western-fed C. scindens proteome is involved in translation followed by carbohydrate
metabolism. Of the 220 C. scindens identified proteins, 36 were statistically
differentiated, with the majority (25) being significantly over-abundant in the Western-fed
mice. These proteins were classified with functions in carbohydrate metabolism and
energy production. For example, the C. scindens ABC-type sugar transport system was
identified with over-abundance in the Western-fed mice compared to the BK-fed mice.
Due to differences in the dietary components, the increased abundance of C. scindens
may be a result of their ability to grow more efficiently on sugar compared to the other
phylotypes in mice that are fed a diet rich in fat and sugar. The community-wide and
individual species-level proteomic data both indicate that translation is significantly more
abundant in the Bacteriodes phylotypes of BK-fed mice whereas particular proteins
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involved in inorganic ion and carbohydrate metabolism and transport are more
abundant in the Western-fed mice based on protein and/or normalized spectra counts.
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Figure 5.13: C. scindens (only) total identified proteins’ distribution based on COG
categories for both diets.
5.4: Conclusions
Based on all of the collective analyses, shotgun proteomics methods is quite effective
for complex consortia comprising species that share a great deal of gene content and
should be expandable to larger, more complex communities. In this study, we
compared the functional differences and estimated the relative abundance of closelyrelated species within a 12-member model consortium of phylotypes belonging to
Bacteroides, Firmicutes, and Actinobacteria. The microbial community proteomes were
evaluated by (i) community-wide normalization (i.e., community-wide response) and (ii)
normalization per individual species in response to diet perturbations and (iii) the
prediction (theoretical peptidome) and identification of unique peptides as a method for
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the relative estimation of species abundance with significant dynamic range. These
analyses suggested that the community structure is dictated by the host’s diet (i.e., diet
is shaping overall community structure).
In conclusion, B. WH2 is highly abundant across proteomes in both diets, but is a
strong diet responder with a preference for the BK diet. B. caccae and C. scindens, on
the other hand, are strong diet responders with a preference for the Western diet in
agreement with the GeneChip expression data. We would hypothesize that either (i) C.
scindens and B. caccae both may directly benefit from one or more compounds in
Western diet (e.g., they share some common traits/preferences with respect to
metabolic niches) or (ii) other species in the community that normally strongly compete
with C. scindens and B. caccae are at a disadvantage in the Western diet where their
loss is these two species' gain. To confirm either or additional hypotheses, further
analysis and supporting genomic data is necessary.
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Chapter 6	
  
Shotgun metaproteomics of the human distal gut microbiota
The text is adapted from:
A. L. Russell, N. C. VerBerkmoes, M. Shah, A. Godzik, M. Rosenquist, J.
Halfvarsson, M. G. Lefsrud, J. Apajalahti, C. Tysk, R. L. Hettich, and J. K.
Jansson. “Shotgun metaproteomics of the human distal gut microbiota.” ISME J.,
2009, volume 3, pages 179-189.
Alison R. Erickson’s contributions include experimental preparation of microbial samples
for proteomics, experimental LC-MS/MS measurements and analysis, and shared
primary authorship with Nathan VerBerkmoes.
6.1: Introduction
The human gastrointestinal (GI) tract is host for myriads of microorganisms
(approximately 1011/gram feces) that carry out vital processes for normal digestive
functions of the host and play an important, although not yet not fully understood, role in
maturation of human immunity and defense against pathogens. Recent findings suggest
that each human has a unique and relatively stable gut microbiota, unless disrupted by
external factors such as antibiotic treatment[156]. Increasing evidence suggests that the
composition of the GI microbiota is linked to inflammatory bowel diseases[157], such as
Crohn’s disease[158], and can even influence the propensity for obesity[131]. Current
estimates based on sequencing of 16S rRNA genes in DNA extracted from feces, are
that 800-1000 different microbial species and >7000 different strains inhabit the GI
tract[159] and that the majority of these (> 80%) have not yet been isolated or
characterized[62]. Therefore, there is a vast microbial diversity with largely unknown
function that is waiting to be explored.
Recently, metagenomic sequencing has revealed information about the
complement of genes in the gut microbiota of two healthy individuals[22]. Although this
data set did not represent the entire GI microbiota, analysis of identified genes revealed
that the GI microbiome has significantly enriched capacities for glycan, amino acid, and
xenobiotic metabolism, methanogenesis, and synthesis of vitamins and isoprenoids.
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This indirect evidence suggested that there are unique microbial functions carried out in
the gut environment.
A major limitation of DNA based approaches is that they predict potential
functions, but it is not known if the predicted genes are expressed at all or if so, under
what conditions and to what extent. In addition, it is not possible to determine whether
the DNA is from active viable cells, dormant inactive cells, or even dead cells. These
limitations can be overcome by directly assessing proteins, because the genes must
have been transcribed and translated to produce a protein product. However, to date
only a couple of microbial proteins have been identified from the human gut and these
were obtained by 2 dimensional polyacrylamide gel electrophoresis (2D PAGE)[47],
followed by excision and de novo sequencing of targeted spots on the gel.
With an established and successful method to study the proteomes of lowercomplexity microbiota in gnotobiotic mice, we expanded this methodology into higher
complexity representative human gut microbiomes to evaluate how well this method
would work in human feces. Here, our aim was to develop a novel high throughput,
non-targeted mass spectrometry (MS) approach to determine the identities of
thousands of microbial proteins in the most complex sample type to date (i.e. feces) and
to test the feasibility of using a non-matched metagenome data set for protein
identification. This MS-based shotgun proteomics approach relies on detection and
identification of all proteins in a lysed cell mixture without the need for gel based
separation or de novo sequencing. Instead, the resulting peptides from an enzymatic
digest of the entire proteome are separated by liquid chromatography and infused
directly into rapidly scanning tandem mass spectrometers (2D-LC-MS/MS) via
electrospray ionization. The resulting peptide mass information and tandem mass
spectra are used to search against protein databases generated from genome
sequences. To date, the shotgun metaproteomics approach has only been
demonstrated in a limited number of studies and only for microbial communities with low
diversity, such as acid mine drainage systems[42,43], endosymbionts[160], and sewage
sludge water[44]. It remains a technical challenge to apply this shotgun approach to
more complex microbial communities, such as those inhabiting the human gut.
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For this study, it was first necessary to develop the shotgun proteomics approach
to work with fecal samples containing large amounts of particulate matter and
undigested food and a large diversity of microbial cells. Figure 6.1 provides an overview
of the experimental approach developed. Fecal samples were chosen because
sampling is non-invasive and feces have been shown to provide material that is
representative of an individual’s colonic microbiota[62]. Our goal was the qualitative
identification of the range and types of proteins that can be confidently and reproducibly
measured (i.e. with high specificity and low false positive rates; 1-5% maximum) from
gut microorganisms by comparing to available metagenome databases[22] and
available gut isolate genomes and to determine if unmatched data sets could suffice for
accurate protein identifications. An additional goal was to apply a novel bioinformatics
approach to assign putative functions to unknown proteins not covered by standard
analysis of clusters of orthologous groups (COGs). Ultimately, our aim was to use the
protein data to provide direct evidence of dominant and key microbial functions in the
human gut for the first time, some of which could serve as indicators of a healthy or
diseased state. In addition, this non-targeted approach enables identification of human
proteins associated with the gut microbiota, thus illustrating potential interactions
between the human microbiome and host.

	
  

112	
  

Figure 6.1: Shotgun metaproteomics approach used to identify thousands of microbial
proteins in human fecal samples.
6.2: Experimental methods
6.2.1: Fecal sample collection
A female healthy monozygotic twin pair born in 1951 was invited to take part in a larger
double blinded study, and details of these individuals with respect to diet, antibiotic
usage, etc. are previously described: individuals numbered 6a and 6b[158], that
provided Samples 7 and 8, respectively, thus were the focus of this study. The only
differences between the individuals according to the submitted questionnaire data were
that Individual 6a had gastroenteritis and Individual 6b had taken NSAIDs the last 12
months. Fecal samples were collected in 20 ml colonic tubes by the twins and
immediately sent to Örebro University Hospital on the day of collection, where they were
placed at –70°C and stored. The Uppsala County Ethics Committee and the ORNL
human study review panel approved the study.
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6.2.2: Microbial cell extraction from fecal samples
Fecal samples were thawed at +4°C and microbial cells were extracted from the bulk
fecal material by differential centrifugation, as previously described[85]. This cell
extraction method has previously been found to result in a highly enriched bacterial
fraction from complex samples, such as soil and chicken feces, with negligible bacterial
cell loss and a good representation of fecal microbiota[85]. The resulting bacterial cell
pellets were immediately frozen at –70°C and stored until use.
6.2.3: Cell lysis and protein extraction from cell pellets
The microbial cell pellets (~100 mg) were processed via single tube cell lysis and
protein digestion. Briefly, the cell pellet was resuspended in 6M Guanidine/10mM DTT
to lyse cells and denature proteins. The guanidine concentration was diluted to 1M with
50 mM Tris buffer/10mM CaCl2 and sequencing grade trypsin (Promega, Madison, WI)
was added to digest proteins to peptides. The complex peptide solution was desalted
via C18 solid phase extraction, concentrated and filtered (0.45um filter). For each LCMS/MS analyses below, ~1/4 of the total sample was used.
6.2.4: 2D-LC-MS/MS
Both samples were analyzed in technical duplicates via two-dimensional (2D) nano-LC
MS/MS system with a split-phase column (RP-SCX-RP)[97] on a LTQ Orbitrap (Thermo
Fisher Scientific) with 22 hr runs per sample (LC as previously described[42,43]. The
Orbitrap settings were as follows: 30K resolution on full scans in Orbitrap, all datadependent MS/MS in LTQ (top five), 2 microscans for both Full and MS/MS scans,
centroid data for all scans and 2 microscans averaged for each spectra, dynamic
exclusion set at 1.
6.2.5: Proteome informatics
All MS/MS spectra were searched with the SEQUEST algorithm[66] and filtered with
DTASelect/Contrast[98] at the peptide level [Xcorrs of at least 1.8 (+1), 2.5 (+2), 3.5
(+3)]. Only proteins identified with two fully tryptic peptides from a 22 hr run were
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considered for further biological study. Tandem MS/MS spectra were searched against
four databases. The first database (db1) contained two human subject’s
metagenomes[22], a human database, and common contaminants such as trypsin,
human keratins, etc. The existing metagenome databases[22] were deficient in
Bacteroides sequences and as Bacteroides are known to be common and abundant in
the human intestine[62], Bacteroides genome sequences were also included in a
second database (metadb), plus other sequences from representatives of the normal
gut microbiota deposited and available at the Joint Genome Institute (JGI) IMG
database (http://img.jgi.doe.gov/cgi-bin/pub/main.cgi). In addition, we included
distracters that one would not commonly expect in the healthy gut. The third and fourth
database were made by reversing or randomizing the db1 and appending it on the end
of db1; these databases were used primarily for determining false positive rates, as
described earlier[43,96].
6.2.6: Hypothetical Protein Prediction
Hypothetical proteins were submitted to the distant homology recognition server
FFAS03[161]. For 80% of the hypothetical proteins, a statistically significant match (Zscore below 9.5) to one of the proteins in the reference databases was obtained.
Functions of the matching proteins were used to assign a provisional function for the
hypothetical proteins identified in this study.
6.3: Results and Discussion
6.3.1: Metaproteomics of fecal samples
Our results present the first large-scale investigation of the human gut microbial
metaproteome. The metaproteomes were obtained from two fecal samples (samples 7
and 8) collected from two healthy female identical twins (subjects 6a and 6b,
respectively, see Dicksved et al. (2008) for a description of the individuals). The shotgun
approach used enabled us to identify thousands of proteins by matching peptide mass
data to available isolate genome and metagenome sequence databases. The total
number of proteins identified from searching the first database (db1) that contained all
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predicted human proteins and the gut metagenomes were 1822 redundant and 1534
non-redundant proteins, with approximately 600 to 900 proteins identified per sample
and replicate (Table 6.1). From the entire non-redundant dataset, ~ 1/3 matched
human proteins, ~ 2/3 matched predicted proteins from the microbial metagenome
sequence data.
Table 6.1: Number of protein, peptide, and spectra identifications for Samples 7 and 8
(2 technical runs each) using the db1 and metadb databases (see supplementary
material).
db1 database
Sample ID

Protein
identifications*

Peptide
identifications

MS/MS
Spectra

Sample 7, Run 1
Sample 7, Run 2
Sample 8, Run 1
Sample 8, Run 2

634
722
974
983

1886
2253
3021
2948

4069
4440
5829
6131

Peptides between
10 and -10
ppm**
81.70
80.42
83.41
81.47

4829
5364
6509
6635

84.47
81.67
84.71
82.92

metadb database
Sample 7, Run 1
970
2441
Sample 7, Run 2
1098
2977
Sample 8, Run 1
1341
3586
Sample 8, Run 2
1275
3374
*Numbers given are non-redundant identifications
** Mass accuracy

The second database (metadb) contained all of the sequences in the db1
database above, in addition to sequences from representatives of the normal gut
microbiota, including strains of Bacteroides, Bifidobacteria, Clostridia, and Lactobacilli,
plus human pathogens and distracters that one would not commonly expect in the
healthy gut, such as environmental isolates. The rice (Oryza Sativa) genome was
included to help identify plant (food)-related proteins. From the metadb, the total number
of proteins identified were 2911 redundant and 2214 non-redundant; between 970 and
1340 proteins were identified per sample and replicate (Table 6.1). The categorical
breakdown of identified proteins from each major database type is shown Table 6.2. In
three out of four runs, the highest percentage of protein identifications corresponded to
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the bacterial genome sequences that were screened. In the fourth run (that is, run 2,
sample 8), most protein identifications matched to one of the metagenomes. By
contrast, 30-35% of spectra matched to the human protein database, most likely due to
a few highly abundant human proteins in the samples with a large number of spectral
counts. The proteins matching to both rice and environmental isolate distracters were
low, between 2 and 9%, indicating that the majority of the sequences matched to
bacterial types and human sequences that one would expect in the human gut
environment. Among the microbial genomes screened, the highest protein matches
were to expected sequences from gut isolates. Of the ~10,000-13,000 total spectra
observed from each run, ~2,000 matched Bacteriodes or Bifidobacterium species, with
the Bacteriodes species always having slightly more spectra, emphasizing the
dominance of these groups and their functional significance in the human distal
intestine. These data correlate well with our previously published microbial fingerprint
data showing an abundance of Bacteroides spp. in both of the individuals studied
here[158].
Table 6.2: Categorical breakdown of all identifications for each database component
per MS run.

	
  

Sample7_Run1
Database
Proteins % Spectra Total %
Gut Isolate Genomes
547
38.17 2926
28.11
Contams
7
0.49
177
1.7
Human Proteins
166
11.58 3276
31.48
Gill Metagenome Set7
205
14.31 1304
12.53
Gill Metagenome Set8
328
22.89 1977
19
Rice
45
3.14
226
2.17
Isolate Distracters
135
9.42
522
5.02
Totals:
1433
10408

Sample8_Run1
Database
Proteins % Spectra Total %
Gut Isolate Genomes
604
32.26 3047
22.12
Contams
5
0.27
85
0.62
Human Proteins
232
12.39 4440
32.24
Gill Metagenome Set7
304
16.24 1835
13.32
Gill Metagenome Set8
568
30.34 3720
27.01
Rice
53
2.83
273
1.98
Isolate Distracters
106
5.66
373
2.71
Totals:
1872
13773

Sample7_Run2
Database
Proteins % Spectra Total %
Gut Isolate Genomes
600
38.73 3111
27.99
Contams
6
0.39
154
1.39
Human Proteins
187
12.07 3752
33.76
Gill Metagenome Set7
243
15.69 1477
13.29
Gill Metagenome Set8
365
23.56 2013
18.11
Rice
57
3.68
246
2.21
Isolate Distracters
91
5.87
360
3.24
Totals:
1549
11113

Sample8_Run2
Database
Proteins % Spectra Total %
Gut Isolate Genomes
515
30.13 2658
20.08
Contams
3
0.18
63
0.48
Human Proteins
214
12.52 4671
35.28
Gill Metagenome Set7
303
17.73 1810
13.67
Gill Metagenome Set8
556
32.53 3535
26.7
Rice
34
1.99
197
1.49
Isolate Distracters
84
4.92
305
2.3
Totals:
1709
13239
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By using established methods of reverse database searching[43,96]; we
estimated a false-positive rate at the peptide level of 1-5% for all identified peptides
depending on the method. If only those peptides with corresponding high mass
accuracy measurements (<10 p.p.m.) were considered (80-85% of all identified peptides
per run), then the rate dropped to 0.05-0.23%.
6.3.2: COG categories in the gut metaproteome
The proteins identified from the db1 search were classified into COG categories and
when compared between the two samples and the two technical runs, the data were
highly reproducible and consistent (Figure 6.2). By comparison to the average
metagenomes previously published from other individuals[22], we found that several
COG categories were more highly represented in the average microbial metaproteomes
of the individuals in the present study (Figure 6.3). The metaproteomes were
significantly skewed, with a more uneven distribution of COG categories than those
represented in the average metagenomes. The majority of detected proteins were
involved in translation, carbohydrate metabolism, or energy production; together
representing more than 50% of the total proteins in the metaproteome. In addition,
more proteins in the metaproteomes were representative of COG categories for posttranslational modifications, protein folding, and turnover. By contrast, other COG
categories were under represented in the metaproteomes when compared with the
metagenomes, including proteins involved in inorganic ion metabolism, cell wall and
membrane biogenesis, cell division and secondary metabolite biosynthesis.
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Figure 6.2: Microbial proteins identified from fecal samples 7 (blue bars) and 8 (yellow

bars) according to clusters of orthologous group (COG) functions. Bars represent

technical proteome runs 1 and 2.

119	
  

Figure 6.3: Comparison of average clusters of orthologous group (COG) categories for
available human metagenomes and metaproteomes. (A) Average COG categories of
the two metagenomes from the gut microbiota of two individuals from a previous study
(Gill et al. 2006), (B) compared to average COG categories of the metaproteomes from
the gut microbiota of two individuals in the present study.
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6.3.3: Label-free estimation of relative protein abundance by normalized
abundance factor
We estimated the relative abundances of the thousands of proteins that were detected
in each sample by calculating normalized spectral abundance factors (NSAF)[127,162].
By comparing the NSAF data from each sample and technical run to each other, it was
clear that the technical runs were highly reproducible for a given sample; R2 values of
0.77 and 0.85 for samples 7 and 8, respectively (Figures 6.4 and 6.5).

Figure 6.4: Comparison of NSAF values. Sample 7, run 1 and run 2 NSAF values are
plotted on a log scale. The dark blue squares represent all of the proteins that were
identified in both runs from metadb.
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Figure 6.5: Comparison of NSAF values. Sample 8, run 1 and run 2 NSAF values are
plotted on a log scale. The dark blue squares represent all of the proteins that were
identified in both runs from metadb.
The most abundant proteins based on this prediction were common abundant
human-derived digestive proteins such as elastase, chymotrypsin C, and salivary
amylases. The most abundant microbial proteins included those for expected
processes, such as enzymes involved in glycolysis (for example, glyceraldehyde-3phosphate dehydrogenase). Ribosomal proteins (in particular for Bifidobacterium) were
also relatively abundant, as were DNA binding proteins, electron transfer flavoproteins,
and chaperonin GroEL/GroES (HP60 family).
The gut microbiomes previously published[22] were enriched for many COGs
representing key genes in the methanogenic pathway, consistent with H2 removal from
the distal gut ecosystem through methanogenesis. By contrast, we found very few
proteins represented by methanogens. One example is a hypothetical protein from
Methanobrevibacterium found in sample 8. Instead, analysis of the list of proteins based
on the NSAF ranking in our study revealed a high relative abundance of
formyltetrahydrofolate synthetase, a key enzyme in the acetyl-CoA pathway of
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acetogens[163]. Acetogenic bacteria utilize H2 to reduce CO2 and form acetate.
Although methanogenesis is an important H2 disposal route in about 30-50% of people
in Western countries, in the remainder H2 is consumed by sulfate reduction or reductive
acetogenesis, and this seems to be the situation for the samples we have studied here.
Similar to the finding of COGs responsible for host-derived fucose utilization that
were enriched in the human gut microbiome[22], we also found several proteins
involved in fucose metabolism, including fucose isomerase and propanediol
fermentation (later steps in the pathway). In particular, we detected proteins
corresponding to polyhedral bodies that are assumed to protect the cell by sequestering
the toxic propionaldehyde intermediate of this pathway[164].
Butyrate kinase was the most highly enriched COG in the previous metagenomic
study by Gill et al. (2006). This enzyme is the final step in butyrate fermentation.
Although we did not identify butyrate kinase, we did find that butyryl-CoA
dehydrogenase had a relatively high abundance based on the NSAF analyses. This
enzyme catalyzes one of the previous steps in the same pathway; interestingly, this
protein was strongly expressed in sample 8 but was not detected in sample 7.
Additional proteins of interest that were relatively abundant included NifU-like homologs
and rubrerythrin. The role of NifU has been proposed as a scaffold protein for Fe-S
cluster assembly[165]. Rubrerythrin is found in anaerobic sulfate-reducing bacteria and
is a fusion protein containing an N-terminal iron-binding domain and a C-terminal
domain homologous to rubredoxin. The physiological role of rubrerythrin has not been
identified, but it has been shown to protect against oxidative stress in Desulfovibrio
vulgaris and other anaerobic microorganisms[166].
Average NSAF values were compared to determine unique and shared proteins
in samples 7 and 8 (Figure 6.6, metadb database; Figure 6.7, db1 database). The
scatter plot reveals five distinct areas: proteins found in similar abundances in both
samples along the diagonal, proteins found in only one sample on the respective axis,
and two distinct lobes that are overexpressed in one sample or the other but present in
both (Figure 6.6). We suggest that the group of approximately equally abundant
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proteins (747 total) represent core gut populations and functions, supported by the
finding that a high proportion of these proteins were from common gut bacteria
(Bacteroides, Bifidobacterium and Clostridium) and represented housekeeping
functions: translation (19%), energy production (14%), post-translational modification
and protein turnover (12%) and carbohydrate metabolism (16%) (Supplementary Table
S10, first tab). By contrast, the proteins found in only one sample contained
proportionately fewer COG categories for housekeeping functions and from common
gut species, but a higher proportion with unknown functions (28% compared to 11%
found in both). These results suggest that the proteins present or over-represented in
only one sample could represent bacterial populations and functions that change
according to environmental influences, such as immediate diet. For example, 33% of
the unique proteins only found in sample 7 are prolamin proteins, that is, plant storage
proteins having a high proline content found in seeds of cereals, suggesting recent
ingestion of cereal grains by that individual. Although these individuals did not specify
any particular dietary habits in the questionnaire data that accompanied the
samples[158], we do not have any detailed information about their specific dietary
intake immediately prior to sampling that would enable us to verify this finding.
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Figure 6.6: Comparison of relative abundances (NSAF values) of proteins detected in
Samples 7 and 8. NSAF values for Samples 7 and 8 were averaged amongst their
individual technical runs and plotted on a log scale. The dark blue squares represent all
of the proteins identified in each sample from screening the metadb database. The
straight diagonal line represents the location of all proteins that had approximately equal
expression in both samples.
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Figure 6.7: Comparison of NSAF values for Samples 7 and 8. NSAF values were
averaged amongst two individual technical runs pre sample and plotted on a log scale.
The dark blue squares represent all of the proteins identified in each sample from db1.
The straight diagonal line is for visualizing the location of all proteins that had
approximately equal expression in both samples.
6.3.4: Analysis of unknown hypothetical proteins
We performed detailed analyses of the unknown proteins (116 from the published
metagenomes[22] and 89 from bacterial isolate genomes) that could not be classified
into COG families. The majority belonged to novel protein families that are overrepresented in genomes of gut microbes (Figure 6.8a). Five of the ten most abundant
hypothetical proteins in the metaproteome belong to the novel protein family
represented by hypothetical protein CAC2564, identified earlier in human
metagenomes[22], whereas four out of the top ten belong to another novel protein
family represented by a hypothetical protein BF3045 from Bacteroides fragilis.
Members of both families are present in several Bacteroides, Clostridium, and Vibrio
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species, where they are always associated with each other (see the red and green
arrows in Figure 6.8b) and various metabolic enzymes and transport systems. The
neighborhood of these two proteins resembles a typical amino acid metabolic pathway,
and we hypothesize that they are involved in amino acid metabolism, most likely
cysteine or methionine.
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Figure 6.8: Detailed analysis of hypothetical proteins identified in human gut
metaproteome. (A) Protein representation in the genomes of human gut associated
microbes; scale changes from 1 (only found in human gut microbes) to -1 (never found
there), 0 represents even distribution. Conserved genomic neighborhoods of the
CAC2564 (B) and BT2437 (C) families.
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Another interesting example is the CPE0573 family of hypothetical proteins,
originally identified in the human gut metagenome[22]. A distant homolog from this
family was recently shown to belong to a novel lacto/galacto-N-biose metabolic
pathway, identified in Bifidobacterium bifidum[167] and Bifidobacterium longum[168].
Other proteins from this pathway were also found in the metaproteome samples,
suggesting that it was active in our subjects who apparently ingested lactose in their
diet. Additionally, an operon formed by a hypothetical protein BT2437 from Bacteroides
thetaiotaomicron VPI-5482 was found which codes for a putative lipoprotein[169].
Proteins from this family are always associated with channel forming eight-stranded
beta-barrel proteins from the OprF family[170] (Figure 6.8c).
6.3.5: Identification of human proteins
Almost 30% of all identified proteins were human. The two largest groups of human
proteins identified in our study were digestive enzymes and structural cell adhesion and
cell-cell interaction proteins. However, the third largest category was comprised of
human innate immunity proteins, including antimicrobial peptides, scavenger receptor
cysteine-rich (SRCR) proteins (represented by the DMBT1 (deleted in malignant brain
tumors) protein), and many other proteins linked to innate immunity and inflammation
response (intellectin, resistin, and others). Most of the abundant human proteins were
similar in the two individuals, but some differences were found in less abundant
proteins.
We were particularly interested in further investigation of DMBT1 (also called
salivary agglutinin and glycoprotein-340) that is predominantly expressed in epithelial
cells and secreted into the lumen. This protein has several proposed beneficial
functions including tumor suppression, bacterial binding, and anti-inflammatory
effects[171,172]. Detailed analysis of the distribution of DBMT1 peptides shows that
they had fairly uniform distribution along the protein, including hits from all 17 domains
present in the DBMT1 protein (Figure 6.9), suggesting that the DBMT1 protein was
present in our samples as a complete, intact protein, that which we postulate is
indicative of a healthy gut environment.
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Figure 6.9: Positions of DMBT1 peptide fragments along the length of the DMBT1
protein are shown as blue boxes (figure is not to scale). DBMT1 has a length of 1785
amino acids. PFAM domain names: SRCR (Scavenger receptor cysteine-rich domain);
CUB (from complement C1r/C1s, Uegf, Bmp1) is a domain found in many in
extracellular and plasma membrane-associated proteins; Zona pellucida, a large,
cysteine rich domain distantly related to integrins, found in a variety of mosaic
eukaryotic glycoproteins, usually acting as receptors.
6.4: Conclusions
This is the first demonstration of an overall method for obtaining metaproteomics
datasets from complex material, in this case human feces, and successful
demonstration of the deepest coverage of a complex metaproteome to date. By
comparison with earlier work on environmental samples with only a few dominant
species[42,43,44], the gut microbiota represents a highly diverse community with
thousands of species. Therefore, we are testing the technical limit of the use of the
shotgun proteomics approach. We were encouraged that the sample extraction and
preparation methods worked well for fecal samples. Although there remain experimental
and computational challenges, this general approach should be applicable to other
complex environments, such as marine and soil microbial communities.
We also successfully demonstrated that it was feasible to use an unmatched
metagenome dataset to obtain valid protein identifications in fecal samples. It is
currently more rapid and less expensive to obtain metaproteome data, as we have
demonstrated here, than metagenome data. This finding is promising for future
metaproteomics studies of other environments that do not have available matched
metagenomics sequence data.
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One particular challenge is to estimate protein abundances in complex samples.
Here, we used label free methods based on spectral counting and NSAFs[127,162].
NSAF is based on spectral counts but also takes into account protein size and the total
number of spectra from a run, thus normalizing the relative protein abundance between
samples. Efforts are underway to develop better tools for label-free methods, such as
the absolute protein expression (APEX) method recently developed by Lu et al.[173].
However, the APEX method was derived specifically for isolate data and is not
applicable to complex microbial communities because it requires an estimate of the
number of expressed proteins in the system and this is not known, for example, in our
case.
Although our results present the largest coverage of the human gut microbial
metaproteome to date, increasing the dynamic range beyond this initial study will be
necessary in the future to more fully understand the function of the human gut
microbiota and its interactions with the human host. Previous studies[42] and current
work (NCV, unpublished results with artificial mixtures) suggest that proteins can be
detected from populations that represent at least 1% of a mixed community. However,
the number of proteins detected (dynamic range) dramatically decreases from
thousands to hundreds of proteins for those populations that are present at lower
abundances. One possibility to increase the dynamic range of detection would be to
enhance the protein separation steps prior to analysis. The trade-off for increasing the
number of separation steps would be the requirement for a greater amount of starting
material and instrument time. Enrichment or depletion techniques could also be
attempted to increase the coverage of community members present at low levels, but
care must be taken to not affect the proteome during any manipulations. Increasing the
dynamic range is a clear challenge for all proteomic applications and this will be a
pressing area for research and method development in the future.
We made several comparisons of our metaproteome data to the existing
metagenome data[22]. Some matches could be made between pathways predicted to
be functioning based on abundant genes detected in the metagenome data to abundant
proteins we found, such as those involved in fucose and butyrate fermentation. There
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were also some interesting discrepancies, such as the implication of methanogenesis in
the former study and the apparent lack of methanogenesis in the samples we analyzed.
The few, low-level, nonunique peptide hits to methanogens that we found were not
sufficient to indicate that these organisms were present or functioning. Instead, our data
suggest that acetogenesis was occurring in our samples, implicating different hydrogen
scavenging routes in the subjects in the two studies.
Although about the same percentage of proteins with ‘unknown function’ was
found in both the metagenomes and the metaproteomes, the metaproteome data
provide direct proof that such proteins are actually expressed. Overall, 67% of
hypothetical proteins identified in this study could be recognized as distant homologs of
already characterized families, allowing putative function assignments, with most of
them further enriching the amino-acid and carbohydrate metabolism categories, but also
including proteins involved in cell-cell signaling and active transport of nutrients across
bacterial membranes. Also, fold recognition level structure predictions are possible for
55% of them, opening doors for modeling and more detailed function analysis.
There were additional discrepancies between some proteins predicted in the
metagenomes that were not detected in the metaproteomes and reasons for this include
all or some of the following: (1) the microbial community compositions and proteins
produced were different in the different individuals, (2) the proteins were produced, but
below the dynamic range of detection, (3) they might not have been expressed at
significant levels at the time of sampling, or (4) the proteins may have mutated to a point
that they are no longer detected by screening an unmatched metagenome[174].
Therefore, although we successfully identified thousands of proteins using an
unmatched dataset, it would still be very valuable to have matching metagenome and
metaproteome data from the same samples and this will certainly be achieved through
ongoing and future initiatives, such as the NIH Human Microbiome Project
(http://nihroadmap. nih.gov/hmp/) and the European Union Meta-HIT project
(http://www.international.inra.fr/ press/metahit). Recently, 13 additional human
metagenome sequences were published from Japan[24] and more representative
genome sequences from commensal gut isolates are currently being sequenced [157].
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Taken together, these represent valuable resources that should eventually aid in
identification of more proteins from the human gut.
A large proportion of the proteins detected in the samples (approximately 30%)
were human proteins. This finding can be explained by the differential centrifugation
method that we used to obtain a bacterial cell fraction, which is not pure but highly
enriched in bacterial cells when compared to human cells and particulate matter in the
original fecal sample. Any human protein that adhered to the microbial cells would have
been collected in the bacterial pellet. Also, there are many more proteins in human cells
than in bacterial cells. Therefore, even a minor contamination of the bacterial fraction
with human cells could represent a significant number of human proteins. In hindsight,
this was advantageous because it enabled us to detect and identify human proteins,
such as antimicrobial peptides, that reflect interaction between the host and the
microbiota. Furthermore, this highlights the power of this technology to distinctly identify
both microbial and human proteins in a combined mixture.
In summary, although it is evident that this massive dataset would require
substantial effort to completely define and characterize, our goal was to develop an
approach to obtain a first large-scale glimpse of the functional activities of the microbial
community residing in the human gut. A wealth of information about functional pathways
and microbial activities could be gleaned from this data, thereby providing one of the
first views into the complex interplay of human and microbial species in the human gut
microenvironment. It is clear that proteomics allows us to directly see potential hostcommensal bacterial interactions. While the human immune response is usually
described in terms of response to infection, it is clear that innate immunity proteins are
part of a normal gut environment, shaping the gut microflora to the desired shape.
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Chapter 7
Strategies for Metagenomic-Guided Whole Community Proteomics of Complex
Microbial Environments
The text is adapted from:
Alison R. Erickson, Brandi L. Cantarel, Nathan C. Verberkmoes, Brian K.
Erickson, Patricia A. Carey, Chongle Pan, Manesh Shah, Emmanuel F.
Mongodin, Janet K. Jansson, Claire M. Fraser-Liggett, and Robert L. Hettich.
“Strategies for Metagenomic-Guided Whole Community Proteomics of Complex
Microbial Environments.” Submitted and in review at PLoS One (2011).
Alison R. Erickson’s contributions include experimental preparation of microbial samples
for proteomics, experimental LC-MS/MS measurements, integrated comparisons and
analyses of all protein database search results, and shared primary authorship with
Brandi Cantarel.
7.1: Introduction
Key questions in environmental microbiology include: (i) what microorganisms are
present in a particular environment, (ii) how are they functioning, and (iii) how does
community structure and function vary in response to environmental
conditions/changes? Recent technological advances have provided powerful
experimental approaches to address these questions, with 16S rRNA-based taxonomic
profiling providing extensive information about microbial composition, and metagenomic
whole-genome shotgun (WGS) sequencing/shotgun community proteomics, or
“metaproteomics,” providing insights into the composition and functional activities of
microbial communities. In particular, metagenome sequencing with next-generation
platforms has revolutionized the ability to measure and fully characterize the genomic
repertoire in microbial communities.
In order to successfully identify peptide sequences using mass spectrometry
(MS)-based proteomics methods, a relevant database of predicted genes derived from
genome or metagenome sequences is necessary. Peptide identifications result from
matching tandem mass spectra (MS/MS) against predicted fragmentation patterns of all
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possible in silico digested peptides using well-established programs[66,67,68].
Therefore, successful MS/MS sequence-database searching is critically dependent on
the quality and accuracy of the metagenomic predicted sequence database.
Although traditional MS-based proteomic analyses of single bacterial isolates are
well established, applying these methods to complex microbial communities can be
challenging for several reasons, including the lack of deep sequence coverage and
difficulty in assembling metagenomes from 454-reads. Considerable improvements in
mass spectrometers and chromatography have been made over the past decade;
however, the development of tools for optimizing metagenome-metaproteome sequence
matching has not kept pace, especially when using the shorter sequence reads
associated with next generation sequencing platforms such as the 454
pyrosequencer[175] and Illumina GAII[176].
While an increasing number of studies have developed computation methods for
proteogenomics[177,178] and begun to integrate metagenomic sequence data with
proteome measurements[42,43,44], these studies have primarily focused on either
single eukaryotic genomes or populations with low diversity, allowing for sufficient depth
of sequence coverage of abundant community members that facilitate proteome
identifications as compared to more complex microbial communities (e.g., human
microbiome, ocean, and soil). In the human distal gut, there are approximately 1,000
estimated species which represent >7,000 prokaryotic strains; therefore, the complete
metagenome is estimated to be >100 times the human genome [159]. Based on
previous studies of these exact same samples, we would expect ~ 30% of the proteins
identified by proteomics to be of human origin[26]. The challenges inherent in a
metagenomic-metaproteomic characterization of complex environmental samples
include (i) considerable sequence diversity among closely related strains/species, (ii)
large number of organisms for which no reference genome sequence is available and
(iii) low nucleotide sequence coverage for the microorganisms, especially low
abundance members.
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In the previous chapter, we demonstrated that whole community proteome
measurements were possible in the human gut microbiome, but were concerned with
the accuracy for how to handle extensive microbial protein redundancy in the
metagenomes. Thus, we stepped back to a applying a systematic bioinformatics
comparison and analysis of how to construct metagenomic sequence databases for
optimum metaproteome measurements. Here we present a benchmarking of strategies
for integration of metagenomic and metaproteomic data derived from the same human
gut microbiome samples. Although the metagenomes were not sequenced to
saturation, they were sufficient to enable us to evaluate how protein predictions based
on metagenome data impact peptide-spectrum assignments in matched metaproteomic
datasets (i.e., metagenome and metaproteome of the exact same sample). Using 454
pyrosequencing, 1,079 Mbp of DNA sequence was obtained from two fecal samples
obtained from a pair of healthy twins[158]. Using these data, four protein sequence
databases were created using several different assembly and gene finding strategies
(Figure 7.1). The resulting databases were evaluated for their utility in MS sequencedatabase searching.

Figure 7.1: Creation of protein sequence databases. Protein sequence databases were
created from metagenomic sequence reads using a variety of methods for assembly
and gene finding.
Assembly of metagenomic reads can potentially generate errors by joining
sequence reads that share sequence identity but are derived from different strains or
species. This can be further complicated by sequencing errors, such as issues with
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homopolymer tracts in 454 pyrosequencing datasets[179,180]. The metagenome
assembly strategies examined in this study were (i) assembly by sample, exemplifying
the traditional approach used for single isolate genomes, (ii) whole-dataset assembly, in
order to increase sequence coverage, and (iii) no assembly, which will theoretically
capture all sequence diversity present in a sample. Since sequencing errors can also
introduce frameshifts and in-frame stop codons, resulting in fragmented gene
predictions, we explored homology-based gene finding, as it allows the ability to ‘gap’
over sequencing errors, and de novo based gene finding which uses models of known
gene structure for prediction.
Proteomics approaches were also benchmarked to identify the parameters
necessary to create accurate peptide-spectrum matches (PSMs; a match of a given
MS/MS spectrum to a specific database peptide sequence) and increase protein
discovery by de novo peptide sequencing. Several MS-related parameters (spectral
quality, delta correlation (deltCN), and high mass accuracy (±10 ppm (parts-per-million))
were examined and proved to be helpful in providing more comprehensive, confident
PSMs. Moreover, we investigated how much de novo peptide sequencing would
increase peptide identification, since it provides novel sequences that were not originally
present in the sequence database (e.g., polymorphisms). By utilizing the genomic and
proteomic tools described in this study, we identified a strategy that increased the
number of PSMs and protein identifications in a complex microbial community that can
provide a more comprehensive and accurate characterization of the human gut
microbiome.
7.2: Experimental Methods
7.2.1: Samples, DNA and protein extraction
Fecal samples from two healthy female human individuals (a concordant twin pair),
numbered 6a and 6b, were collected under a separate study, as described and studied
previously[26]. Both samples were used for DNA and protein extraction. An additional
three twin pairs corresponding to six human fecal samples: numbered 15a and 15b
(concordant pair with Crohn’s disease), 16a and 16b (discordant pair, healthy 16a and
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16b with Crohn’s disease), and 18a and 18b (discordant pair, healthy 18a and 18b with
Crohn’s disease), were used for metagenomic sequencing only and were included in
several of the sequence databases as described in “Protein Database Construction.”
Therefore, a total of two healthy samples (6a and 6b) were used for metaproteomics
and eight (four healthy: 6a, 6b, 16b, and 18b and four diseased: 15a, 15b, 16a, 16b)
samples were used for metagenomics. Throughout the manuscript, the diseased
samples and individuals other than 6a and 6b are referred to as “unrelated” because we
are only focusing on 6a and 6b samples’ metaproteomes, thus, we have a “matched” or
“related” metagenome-metaproteome. Since these fecal samples were collected under
a separate research program and were supplied as de-identified information for this
study, this work was approved in March 2010 by the Oak Ridge Site-wide Institutional
Review Board (ORSIRB; Dr. Leigh Greeley, chair-person) as “human studies exemption
4”, IRB REFERENCE #: ORNL EX(10)-3.
Total genomic DNA was extracted using the MoBio PowerSoil DNA Isolation kit
(MoBio Laboratories, Carlsbad, CA) following the manufacturer’s recommendations.
Sample 6a was also extracted using the Zymo extraction protocol recently published by
Ravel and colleagues[181]. Each sample was then sequenced using Roche 454 FLXTitanium pyrosequencing according to manufacturer specifications. Raw sequence
data were processed using the Roche/454 run processing software to filter short, mixed,
and low quality reads. The sequencing generated 418K - 627M passed-filter reads and
170 – 381 Mbp per sample for the eight human fecal samples (15a, 15b, 16a, 16b, 18a,
18b, 6b, and 6a). Microbial cells (~100 mg cell pellet) and proteins were extracted and
processed for 2D-LC-MS/MS. The protocol for cell lysis and protein extraction has been
rigorously tested and developed by our laboratory[74,86] with specific details
corresponding to these samples detailed in Verberkmoes et al.[26].
7.2.2: Protein database construction
Starting with 454 pyrosequencing reads, four metagenomic processing methods (NM,
RM, RFM, and CAFM) were evaluated for the construction of predicted protein
databases (Figure 7.1 and Table 7.1). Sequences were first filtered for human
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contamination by alignment of reads to the human genome (v 36) using NUCMER[182]
using default parameters. The Newbler-Metagene (NM) protein sequence database
was created using the single-genome strategy by generation of a de novo assembly
followed by de novo gene finding. While there are a variety of gene prediction
algorithms available, we chose to focus on MetaGene Annotator[183], a platform that
we have extensive experience with for 454 sequencing datasets. Certainly, newer
approaches, such as Orphelia[184], MetaGeneMark[185], and FragGeneScan[186]
have appeared and shown promise for Illumina datasets; the accuracy of these
algorithms do not differ greatly for 300-400 bp reads and MetaGene Annotator is well
suited for assembled datasets.

	
  

139	
  

Table 7.1: Performance and comparison of the metagenomic predicted protein
sequence databases. The database composition and SEQUEST/DTASelect search
results (compute time, identified non-redundant spectra and peptides) with a 2-peptide
and deltCN of 0.08 filters are shown for samples 6a (Run 2 and 3) and 6b (Run 1 and
2).
Metagenomic
Predicted Protein
Sequence Database
Database Acronym
Number of Sequences
(thousand)
Number of Amino
Acids (million bp)
Compute Time Per
Run (minutes)
6a
Run 2
6a
Number of
Run 3
Non-redundant
6b
Spectra
Run 1
6b
Run 2
Total Spectra
Total number of PSMs
within ±10ppm
6a
Run 2
6a
Number of
Run 3
Non-redundant
6b
Peptides
Run 1
6b
Run 2
Total Peptides
Total NR Peptides

	
  

Raw
Celera
Raw
Raw Reads,
Newbler,
Raw
Reads,
Assembler, Newbler,
Reads,
FastX,
Metagene +
Reads,
Metagene
Fastx,
Metagene
FastX,
Metagene +
Kurokawa/Gill Metagene
Paired
Metagene
Metagene Kurokawa/Gill
Search
CAFM

NM

NM_KG

RM

RFM

RFM_KG

RMPS

1,844

190

540

1,903

1,520

1,907

2,146

200

45

115

189

173

262

191

670

80

320

750

1,060

1,030

435

5,179

6,235

10,441

9,100

9,074

10,975

13,806

4,326

5,376

9,272

8,152

8,538

10,330

18,401

4,092

5,615

10,830

8,639

8,480

11,254

12,363

3,873

5,800

10,724

8,775

8,573

11,167

12,212

17,470	
  

23,026	
  

41,267	
  

34,666	
  

34,665	
  

43,726	
  

56,782	
  

14,317	
  

16,906	
  

31,289	
  

26,181	
  

25,997	
  

33,347	
  

39,681	
  

4,383

3,093

5,678

4,710

4,669

5,911

7,592

3,655

2,403

4,617

3,804

3,963

5,068

6,303

3,404

2,426

5,409

3,919

3,879

5,549

5,923

3,216

2,297

5,088

3,747

3,690

5,238

5,605

14,658	
  
8,632	
  

10,219	
  
5,994	
  

20,792	
  
12,406	
  

16,180	
  
9,618	
  

16,201	
  
9,608	
  

21,766	
  
13,111	
  

25,423	
  
16,055	
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Shotgun sequences from each sample were assembled using the Newbler
Assembler (v2.0.01.14), and genes were predicted on contigs greater than 500 bp using
Metagene[187], resulting in a total of 153,586 predicted open reading frames (ORFs)
larger than 50 nt across a total of the seven metagenome samples included in this
study. The second database, Reads-Metagene (RM), was created by directly predicting
ORFs from raw sequencing reads to prevent loss of sequence diversity when collapsing
unrelated sequencing reads during genome assembly. ORFs were predicted using
Metagene, yielding 1,866,893 predicted ORFs larger than 50 nt. Sequencing errors
often seen in pyrosequencing datasets[179,180] can lead to artificially fragmented
predicted ORFs. Because these errors cause frameshifts and in-frame stop codons in
gene predictions, we used protein-to-DNA alignments, generated by sequence similarity
searches against NCBI’s NR using FASTX[188] with an expectation value threshold of
1e-6, to predict genes by homology. Homology-based gene finding was performed on
raw 454 sequencing reads yielding 1,483,958 predicted ORFs larger than 50 nt, called
Reads-FASTX-Metagene (RFM) protein database.
Additionally, three databases were created from assembled reads, with the intent
of creating longer genes and fewer protein fragments. The combination of short
sequencing reads, averaging 369 bp, and the high bacterial diversity found in the
human gut, produced a dataset with many fragmented genes. Since assembled
sequences were not much longer than raw sequencing reads, these genes were also
fragmented, therefore, we were unable to validate proteins identified by multiple peptide
matches. Thus, an assembly was created by combining the shotgun sequence data
from these samples using the Celera Assembler (v5.4), called Celera AssemblerFASTX-Metagene (CAFM), yielding 1,807,963 predicted proteins on all contigs and
singletons larger than 50 nt. Homology-based gene finding was also used for this
CAFM database, using the same parameters as RFM. In addition to sequences
generated in this study, we included the following published human gut metagenomic
datasets: two metagenomes from Gill et al. [22] and thirteen metagenomes from
Kurokawa et al.[24], that were concatenated with the NM (termed NM_KG) and RFM
(termed RFM_KG) sequence databases to provide additional sequence variation and
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increase proteome coverage. The metagenomes published from Gill et al.[22] (17,688
contigs; ORFs ≥ 20 amino acids; ~50,000 predicted proteins; available at the Joint
Genome Institute (JGI) IMG database under NCBI project ID 16729) and Kurokawa et
al.[24] (81,968 contigs; ORFs ≥ 50 amino acids; ~300,000 predicted proteins; available
at CAMERA (2007)) studies were sequenced via Sanger-based methods. The amino
acid sequence of the proteins belonging to the two samples’ metagenomes used in this
study (6a and 6b in addition to 15a, 15b, 16a, 16b, 18a, 18b) can be accessed through
the NCBI Protein Database under NCBI project ID 46321.
For each of the protein sequence databases described above (NM, CAFM, RFM,
NM_KG, and RFM_KG), we concatenated the metagenomic protein predictions from
multiple individuals into a single database. For example, NM, RM, RFM, and CAFM
each contain metagenomic sequences from seven individual human samples from this
study (15a, 15b, 16a, 16b, 18a, 18b, and 6b), which include an unrelated healthy
sample 16b (Figure 2 comparisons). The NM_KG and RFM_KG protein databases
contain the same 7 metagenomic predicted protein sequences (15a, 15b, 16a, 16b,
18a, 18b, and 6b), but unlike NM and RFM, contain the published 13 Japanese
metagenome sequences[24] and 2 American metagenome sequences[22] for a total of
22 concatenated metagenomes per protein sequence database.
Deeper whole genome shotgun sequencing was obtained from an extra run on
6b and an additional sample (6a), extracted using the Zymo and MioBio method, which
resulted in a four-fold increase in sequence data for these two healthy samples (Table
7.2). Due to the limitations of analyzing this larger metagenomic sequence dataset,
these sequences were processed similar to the RM strategy and compiled into 2independent protein databases, termed RMPS, for 6a and 6b in this assessment. Each
of these 8 protein databases (NM, NM_KG, CAFM, RFM, RFM_KG, RM, RMPS-6a and
RMPS-6b) included human reference sequences (July 2007 release, NCBI; ~36,000
protein sequences) and common contaminants (i.e., trypsin and keratin; 36 protein
sequences). Lastly, a 6-frame translation library was generated for sample 6a and
searched against one MS experiment.
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Table 7.2: Metagenomic sequencing metrics.
Metagenome
15a
15b
16a
16b
18a
18b
6a
6b
6b

LC Prep
1
1
1
1
1
1
1
1
2

DNA Extraction
MoBio
MoBio
MoBio
MoBio
MoBio
MoBio
MoBio
MoBio
MoBio

Total Reads
563,893
550,360
585,262
418,759
627,543
424,935
1,079,211
584,264
599,107

Total KiloBP
220,685
204,845
229,389
147,547
221,475
142,718
403,882
220,354
188,577

Avg Read Length
391
372
392
352
353
336
374
377
315

7.2.3: Spectral analysis
Microbial proteins were extracted and processed for 2D-LC-MS/MS as described[26]
using an Ultimate HPLC system (Dionex, Sunnyvale, CA) coupled to a high resolution
LTQ-Orbitrap (Thermo Fisher Scientific, San Jose, CA). Peptide mixtures from the two
samples, 6a and 6b, were separated by a 12 step, multidimensional high-pressure liquid
chromatographic elution consisting of eleven salt pulses followed by a 2 hr reversephase gradient from 100% solvent A (A: 95% H2O, 5% acetonitrile, 0.1% formic acid) to
50% solvent B (B: 30% H2O, 70% acetonitrile, 0.1% formic acid). Precursor full MS
spectra (from 400-1700 m/z) were acquired in the Orbitrap with resolution = 30,000
followed by five data-dependent MS/MS scans at 35% normalized collision energy in
the LTQ with dynamic exclusion enabled. All RAW files were converted to mzXMLs
using ReAdW (v4.3.1; 2009) and mzXMLs subsequently converted to dta files using
MzXML2Search (v4.3.1; 2009). All MS/MS were searched with SEQUEST (v.27)[66] for
fully tryptic peptides (≤ 4 missed cleavages, 3 Da parent mass tolerance window, 0.5 Da
fragment ion window) against each of the 8 custom-made FASTA formatted protein
sequence databases described above. Since it is well established that trypsin cleaves
primarily C-terminal to Arg and Lys[189], we have found in a variety of microbial
communities[42,190,191] that using fully tryptic searches provides increased confidence
in the peptide assignments while minimizing the potential for increased false positives
due to incorrect candidate peptide sequences. All SEQUEST output files were
assembled and filtered using DTASelect (v1.9)[98] at either a 2-peptide level for all
seven: NM, NM_KG, RM, RFM_KG, RFM, CAFM, and RMPS databases and also 1	
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peptide level for the RMPS database searches with the following widely accepted
parameters: cross correlation scores (XCorr) of at least 1.8, 2.5, 3.5 for +1, +2, and +3
charge states[42,92,98], respectively and a minimum deltCN of either 0.08 (default) for
all seven databases (NM, NM_KG, RM, RFM_KG, RFM, CAFM, and RMPS databases)
and/or 0.0 for NM, NM_KG, RFM, RFM_KG, RMPS-6a and -6b, and target-decoy
databases (described under “false discovery rates”). Post-translational modifications
and other fixed modifications were not included in the search criteria.
We used the high mass accuracy capabilities of the Orbitrap with a wide mass
tolerance to measure precursor ion (peptides) masses at low parts-per-million (ppm)
and the ion trap to efficiently measure fragment ions at lower resolution. A “postdatabase search” filter with high precursor mass accuracy was used by comparing the
theoretically derived peptide from the SEQUEST mass with what was observed in the
Orbitrap in the full scan preceding the MS/MS scan. Recently, Hsieh et al. indicated
that a wide precursor mass window in a database search[192] and a post-database high
precursor mass accuracy filter is a more superior method to control false positives.
Therefore, for post-filtering the database results by high mass accuracy, the mass
deviation (in ppm) of a PSM was calculated using the measured monoisotopic mass
and theoretical monoisotopic mass of the peptide. For all of the database searches
(NM, NM_KG, RM, CAFM, RFM, RFM_KG, RMPS-6b and -6a, and target-decoy
databases) and comparisons, DTASelect was run with a t0 option to report all MS/MS
spectra, in which case two spectra per protein, rather than two peptides, are required for
identification. We compared each of the database results in a relative fashion such that
all comparisons (degenerate peptides) are consistent to one another. Every MS/MS
spectrum that is assigned to a peptide (unique and non-unique peptides) was noted and
handled by DTASelect as described[98]; therefore, we recognize peptides that are
shared (non-unique) among multiple proteins. While we recognize that non-unique
peptides are somewhat problematic for label-free quantification using spectral counts,
this was not the focus of the current study.
Spectral quality assessment was accomplished utilizing an in-house developed
script that parses the SEQUEST output and mzXML formatted spectral data. All
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spectra collected during an analysis were categorized according to type: full scan (MS1)
or tandem mass spectra (MS/MS). MS/MS spectra assigned to a peptide by SEQUEST
were noted while the remaining unassigned MS/MS spectra were classified as highquality or poor based on the following conditions: a. the charge state of the parent ion
must be greater than 1, b. the minimum absolute intensity must be greater than 2500
counts, and c. greater than three fragment peaks within 20% of the based peak must be
present (all other details in preparation to be submitted for publication). To quantify the
peptide-spectrum success, MS/MS were categorized as (i) assigned or unassigned to a
peptide and (ii) if unassigned, a score of high-quality or poor as reflected by four
methods (NM, CAFM, RFM, and RMPS) and six databases (NM, CAFM, RFM,
RFM_KG, and RMPS-6a and -6b).
7.2.4: False discovery rates
A target-decoy database[96,126] was generated for each of the five metagenomic
processing methods (NM, CAFM, RM, RFM, RMPS), for a total of six forward-reverse
databases (RM, RFM, CAFM, KG, NM_KG, and RMPS-6b) and searched against one
of the two samples (6b) used in this study to estimate the peptide-level false discovery
rate (FDR) with the new metagenomic processing methods. One sample and technical
run (6b, Run1) was used to represent the entire sample set (2 samples; 4 runs) for each
target-decoy database search in order to reduce the total number of target-decoy
databases, search time, and complexity of comparisons. All target-decoy SEQUEST
output files were assembled and filtered using DTASelect (v1.9)[98] with the same
XCorr filters as described previously, and either a ≥1 peptide per protein with a deltCN
filter of 0.0, or a ≥2 peptide per protein with a deltCN of 0.0 (RMPS-6b) or 0.08
(NM_KG, CAFM, RM, RFM, and KG), with an empirical FDR threshold of ≤ 2.0%. The
initial, 1-peptide filter and deltCN 0.0, forward-reverse database searches provide FDRs
for NM_KG, CAFM, RM, RFM, KG, and RMPS-6b (read-based) database analyses
while the latter, 2-peptide and deltCN 0.08 filter, forward-reverse database searches
contain the same filtering criteria as the original forward databases (NM, NM_KG, RM,
RFM_KG, RFM, CAFM, and RMPS databases; Table 1 results) described earlier.
Finally, a forward-reverse database was also created for the final paired metagenome
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sequence strategy (RMPS) for 6b and searched against the spectra collected from 6b,
Run 1 and Run 2 using a deltCN 0.0, 1-peptide minimum, and high mass accuracy
filtering. The identified peptides (both forward and reverse) were then mapped back to
the protein sequences derived from the assembled metagenomic sequences using a
post-database 2-peptide filter by exact string comparisons. Although the peptides with
corresponding high mass accuracy measurements (±10 ppm) were considered for all
downstream analyses, the peptide-level FDRs were estimated for both, with (-10 ≤ ppm
≤ 10) and without (ppm < -10 and ppm > 10) high mass accuracy, for 6b, Run1 against
six genomic processing methods (NM_KG, CAFM, RM, RFM, KG, and RMPS-6b).
Each protein entry (sequence) was reversed, i.e., the original N-terminus became the Cterminus. The new reverse (false) sequences were then appended onto the backend of
the original forward sequences where each set, forward and reverse, represents 50% of
the entire database. A peptide-level FDR was calculated based on the calculation:
2[nrev/(nrev + nreal)]*100 where nrev is the number of peptides identified from the reverse
database and nreal is the number of peptides identified from the real (forward)
database[96].
7.2.5: Sequences similarity searches
Peptides obtained from our SEQUEST/DTASelect searches were searched against the
6b and 16b protein databases using the FASTS algorithm and against raw sequencing
reads using TFASTS[193], algorithm that compares peptides to DNA sequence, using
an e-value cutoff of 10-5.
7.2.6: De novo sequencing of peptides by MS
PepNovo+[105] and PEAKS[109] algorithms were used to de novo sequence MS/MS
spectra collected from both samples, independent of all sequence databases. The
PEAKS (v4.5 SP2) algorithm computes the best possible sequence among all probable
amino acid combinations at a full peptide length confidence followed by individual amino
acid confidence per residue in the predicted sequence for a MS/MS. PEAKS was run
with default parameters with a parent mass error tolerance of 0.5 Da, fragment mass
error tolerance of 0.5 Da, and trypsin digestion. First, a 90% confidence level was
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required for the overall, full length prediction to be correct and second, an 80%
confidence level was required for each residue within that sequence, which is consistent
with Ma et al.[109]. PepNovo+ (v3.1) was executed using the following recommended
parameters: -model CID_IT_TRYP -digest TRYPSIN -pm_tolerance 0.05 num_solutions 5 -output_cum_probs. The top-scoring tags of all spectra were filtered
using a cumulative probability cutoff of 0.5. In the sequence tags produced from both
algorithms, the isobaric amino acid pair of Isoleucine (I) and Leucine (L) and the nearly
isobaric pair of Lysine (K) and Glutamine (Q) are considered equivalent. L and I were
both substituted with the letter, J, for convenience. Additionally, Q and K were
substituted with the letter, U, since they are not easily resolvable (small mass difference
of 0.036 Da) with ion trap MS/MS data. For all three algorithms, SEQUEST, PEAKS,
and PepNovo+, a minimum of 3 residues has to be assigned to a spectrum for it to be
considered for any additional analysis and comparison to other algorithms. For PEAKS,
only the high confidence sequence tag was used for all analyses, not the predicted fulllength peptide sequence. For the comparison of PSMs between all three algorithms, a
“partial” consensus sequence was considered as a peptide sequence that has ≥3 amino
acids that are exactly the same for the same mass spectrum between either SEQUEST
peptide sequences, Peaks’ high confidence sequence string, and/or Pepnovo+s’
sequence tag. If a PSM has an “exact” consensus sequence with 100% sequence
identity between any two or more algorithms, it would be considered a shared, exact
consensus sequence. If a PSM does not have at least 3 residues within a peptide
sequence string that match two or more algorithms, that spectrum would be considered
unique to that algorithm. The identified SEQUEST/DTASelect PSMs for RMPS-6a and 6b sequence databases with a 1-peptide minimum and deltCN of 0.00 for 6a (Run 2 and
3) and 6b (Run 1 and 2) were compared to the PSMs from PEAKS and PepNovo+. The
breakdown of partial and exact consensus sequences versus PSMs that are unique to a
specific algorithm can be found in the Venn diagram. We did not take into account any
single amino acid polymorphisms in the algorithms’ consensus sequence comparisons.
In this study, we controlled the false discovery rate by only using the high confidence
consensus sequences tags found between the two de novo algorithms using their
respective optimum parameters.
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7.3: Results
7.3.1: Protein sequence database comparison
Four protein prediction strategies (Figure 7.1) were implemented for metagenomic DNA
sequences obtained from two healthy human fecal samples (referred to as 6a and 6b),
using a combination of assembly and gene prediction methods. Each protein sequence
database has a defined acronym (2-4 letters), designating the strategy used (Figure 7.1
and Table 7.1). Our goal was to increase peptide-spectrum matches (PSMs) using MS
database searching for which the MS data was collected from the same samples as the
DNA sequence data. The ability to accurately match peptides to tandem mass spectra
(MS/MS) was assessed by comparing the number of PSMs and unique peptides
identified for each database search with SEQUEST/DTASelect at a 2-peptide level,
deltCN 0.08, and XCorr filtering against the same 2 samples, 6a (with spectra from runs
2 and 3) and 6b (with spectra from runs 1 and 2) (Table 7.1). These results illustrate
how common metagenomic processing methods (assembly and ORF finding) affect
peptide and spectra identification (Table 7.1). From these results, three major trends
emerge: (A) Collapsing of the sequence data by assembly decreases the number of
assigned spectra. There was a decrease of assigned spectra when all reads were
assembled from all samples compared to assembly by individual sample (NM, 23,026
spectra vs. CAFM, 17,470 spectra). Additionally, if reads are annotated without
assembly, PSMs increase (NM, 23,026 spectra vs. RM, 34,666 spectra). This can be
largely attributed to the increased diversity of possible peptides, determined by in silico
trypsin digestion, in the unassembled data, which is over 3 times what is found in
assembled data (5,638,100 vs. 1,639,802). (B) An increase in spectrum assignment
usually translates to an increase in unique peptide identifications. For example, the
11,640 gains in spectral assignment translate to a 3,624 gain in identification of unique
peptide sequences for RM compared to NM (Table 7.1). However, this was not
observed when comparing CAFM to NM, where the 5,556 gains in spectra assignment
translated to a decrease of 2,638 unique peptides (Table 7.1). (C) De novo gene
finding methods are sufficient for optimal spectrum assignment. The combined de novo
and homology-based gene finding method did not increase PSMs as hypothesized
	
  

148	
  

(RFM, 34,665 spectra vs. RM, 34,666 spectra) nor the number of identified unique
peptides (RFM, 9,608 peptides vs. RM, 9,618 peptides; Table 7.1).
Because of the low relative sequence coverage of our metagenomic samples, we
wanted to evaluate whether adding metagenomic sequences from 15 unrelated
samples in two published studies would enhance our spectrum assignment. Therefore,
to protein databases NM and RFM, we added the proteins sequences from predicted
ORFs from two published human gut metagenomic studies, referred to as “KG” for
Kurokawa et al. and Gill et al.[22,24], which are referred to as NM_KG and RFM_KG
respectively. The KG database contains 13 metagenomes from a Japanese cohort[24]
and 2 metagenomes from an American cohort[22], both geographically distinct from
samples in this study. When compared to the metagenomic sequences in this study,
only 9% of sequences align in KG at 99% identity or greater; thus, they provide over 2
million additional unique peptides for MS/MS assignment, that are not identified in any
of the matched metagenomes. Because the assemblies from these studies are on
average longer (average contig length of 2,300 nt for Kurokawa et al. compared to an
average contig length of 1,128 nt in this study), the predicted proteins are more likely to
be full-length compared to ORFs in this study (average protein length of 194.5 aa for
Kurokawa et al. metagenomes; average protein length of 225 aa for Gill et al.
metagenomes compared to an average protein length of 168.5 aa in this study). By
including metagenomic sequence from additional sources[22,24], the number of
identified spectra increased (NM versus NM_KG (23,026 versus 41,267 spectra) and
RFM versus RFM_KG (34,665 versus 43,726 spectra)) for 6a (Run 2 and 3) and 6b
(Run 1 and 2) in total (Table 7.1). However, the additional KG sequence data came at
the cost of increased peptide degeneracy and subsequent protein redundancy (i.e.,
peptides mapping to multiple proteins or to the same protein in multiple metagenomes
within the sequence database). Although the level of redundancy ranges with the
sequence diversity of a sample and has no effect on the actual database search
algorithms, this complicates protein inference and assigning its’ corresponding
phylogenetic origin in a complex environmental community.
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While the four metagenomic processing methods were compared based on their
ability to comprehensively assign all collected MS/MS spectra to peptides, the
percentage of assigned and high-quality unassigned MS/MS is equally important to
establish the utility of each sequence database. For the following spectral analyses, the
collected and assigned spectra from sample 6a (Run 2 and 3) and 6b (Run 1 and 2)
were assessed and categorized after applying the same filters described above (2peptide level and deltCN 0.08 filter) with the following databases. Of the total MS/MS
collected during one MS experiment (70,000-81,000), on average 6,600 spectra were
assigned to a peptide sequence in the NM database (~8% of total collected MS/MS
spectra for a single run; Table 7.3). In contrast, the processing strategy used to create
RFM resulted in the assignment of an additional 1,800 MS/MS from the same sample,
for a total of 8,430 peptide-spectrum matches on average (11% of total collected
MS/MS). Furthermore, the addition of unrelated KG sequences to RFM (a 25%
increase in sequence data) resulted in an increase of the number of assigned spectra
by only 2-3%. Finally, the strategy used to create RMPS resulted in an additional 4,000
MS/MS spectra assigned, for a total of 12,461 peptide-spectrum matches on average
per sample (16% of total collected MS/MS spectra). Although the total number of
assigned MS/MS increased from NM < RFM < RFM_KG < RMPS, the number of
unassigned, high-quality spectra decreased with database quality (NM > RFM >
RFM_KG > RMPS).
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Table 7.3: Database dependent distribution of acquired full MS and MS/MS and
assigned MS/MS for samples 6a and 6b. Unassigned MS/MS were parsed into either
quality or poor spectra.
Sample

Run # Database

Run 2
6a
Run 3

Run 1
6b
Run 2

NM
CAFM
RFM
RFM_KG
RMPS
NM
CAFM
RFM
RFM_KG
RMPS
NM
CAFM
RFM
RFM_KG
RMPS
NM
CAFM
RFM
RFM_KG
RMPS

Total Spectra
Collected

# MS1
Collected

# MS/MS
Collected

94,379

15,998

78,381

85,191

14,685

70,506

97,907

16,705

81,202

97,301

16,504

80,797

#
%
Assigned Assigned
MS/MS
MS/MS
6,163
7.86
8,872
11.32
8,854
11.30
10,576
13.49
13,426
17.13
5,301
7.52
7,918
11.23
8,305
11.78
9,911
14.06
12,413
17.60
7,434
9.15
8,391
10.33
8,234
10.14
10,778
13.27
12,077
14.87
7,498
9.28
8,517
10.54
8,327
10.31
10,715
13.26
11,927
14.76

# Unassigned
MS/MS

# of Quality MS/MS
(ID'd + Qual Unass.)

# Poor Unass.
MS/MS

# Quality
Unass. MS/MS

72,218
69,509
69,527
67,805
64,955
65,205
62,588
62,201
60,595
58,096
73,768
72,811
72,968
70,424
69,125
73,299
72,280
72,470
70,082
68,870

13,375
15,681
15,622
16,983
19,139
6,752
9,215
9,522
11,041
13,390
16,380
16,921
16,802
18,698
19,543
16,893
17,594
17,447
19,182
20,124

65,006
62,703
62,759
61,398
59,242
63,754
61,291
60,984
59,465
57,119
70,222
64,281
64,400
62,504
61,659
63,904
63,203
63,350
61,615
60,673

7,212
6,809
6,768
6,407
5,713
1,451
1,297
1,217
1,130
977
8,946
8,530
8,568
7,920
7,466
9,395
9,077
9,120
8,467
8,197

The effects of two common filtering parameters (deltCN and high mass accuracy)
on MS/MS peptide assignment were examined by determining the quantity of MS/MS
spectra not assigned to the same peptide in multiple database searches (Supporting
Text). These results (Figure 7.2) suggest that filtering on high mass accuracy rather
than deltCN can decrease ambiguous peptide-spectrum matches and provide more
consistent and reproducible MS/MS identifications. In order to maintain high specificity
and accuracy with increasing metagenomic sequence data, a false discovery rate (FDR)
was estimated at the peptide level using an established method of reverse database
searching[96,126] for each metagenomic processing method for a total of 6 targetdecoy databases (RM, RFM, CAFM, KG, NM_KG, RMPS-6b). Because we are using
methods that directly measure peptides, not proteins, the FDR was estimated at the
peptide level. In addition, we are primarily comparing the performance of all databases
by peptide-spectrum matches, not proteins, given the nature of the metagenomic
processing methods and their corresponding databases (i.e., not all databases contain
assembled contigs, but only reads). It has previously been noted[75] that false
discovery rates can be difficult to accurately determine with metaproteome datasets due
to problems associated with massive peptide degeneracy. In this study, for example, of
all the identified peptides for 6a (Run 2), only 7-30% were unique peptides from each
database. Consequently, if only unique peptides are used, the false discovery rate
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would be overestimated; on the contrary, if all peptides are used the false discovery rate
could be underestimated[75]. Therefore, to set a static FDR threshold and filter multiple
databases (6 sequence databases in this study) of different sizes and internal levels of
peptide redundancy to that threshold (i.e., 1%) becomes a challenge, in this case, for
comparing and identifying the best metagenomic processing method for MS/MS
database searching and peptide-spectrum matching. As the level of redundancy affects
the FDR, we have chosen a set of fixed scoring filters in order to accurately compare
database assignments. Thus, the same filter criteria to all database searches (i.e.,
Xcorr and ppm filtering) was applied to all database searches with a requirement that
the FDR be less than or equal to, i.e., 2.0%. The FDRs for the 1-peptide level, deltCN
0.0, with and without HM filtering were 1.17%-2.03% and 16.09-31.47%, respectively for
6b, Run 1 (Table 7.4). The 2-peptide level and deltCN 0.08 filtered reverse database
searches serve to represent the FDR of peptide identifications found in Table 1. The
FDRs for these PSMs, with and without HM filtering were within 0.09%-0.38% and 2.174.15%, respectively for 6b, Run 1 (Table 7.5). Following the application of a postdatabase high precursor mass accuracy filter (± 10 ppm) to both, the 1- and 2-peptide
filtered forward-reverse datasets, the number of identified reverse peptides decreased
by, on average, 93% for each database which resulted in a reduction of the FDR to
0.09%-0.38%.
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Figure 7.2: Accuracy Assessment by DTASelect Filtering. (A) For each DTASelect
peptide prediction search, the number of identified spectra was calculated and
compared using three different parameter combinations, deltCN filtered results at a
deltCN of 0.08 only, both deltCN of 0.08 and HM (±10 ppm), and HM (±10 ppm) only,
where identified peptide sequences were designated either ‘Consistent’ (solid gray) or
‘Inconsistent’ (diagonal stripes). (B) A VENN diagram with assignable spectra for RFM,
RFM_KG, NM, and NM_KG databases, filtered by high mass accuracy, for both
samples combined.
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Table 7.4: False discovery rates for sample 6b (Run 1) against six different
metagenomic-predicted sequence databases. The database results were filtered at a 1peptide level with and without high mass accuracy.
Sample

6b, Run1

Database
(Forward/Reverse)
RM
RFM
CAFM
KG
NM+KG
RMPS

Total Identified Forward
<±10 ppm
>±10 ppm
19,589
8,747
18,229
8,375
17,443
7,676
20,059
7,672
23,881
8,709
27,218
8,722

% of Forward Identified
<±10 ppm
>±10 ppm
69.13%
30.87%
68.52%
31.48%
69.44%
30.56%
72.33%
27.67%
73.28%
26.72%
75.73%
24.27%

Total Identified Reverse
<±10 ppm
>±10 ppm
321
4,551
320
4,648
277
4,094
256
3,419
256
3,603
228
2,917

False Discovery Rate
Total FP FP <±10 ppm
29.34%
1.93%
31.47%
2.03%
29.64%
1.88%
23.40%
1.63%
21.17%
1.40%
16.09%
1.17%

Table 7.5: False discovery rates for sample 6b (Run 1) against six different
metagenomic-predicted sequence databases. The database results were filtered at a 2peptide level with and without high mass accuracy.
Sample

6b, Run1

Database
(Forward/Reverse)
RM
RFM
CAFM
KG
NM+KG

Total Identified Forward
<±10 ppm
>±10 ppm
15,363
3,523
13,971
3,057
13,783
2,902
16,840
3,695
19,898
4,320

% of Forward Identified
<±10 ppm
>±10 ppm
81.35%
18.65%
82.05%
17.95%
82.61%
17.39%
82.01%
17.99%
82.16%
17.84%

Total Identified Reverse
<±10 ppm
>±10 ppm
27
310
33
328
16
291
15
248
11
255

False Discovery Rate
Total FP FP <±10 ppm
3.51%
0.28%
4.15%
0.38%
3.61%
0.19%
2.53%
0.14%
2.17%
0.09%

7.3.2: Tracking Missing Peptides
By adding the unrelated KG metagenomic sequences to the RFM protein database, the
number of additional predicted unique peptide sequences increased by 40%.
Therefore, we wanted to determine how many additional peptide-spectrum matches
were gained by adding these KG proteins sequences to the database. The RFM_KG
assigned MS/MS were distributed into three different categories: RFM only, KG only,
and RFM plus KG (shared) for each sample (Table 7.6). The majority of RFM_KG
assigned spectra were “shared” between both RFM and KG protein sequences. About
26% of the total spectrum assignments were unique to the RFM protein sequences
(zero overlap with KG sequences) and only ~8% of the spectra were unique to the KG
protein sequences (no overlap with the RFM sequences) (Table 7.6).
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Table 7.6: Distribution of RFM_KG assigned PSMs for 6a (Run 2 and 3) and 6b (Run1
and 2). The assigned PSMs were distributed into three different categories: RFM only,
KG only, and RFM plus KG based on their sequence uniqueness to each set of
sequences. If a PSM was unique to protein sequences in RFM, but was not present in
KG, the PSM was classified and categorized as RFM only and vice versa. If a PSM
was found to match a protein in both, RFM and KG, the PSM was categorized as a
shared spectrum.

Sample
6a, Run 2
6a, Run 3
6b, Run 1
6b, Run 2
Runs Averaged

Unique
Spectra
8,012
6,995
5,651
5,595
6,563

RFM Only
% of RFM & KG
Spectra
34.33%
31.20%
27.09%
28.29%
30.23%

% of Total
Spectra
30.35%
27.73%
23.64%
23.93%
26.41%

RFM_KG Database
Kurokawa & Gill (KG) Only
Unique
% of RFM &
% of Total
Spectra
KG Spectra
Spectra
1,454
6.23%
5.51%
1,341
5.98%
5.32%
2,431
11.65%
10.17%
2,149
10.86%
9.19%
1,844
8.68%
7.55%

Shared
Spectra
13,869
14,085
12,779
12,036
13,192

RFM and KG
% of RFM &
KG Spectra
59.43%
62.82%
61.26%
60.85%
61.09%

% of Total
Spectra
52.53%
55.84%
53.46%
51.48%
53.33%

Total Assigned
Spectra
26,403
25,223
23,902
23,378
24,727

There are two possible hypotheses for why the metagenomes from these
samples (i.e., RFM) cannot be used to assign peptides to spectra which are assignable
by the unrelated protein database KG: (1) because of low sequencing depth, peptides
are not assigned because our protein database is incomplete or (2) because of a
sequencing error or limitation for predicting ORFs, we are unable to predict the proteins
that are present. Therefore, we have aligned the RFM_KG (2-peptide, deltCN 0.08, HM
filtered) identified peptides (Figure 7.3, y-axis) from 6a (left panel) or 6b (right panel) to
predicted raw reads from the related/same sample (6b) and an unrelated sample (16b)
(Fig. 7.3, x-axis) using TFASTS (Fig. 7.3, white, fine striped bars). Those results were
compared to alignments of the same identified peptides to the predicted protein
database from the related/same sample (6b) and the unrelated sample (16b) using
FASTS[193] (Fig. 7.3, gray, solid bars). As expected, more peptides mapped to the
related/same (matched metagenome-metaproteome) sample (15% for 6a: left panel,
Fig. 7.3 and 6b: right panel, Fig. 7.3) than to the unrelated, 16b, predicted protein
sequences (8% for 6a and 10% for 6b). When these same peptides were compared
using TFASTS (algorithm that compares peptides to DNA sequence) to the raw
sequencing reads (Fig. 7.3, white, fine striped bars), the number of peptides matching to
reads increased by two-fold for both 6a and 6b.
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Figure 7.3: Comparison of identified peptides using sequence similarity techniques.
Percentage of matches found when comparing identified peptides from sample 6a (left
panel) or 6b (right panel) to predicted proteins using FASTS (gray bars) and raw
sequencing reads using TFASTS (white striped bars).
7.3.3: Targeting Peptide Discovery
Throughout the course of our study, we were able to accumulate more metagenomic
sequence data for the two healthy samples, 6a and 6b, by ~5 fold (Table 7.2, italicized
text). Although this increase in predicted ORFs resulted in an increase in the number of
assigned MS/MS spectra, it can reduce the throughput of MS/MS sequence-database
searching. Therefore, we investigated the impact of searching a metagenomic-based
protein database derived from the exact same single sample to that of a concatenated
sequence library of all available metagenomic data from this study. The additional
metagenomic sequences were used to construct a sequence database similar to that of
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RM (non-assembled reads with 5.6 million predicted unique peptides), called RMPS
(Figure 7.1) which has ~ 1.3 million predicted unique peptides, on average, per healthy
sample 6a and 6b. Searching the RMPS sequence databases with SEQUEST using
standard 2-peptide, deltCN 0.08, and high mass accuracy filtering decreased the
compute time to ~ 300-500 minutes per MS raw file. By increasing the amount of
metagenomic sequence data for a single sample, the total number of assigned spectra
increased by 63% (from 34,666 to 56,782) and the number of total identified nonredundant (NR) peptides increased by 67% (from 9,618 to 16,055) (Table 7.1, RM
versus RMPS), resulting in a 54% increase in protein identifications (3,394 to 5,233)
when mapping these peptides to a protein dataset generated from assembled reads for
the exact same metagenomic sample.
Other than limitations associated with computational resources, there was also a
concern that real peptides predicted from 454-reads would be filtered out given a 2peptide per protein minimum filter (Table 7.7, top panel). Therefore, the filtering
parameters were readjusted with a deltCN 0.0, 1-peptide minimum, and a high mass
accuracy filter (±10 ppm) for the SEQUEST RMPS database searches for both 6a (Run
2 and 3) and 6b (Run 1 and 2). The identified peptides were then mapped back to the
predicted protein sequences derived from the assembled metagenomic sequences with
a 2-peptide filter, resulting in an increase of protein identifications, from 5,233 to 6,186
(Table 2, RMPS top panel versus bottom panel). The filtering parameters were also
readjusted with a deltCN 0.0 and a high mass accuracy filter (±10 ppm) for the
SEQUEST-RFM database searches for both 6a (Run 2 and 3) and 6b (Run 1 and 2).
The protein identifications also increased, from 3,431 to 3,706 (Table 7.7, RFM top
versus bottom panel). While this increase might seem minimal, there is significantly
less redundancy, less false positives, and no computational cost added to these filtering
parameters. The false discovery rate, using the same filtering parameters (deltCN 0.0,
1-peptide minimum and HM) for the RMPS database was 1.17% for 6b (Table 7.4),
however, these identified peptides (≥ 1 peptide/read) were mapped back to the
predicted protein sequences derived from the assembled metagenomic sequences
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using a post-database ≥2-peptide/protein filter. Following application of this 2peptide/protein filter, the FDRs dropped to 0.1%-0.2% for 6b, Run 1 and 2 (Table 7.8).
Table 7.7: Comparison of RFM and RMPS database results with different filtering
metrics and a post-database mapping strategy. Comparison of SEQUEST/DTASelect
database search results, non-redundant spectra and protein counts with different
filtering parameters and HM, post-database mapping of identified peptides to a protein
dataset generated from assembled reads for the same metagenomic sample.
Protein Database

RFM

RMPS

2-peptide, deltCN 0.08, HM Filter
Spectra

Protein

Spectra

Protein

6a Run 2

3,246

1,154

6,542

1,761

6a Run 3

3,091

1,010

6,237

1,544

6b Run 1

2,639

637

5,212

973

6b Run 2

2,552

630

4,870

955

Total

11,528

3,431

22,861

5,233

1- or 2-peptide, deltCN 0.0, HM Filter
Spectra
Peptide Criteria

Protein

≥ 2 peptide

Spectra

Protein

≥ 1 peptide

6a Run 2

3,541

1,252

7,497

2,069

6a Run 3

3,346

1,088

7,048

1,808

6b Run 1

2,879

686

5,881

1,182

6b Run 2

2,786

680

5,502

1,127

Total

12,552

3,706

25,928

6,186

Table 7.8: False discovery rates for sample 6b (Run 1 and 2) against the RMPS
database. An initial ≥1-peptide, deltCN 0.0, and high mass accuracy (±10ppm) filter
were applied to the read-based identifications followed by a ≥2-peptide/protein postdatabase mapping filter.
Sample
6b, Run 1
6b, Run 2

	
  

Total
Peptides
5,500
5,325

Non-redundant
Peptides
3,765
3,538

Total Identified
Forward Peptides
5,498
5,316

Non-redundant
Forward Peptides
3,763
3,535

Total Identified
Reverse Peptides
2
9

Non-redundant
Reverse Peptides
2
3

Total
FDR (%)
0.07
0.34

Non-redundant
FDR (%)
0.11
0.17
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7.3.4: De novo Peptide Sequencing
Two popular algorithms, PepNovo+[105] and PEAKS[109], were used to identify peptide
sequences de novo from MS/MS spectra collected from both samples, independent of
all protein sequence databases. Initially, the two algorithms were run independently on
the same raw MS data and samples as described. The identified, high confidence
consensus sequence tags (≥3 residues) were acquired from each de novo algorithm.
The de novo consensus sequence tags (Supporting Text) for PEAKS and Pepnovo+
were compared for every MS/MS to identify the partial (≥3 residues) and exact
consensus sequence tags that would represent the most confident PSMs identified by
the two different de novo algorithms. In this study, it was not our goal to compare the
performance of the two programs; instead, we want to combine the best results from the
two programs using their respective optimum parameters. The final, representative de
novo consensus tags were compared to the previously mentioned SEQUEST results
from the RMPS sequence database searches that were filtered at a ≥1 peptide/read,
deltCN 0.0, and high mass accuracy with a post-database ≥2 peptide/protein filters.
On average, ~593-724 MS/MS spectra were assigned with a high confidence
consensus peptide sequence between the two de novo algorithms, but were not
assigned with the SEQUEST–RMPS database search (Figure 7.4). These de novo
peptide sequences were mapped to protein sequences predicted from assembled
contigs with a 2-peptide minimum per protein and compared to the peptides that were
identified from the SEQUEST-RMPS database searches. A total of 421 new, nonredundant proteins were identified with the de novo sequenced peptides for
metagenome 6b, and 333 non-redundant proteins for metagenome 6a; these proteins
were not identified using SEQUEST. Approximately 450 de novo sequenced peptides
(non-redundant) per sample could not be mapped to the matched metagenomic
sequence data.
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Figure 7.4: Performance and comparison of de novo peptide sequencing results.
Distribution of assigned spectra per de novo algorithm with a predicted consensus
sequence (partial and/or exact sequence match) among all three algorithms, PEAKS,
PepNovo+, and SEQUEST. Identified peptides from SEQUEST and RMPS sequence
database were compared to the de novo predicted peptides for (A) 6a and (B) 6b.
7.4: Discussion
One of the major goals of MS-based proteomics is to comprehensively identify the
protein complement of a given sample (isolate, mixture, or community). The
proteome(s) of microbial communities are highly complex and pose numerous
challenges for MS experimentation and analysis. These challenges include the
dynamic range of peptide abundances and a number of informatics hurdles, such as
differentiation between closely related species, identification of sequence
polymorphisms, and global identification of post-translational modifications. Many of the
algorithms used in MS/MS database searching are based on the assumption that a
protein is derived from a single organism with little sequence diversity. However, these
assumptions are no longer valid in the case of complex microbial communities. This
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study presents several strategies for improving metagenomic guided MS-based
metaproteomic peptide-spectrum matching in complex samples.
It has become very clear that the quality of metagenomic sequence data and
resulting protein sequence database has a significant impact on community MS-based
proteomics and the ability to achieve deep proteome coverage. This study initially
explored how assembly and gene finding methods for metagenomic sequences affects
peptide-spectrum matching. Our findings suggest that predicting ORFs from an ab-initio
gene finder on metagenomic reads provides the best database for maximal MS/MS
assignment. While assembly of metagenomic data can greatly reduce the necessary
compute time for gene finding and database searching, it essentially collapses
sequence diversity; thus, it is sub-optimal for maximal spectral assignment. Yet,
introducing a homology-based gene finding method (RFM) does not increase the
number of assigned spectra. Lastly, with an increase in sequence coverage for a
biological sample, our results suggest that predicted protein sequence databases
derived from matched metagenomic sequenced reads (RMPS), increases the number
of MS/MS spectra, peptides, and protein identifications. In conclusion, expanding the
metagenomic sequence library for matched or related samples improved peptidespectrum matching. However, improvements in gene finding are equally important to
maximize protein identification and coverage.
As the matched metagenomic predicted protein sequence database (RMPS)
more accurately reflected the “true proteome”, previously unassigned high-quality
spectra are now being identified and provided greater proteomic depth. When these
results were compared to a standard bacterial isolate (e.g., E. coli) with a well-curated
genome, ~ 41,000 MS/MS spectra were assigned to peptides (37% of total collected
MS/MS) (data not shown) using the same database searching filters (≥2 peptide and
deltCN 0.08). This would suggest that underlying challenges are still inhibiting the
identification of a majority of spectra collected from the community samples compared
to that of a standard bacterial isolate. The classification of acquired and assigned
MS/MS spectra and quantification of total identified peptides suggested that the RMPS
processing method provided the most comprehensive assignment of MS/MS spectra.
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When we examine why some peptides are assigned from the read-based ORFs
(e.g., RMPS processing method) and not assigned from the contig-based ORFs (e.g.,
NM processing method), we find that these “lost peptides” fall into three categories: (i)
some reads are not assembled and therefore their protein predictions are not in the
contig-based ORF predictions, (ii) because of SNPs and frameshifts, the peptides are
100% similar to a predicted contig-based ORF, but are not 100% identical, and (iii)
some peptides were very different (<50% identical) or missing from the contig-predicted
ORF. A 6-frame translation protein database was generated for sample 6a to capture
all possible candidate peptide sequences and searched against one MS experiment
(Run 2). However, routine use of this sequence database is impractical due to the
increased quantity of sequences which directly correlates with an increased quantity of
candidate peptides, therefore, more scoring and prohibitively large search times (~134
hrs per MS experiment) (data not shown). As sequencing data generation increases,
even a read-based strategy could become unsustainable, which will only worsen as new
larger ‘omic’ datasets become available. The testing and comparison of new search
algorithms that are faster, accurate, and developed for omic’ datasets may help
researchers overcome these challenges.
Identifying the most reliable set of peptides from a MS-based metaproteomic
experiment can be complicated, as we have shown that MS/MS assignments can vary
and be assigned to different peptide sequences with different protein databases. While
filtering on deltCN is a common practice for reducing false positives, this type of filtering
may (i) continue to include many ambiguous peptides based on the different database
predictions and (ii) remove many legitimate peptides as a result of a highly redundant
database. Although filtering on deltCN and peptide-protein matches has proven
effective for single genome searching, these filters decrease both precision and
sensitivity in metagenomic predicted sequence databases. As common filtering
strategies have proven to be less effective and practical for large-scale proteomics
studies (e.g., post-translational studies), these and other challenges will surface as the
MS field moves towards sampling more environmental communities. Alternatively, we
propose that when high mass accuracy is used in conjunction with other filtering
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metrics, such as, cross correlation (XCorr) and enzyme cleavage specificity, one can
confidently identify the most comprehensive and reproducible set of PSMs and control
false positives adequately in a complex environmental community sample. As shown,
this strategy greatly reduces the rate of ambiguous peptide predictions thereby giving
higher confidence to our final peptide-protein identifications. Once peptides are
identified and mapped to metagenomic sequences, which have been assembled, the
subsequent use of a 2-peptide filter greatly reduces the number of false positives in
protein discovery for complex microbial environments.
Finally, de novo peptide sequencing can complement MS/MS database
searching to identify peptides absent in the protein sequence database due to the
limitations of the gene finding algorithms or low metagenomic sequence coverage. We
believe that novel peptides were identified with high confidence in this study, because
these peptides were independently identified by two de novo sequencing algorithms.
However, there is no widely accepted method for us to use for rigorously evaluating the
FDRs of novel peptides identified from our microbial community samples. Thus, de novo
sequencing results should be used with the caveat of uncertain FDRs as supplement to
database searching results[194].
7.5: Conclusions
By using a variety of MS filtering metrics, we were able to assess the quality and
accuracy of MS/MS peptide sequencing for each MS experiment against four predicted
protein sequence databases derived from whole genome shotgun sequences. Our
findings suggest that: (i) proteomic data is twice as likely to match metagenomic data
derived from the same sample, (ii) although unrelated metagenomic data may capture
more sequence diversity, large protein databases can create unreasonable sequence
redundancy, thereby hampering the ability to differentiate real peptide-protein
identifications, (iii) the percentage of unassigned, high-quality MS/MS spectra
decreases with increased quality of metagenomic sequences, (iv) metagenomic data
processing, such as assembly and gene finding, affects the ability to assign peptides to
spectra, (v) MS filtering metrics can affect the accuracy of peptide-spectrum matching,
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(vi) deeper metagenomic sequencing coverage results in deeper coverage of matched
metaproteomes and (vii) de novo peptide sequencing can overcome potential
sequencing errors and provide evidence for novel sequences not yet sequenced or not
identified by database searching methods. The high-quality unassigned MS/MS from
sequence-database searching would be ideal target spectra to submit for de novo
peptide sequencing whereby these sequences could be mapped back to help refine the
metagenome and identify potential sequencing errors. Finally, this study illustrates how
common metagenomic processing methods (assembly and ORF finding) and database
construction can affect metaproteomics search results.
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Chapter 8
Meta-omics reveals human host-microbiota signatures of Crohn’s disease
The text is adapted from:
Alison R. Erickson, Brandi L. Cantarel, Regina Lamendella, Youssef Darzi,
Emmanuel F. Mongodin, Chongle Pan, Manesh Shah, Jonas Halfvarson, Curt
Tysk, Bernard Henrissat, Jeroen Raes, Nathan C. Verberkmoes, Claire M.
Fraser-Liggett, Robert L. Hettich, and Janet K. Jansson. “Meta-omics reveals
human host-microbiota signatures of Crohn’s disease.” Draft will be submitted to
the journal, Molecular Systems Biology (2012).
Alison R. Erickson’s contributions include experimental preparation of all microbial
samples for proteomics, experimental LC-MS/MS measurements, integrated matched
MG-MP comparisons and analyses, biological inference of human proteins, and shared
primary authorship with Brandi Cantarel and Regina Lamendella.
8.1: Introduction
Humans live in close association with communities of microorganisms (the human
microbiota) that inhabit every exposed surface and cavity in the body[195]. The
collective genetic information of the human microbiota represents a second genome,
the human microbiome, currently the focus of intense international sequencing and
research efforts[14],[196],[25]. Although most human host-microbe associations are
beneficial, changes in the composition and function of the human microbiota are
associated with a growing list of diseases, including inflammatory bowel disease
(IBD)[197]. Several studies using both culture-dependent and molecular approaches
have suggested that there is a dysbiosis in the gut microbiota of patients with Crohn’s
disease (CD) compared to healthy subjects[158],[198],[199].
Recent advances in DNA sequencing and proteomics technologies have opened
the door to explore the structure and function of the gut microbiota without the necessity
for cultivation. However, there have been very few reports to date that have used a
multi-“omics” approach to study the complex ecosystem in the human gut. The ability to
combine information about the identities of microbial community members (obtained
from 16S rRNA gene-based measurements), metabolic potential (obtained from
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metagenome sequence data) and expressed proteins (obtained from metaproteome
data) enables explorations of the gut microbiota at multiple molecular levels
simultaneously[200].
In the previous chapter, we compared metagenomic data processing methods,
such as assembly and gene finding, and their affects on the ability to assign peptides to
MS/MS spectra. Using the best performing informatics workflow, predicted protein
sequence databases derived from matched metagenomic sequenced reads (RMPS),
we can now apply this workflow to focus on biological inference and human disease as
opposed to chapter 6, which focuses only on measurements of a healthy twin pair. This
study was focused on a subset of fecal samples collected from a large Swedish twin
cohort with inflammatory bowel disease (IBD) that was previously characterized, with
respect to their bacterial community composition by deep 16S rRNA pyrotag
sequencing[158,198,201] and metabolite profiling[202]. Previous data indicated that
healthy twin pairs had a similar gut microbiota, even when they had been living
separately for decades. By contrast, twin pairs in which one or both subjects had CD
harbored very dissimilar gut microbial compositions[158]. This disparity of the gut
microbiota was particularly striking for subjects with inflammation in the ileum (ileal CD,
ICD) compared to healthy subjects[158],[202],[201] and was primarily characterized by
the reduced abundance of several key beneficial members of the community, such as
Faecalibacterium prausnitzii.
Here our aim was to further explore a subset of the same Swedish twin cohort
that had demonstrated microbial dysbiosis in fecal samples according to CD phenotype,
for functions that were correlated to CD by applying non-targeted metagenomics12 and
metaproteomics[26]. This eco-systems biology approach[200] allowed us to detect and
directly correlate genes and expressed proteins for the first time in the same samples.
It was particularly valuable to include discordant twin pairs in the sample set, where one
twin was diseased and one was healthy, to mitigate the influence of host genetics on
the microbiome[158],[112],[150]. The sample cohort included one healthy twin pair with
existing metaproteome data[26], one colonic Crohn’s (CCD) twin pair, two ICD
concordant twin pairs and two ICD discordant twin pairs (Table 2.1). All samples were
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collected when the Crohn’s subjects were in endoscopic remission, or had minor
inflammatory activity in the neo-terminal ileum only.
8.2 Experimental Methods
8.2.1: Sample collection
Fecal samples were collected from 6 monozygotic twin pairs: 1 healthy twin pair with
existing metaproteome data[26], 1 concordant pair with CCD, 2 concordant twins with
ICD and 2 ICD discordant twin pairs (Table 2.1). DNA was extracted by the MoBio[158]
and IGS-Zymo[203] protocols producing 3 – 5ug of purified metagenomic DNA from
each sample. Proteins were extracted and processed for 2D-LC-MS/MS as previously
described[26].
8.2.2: Metagenomics
Sequences were generated and processed using the 454 Titanium Roche platform and
assembled using Newbler (v2.0.01.14). Genes were predicted on contigs greater than
500 bp using METAGENE[187] and for those less than 500 bp using a combination of
METAGENE and FASTX[188] from alignments to homologous sequences in reference
genomes. Proteins were clustered using BLASTP[204], using e-value cutoffs of 10-5,
and MCL[205], with an inflation value of 1.5. ORFs were searched against the
eggnog[206], CAZY[129] and KEGG genes[207] using NCBI-BLAST[204] using e-value
cutoff of 10-6 and bits per position cutoff of 1.
8.2.3: Metaproteomics
MS-based shotgun proteomics was performed as described[26] and acquired MS/MS
searched against two databases: 1) matched metagenomic-predicted protein database
(MM) and 2) human microbial reference genome database (HMRG); both including the
human genome. The spectral count for a microbial protein cluster was calculated as the
number of unique peptide identifications that can be attributed to proteins from that
cluster only and not any other cluster. Spectral counts for human proteins were
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calculated from both unique and non-unique peptide identifications. All spectral counts
were normalized by the total numbers of MS/MS spectra per run.
8.2.4: Statistics
Non-metric multidimensional scaling was performed using normalized spectral
abundances of identified proteins. Protein lists were generated for proteins that
correlated with a particular phenotype using Indicator Species Analysis and Wilcoxon’s
rank sum tests.
8.3: Results
We generated whole genome shotgun metagenomic (Table 8.1) and shotgun mass
spectrometry (MS)-based metaproteomic (Tables 8.2 and 8.3) datasets from the same
samples for direct comparisons. Metagenomic data were used to assess community
gene content and predicted functional capability, while metaproteomics was used to
identify the most abundant expressed microbial and human proteins. The number of
genes identified in each sample was two orders of magnitude greater than that of
proteins (since proteins cannot be amplified like DNA), although both represent only the
more abundant fraction of the total gene and protein reservoir in the human gut
microbiome.
Table 8.1: Metagenomic sequence data and statistics.

	
  

Subject

Mega base
pairs (Mbp)

6a
6b
9a
9b
10a
10b
15a
15b
16a
16b
18a
18b

684
409
245
290
502
541
504
484
229
319
425
258

Number of
Reads
(thousands)
1,901
1,183
782
845
1,211
1,327
1,358
1,270
585
1,126
1,341
955

Number of
Singletons
(thousands)
299
372
155
197
82
140
256
272
207
511
215
372

Number of
Contigs

Mbp in
Contigs

Average Contig
Length

Contigs >
500 bp

Fraction
Singleton

Fraction Contigs >
500

55,650
55,463
19,893
35,571
36,328
30,642
38,046
36,871
22,764
46,845
26,803
28,631

66
43
21
27
49
39
42
36
18
28
27
19

1195
776
1053
754
1337
1259
1109
981
798
591
1014
671

39,318
33,375
13,439
20,011
24,726
20,219
25,909
21,555
15,545
23,857
17,971
13,862

0.157
0.3147
0.1988
0.2328
0.0681
0.1053
0.1887
0.2146
0.3544
0.4541
0.1604
0.3898

0.7065
0.6018
0.6756
0.5626
0.6806
0.6598
0.681
0.5846
0.6829
0.5093
0.6705
0.4842
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Table 8.2: Normalized total spectra counts across all subjects and 24 MS runs for the
matched metagenome (MM) database searches.
Phenotype
healthy

colonic CD

ileal CD

ileal CD

ileal CD
healthy
ileal CD
healthy

	
  

Sample Run Proteins
2
2,315
6a
3
2,009
2
1,385
6b
1
1,413
1
871
9a
2
829
1
723
9b
2
728
3
1,089
10a
1
1,049
1
1,118
10b
2
1,141
1
946
15a
2
1,183
2
787
15b
1
769
2
369
16a
1
407
2
1,248
16b
3
1,256
2
687
18a
1
654
1
794
18b
2
829

Peptides
9,110
8,005
5,548
5,796
3,738
3,381
2,551
2,532
4,474
4,286
4,078
3,984
3,913
4,862
3,890
3,421
1,716
1,844
4,581
4,416
3,233
2,733
3,018
3,245

Total Identified MS/MS
15,724
15,452
11,300
11,258
7,628
7,879
5,153
5,074
8,891
8,244
8,057
8,546
9,276
10,616
8,647
8,619
4,079
4,012
11,659
11,914
7,951
7,281
7,640
7,442

Total Collected MS/MS
78,381
70,492
80,797
81,202
92,865
91,745
82,546
84,089
90,775
91,145
75,873
74,574
83,254
77,906
81,970
80,718
78,811
73,878
92,460
91,865
76,489
78,661
92,795
93,485

#DB Entries
1,356,947
862,006
527,904
594,986
1,428,694
1,618,290
1,005,286
982,092
1,119,221
843,556
781,500
628,384
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Table 8.3: Normalized total spectra counts across all subjects and 24 MS runs for the
human microbial isolate reference genome database (HMRG) searches.
Phenotype
healthy

colonic CD

ileal CD

ileal CD

ileal CD
healthy
ileal CD
healthy

Sample Run Proteins
2
3,138
6a
3
2,618
2
2,716
6b
1
2,612
1
2,477
9a
2
2,337
1
2,089
9b
2
2,062
3
2,172
10a
1
1,985
1
1,859
10b
2
1,878
1
1,874
15a
2
2,122
2
2,146
15b
1
1,916
2
1,733
16a
1
1,840
2
3,049
16b
3
3,108
2
1,964
18a
1
1,648
1
2,855
18b
2
3,139

Peptides

8,679
6,838
6,653
6,308
5,910
5,416
5,231
5,161
5,997
5,635
4,483
4,071
5,494
6,783
6,235
5,430
4,738
4,956
6,926
7,070
5,931
5,108
6,830
7,626

Total Identified MS/MS

13,254
11,351
11,022
10,919
10,089
10,388
8,485
8,354
10,199
9,291
7,964
7,919
10,291
11,698
9,816
9,695
7,728
7,830
12,610
13,281
11,161
10,350
12,669
12,642

Total Collected MS/MS
78,381
70,492
80,797
81,202
92,865
91,745
82,546
84,089
90,775
91,145
75,873
74,574
83,254
77,906
81,970
80,718
78,811
73,878
92,460
91,865
76,489
78,661
92,795
93,485

8.3.1: Taxonomic Community structural differences
Taxonomic profiles of the metagenomic data were determined using nucleotide
alignments and compared based on disease status (healthy, CCD, ICD). Greater than
60% of the metagenomic sequence reads in the healthy samples could not be assigned
at the phylum, family or genus level, as compared with ~40% of the reads in ICD or
CCD subjects, potentially resulting from reduced diversity in CD. Of the metagenomic
reads for which a taxonomic assignment could be made, 396 genera were represented
in all of the samples, and nine of those were present at > 5%. Eleven genera of the
Firmicutes phylum (Faecalibacterium, Geobacillus, Desulfotomaculum,
Desulfitobacterium, Holdemania, Thermoanaerobacter, Thermosinus,
Carboxydothermus, Enterococcus, Alkaliphilus, Subdoligranulum and Anaerotruncus)
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and one genera of the Proteobacteria phylum (Pelobacter) were less abundant in the
ICD compared to healthy subjects (Table 8.4). The depletion of Faecalibacterium and
Subdoligranulum was previously reported using 16S rRNA gene sequencing in these
same samples[201]. Bacteria that were more abundant in the microbiota of ICD
compared to healthy subjects included genera of Pasteurella. These data are
consistent with other reports of dysbiosis of the microbiota in subjects with CD[198],
however, the list of differentially abundant genera are not entirely consistent between
studies, which most likely reflects the different cohorts that have been studied to date.
Table 8.4: Relative abundances of differentially abundant species.

	
  

Taxonomy

CCD 16S

CCD WGS

ICD 16S

ICD WGS

H 16S

H WGS

Desulfitobacterium

0.00E+00

0.00E+00

0.00E+00

1.67E-06

0.00E+00

1.50E-05

Desulfotomaculum

0.00E+00

0.00E+00

0.00E+00

0.00E+00

0.00E+00

5.00E-06

Geobacillus

0.00E+00

1.00E-05

0.00E+00

0.00E+00

0.00E+00

7.50E-06

Pasteurella

0.00E+00

2.00E-05

0.00E+00

8.33E-06

0.00E+00

2.50E-06

Thermoanaerobacter

0.00E+00

0.00E+00

0.00E+00

0.00E+00

0.00E+00

1.50E-05

Enterocytozoon

0.00E+00

5.00E-06

0.00E+00

0.00E+00

0.00E+00

7.50E-06

Carboxydothermus

0.00E+00

0.00E+00

0.00E+00

0.00E+00

0.00E+00

5.00E-06

Thermosinus

0.00E+00

0.00E+00

0.00E+00

0.00E+00

0.00E+00

2.50E-06

Pelobacter

0.00E+00

0.00E+00

0.00E+00

0.00E+00

0.00E+00

2.50E-06

Holdemania

0.00E+00

1.65E-04

6.67E-05

1.25E-04

0.00E+00

5.08E-04

Anaerotruncus

1.20E-03

1.85E-04

2.83E-04

2.00E-04

6.25E-04

1.18E-03

Enterococcus

2.45E-03

1.77E-02

0.00E+00

1.19E-03

0.00E+00

7.87E-04

Faecalibacterium

1.53E-02

2.69E-03

1.55E-03

1.65E-03

1.50E-02

1.25E-02

Neorickettsia

0.00E+00

1.50E-05

0.00E+00

0.00E+00

0.00E+00

0.00E+00

Fibrobacter

0.00E+00

5.00E-06

0.00E+00

0.00E+00

0.00E+00

7.50E-06

Alkaliphilus

0.00E+00

0.00E+00

0.00E+00

0.00E+00

0.00E+00

1.75E-05

Subdoligranulum

8.50E-03

2.58E-03

7.75E-03

4.97E-04

3.25E-03

2.99E-03
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8.3.2: Peptide-Spectrum Matching (PSM) and broad functional comparisons
In addition to taxonomic information, metagenomic data provides information on gene
content of the gut microbiome; however, it does not reveal the identities and relative
abundances of expressed gene products (proteins) under the conditions studied.
Therefore, to directly address gene function and expression, we performed database
searches with tandem mass spectra (MS/MS) of peptides from the same samples.
These extensive MS/MS datasets were searched both against their corresponding
matched microbial metagenome (MM) (Table 8.1) or a representative set of 51
sequenced human microbiome isolate reference genomes (HMRGs) (Table 8.5), each
concatenated with the human genome. The HMRGs provide nearly complete DNA
sequence coverage of a bacterial species, and the predicted genes are often full length,
as compared to the MMs that are not sequenced to sufficient depth to contain complete
genomes, and the predicted genes are often fragmented. However, many sequences
captured from a clinical sample do not map to HMRGs. One challenge in using a
HMRG database is gene redundancy between strains/species belonging to the same
genera, which can make it difficult to uniquely assign a peptide to a mass spectrum.
Therefore, we developed a novel method for clustering functionally similar proteins from
the MMs to provide a more robust method of assigning peptide-spectrum counts for
relative quantification. This approach enabled us to take advantage of both MMs and
HMRGs to identify both ‘core’ proteins and disease-specific proteins associated with the
human gut microbiota, including those with unknown function.
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Table 8.5: Human microbial isolate reference genome database (HMRG) database
components. 51 bacterial isolates were downloaded from the JGI IMG human
microbiome project (IMG-HMP) into a single FASTA-formatted protein sequence
database.
Database'Identifier
Aero_hydr_hydr_ATCC_7966
Cate_mits_DSM_15897
Dore_form_ATCC_27755
Ente_faec_PC4.1
Shig_sp._D9
Akke_muci_ATCC_BAAL835
Alis_putr_DSM_17216
Anae_ster_DSM_17244
Bact_cacc_ATCC_43185
Bact_dore_DSM_17855
Bact_frag_NCTC_9343
Bact_ovat_ATCC_8483
Bact_pect_ATCC_43243
Bact_sp._2_2_4
Bact_sp._3_1_33FAA
Bact_sp._3_2_5
Bact_sp._4_3_47FAA
Bact_sp._9_1_42FAA
Bact_sp._D4
Bact_thet_VPIL5482
Bact_unif_ATCC_8492
Bact_vulg_ATCC_8482
Bifi_adol_L2L32
Bifi_long_infa_ATCC_15697
Blau_hans_DSM_20583
Blau_hydr_S5a33_DSM_10507
Citr_kose_ATCC_BAAL895
Clos_bart_DSM_16795
Clos_bolt_ATCC_BAAL613
Clos_lept_DSM_753
Clos_nexi_DSM_1787
Clos_sp_M62L1
Clos_sp._SS2L1
Coll_aero_ATCC_25986
Coll_inte_DSM_13280
Copr_come
Dial_invi_DSM_15470
Esch_coli_KL12_MG1655
Euba_rect_ATCC_33656
Faec_prau_A2L165
Faec_prau_M21L2
Lact_reut_CF48L3A
Meth_smit_F1_DSM_2374
Myco_tube_CDC1551
Para_dent_F0305
Prev_copr_CB7_DSM_18205
Rose_inte_L1L82
Rumi_gnav_ATCC_29149
Rumi_lact_ATCC_29176
Rumi_obeu_ATCC_29174
Rumi_sp._5_1_39BFAA

	
  

Genome
Aeromonas2hydrophila2hydrophila2ATCC27966
Catenibacterium2mitsuokai2DSM215897
Dorea2formicigenerans2ATCC227755
Enterococcus2faecalis2PC4.1
Shigella2sp.2D9
Akkermansia2muciniphila2ATCC2BAAL835
Alistipes2putredinis2DSM217216
Anaerofustis2stercorihominis2DSM217244
Bacteroides2caccae2ATCC243185
Bacteroides2dorei2DSM217855
Bacteroides2fragilis2NCTC29343
Bacteroides2ovatus2ATCC28483
Bacteroides2pectinophilus2ATCC243243
Bacteroides2sp.22_2_4
Bacteroides2sp.23_1_33FAA
Bacteroides2sp.23_2_5
Bacteroides2sp.24_3_47FAA
Bacteroides2sp.29_1_42FAA
Bacteroides2sp.2D4
Bacteroides2thetaiotaomicron2VPIL5482
Bacteroides2uniformis2ATCC28492
Bacteroides2vulgatus2ATCC28482
Bifidobacterium2adolescentis2L2L32
Bifidobacterium2longum2infantis2ATCC215697
Blautia2hansenii2VPI2C7L242DSM220583
Blautia2hydrogenotrophicus2S5a332DSM210507
Citrobacter2koseri2ATCC2BAAL895
Clostridium2bartlettii2DSM216795
Clostridium2bolteae2ATCC2BAAL613
Clostridium2leptum2DSM2753
Clostridium2nexile2DSM21787
Clostridium2sp2M62L1
Clostridium2sp.2SS2L1
Collinsella2aerofaciens2ATCC225986
Collinsella2intestinalis2DSM213280
Coprococcus2comes
Dialister2invisus2DSM215470
Escherichia2coli2str.2KL122substr.2MG1655
Eubacterium2rectale2ATCC233656
Faecalibacterium2prausnitzii2A2L165
Faecalibacterium2prausnitzii2M21L2
Lactobacillus2reuteri2CF48L3A
Methanobrevibacter2smithii2F12DSM22374
Mycobacterium2tuberculosis2CDC1551
Parascardovia2denticolens2F0305
Prevotella2copri2CB72DSM218205
Roseburia2intestinalis2L1L82
Ruminococcus2gnavus2ATCC229149
Ruminococcus2lactaris2ATCC229176
Ruminococcus2obeum2ATCC229174
Ruminococcus2sp.25_1_39BFAA

GID
639633004.faa
643886110.faa
641736133.faa
647000238.faa
645058835.faa
642555104.faa
641736205.faa
641736193.faa
640963023.faa
642979370.faa
637000024.faa
641380449.faa
642979337.faa
646206266.faa
647533113.faa
646206273.faa
646206274.faa
646206263.faa
646206258.faa
637000026.faa
641380447.faa
640753008.faa
640963015.faa
643348516.faa
643886146.faa
643886199.faa
640753015.faa
641736113.faa
641380428.faa
641380427.faa
642979369.faa
643886005.faa
641736270.faa
640612206.faa
642979320.faa
643886116.faa
645951833.faa
646311926.faa
644736367.faa
645951831.faa
641380420.faa
643886138.faa
643886215.faa
637000172.faa
647533193.faa
643886200.faa
642979356.faa
640963057.faa
642791604.faa
640963024.faa
646206280.faa

Total'#'of'Predicted'Proteins
4,129
2,977
3,277
2,695
4,463
2,176
2,742
2,331
3,855
4,966
4,299
5,536
3,246
5,959
4,666
4,505
4,613
4,871
4,431
4,816
4,663
4,076
2,428
2,486
3,218
3,869
5,031
2,787
7,284
3,923
4,239
4,266
3,167
2,367
1,786
3,913
1,954
4,148
3,621
3,475
3,493
2,164
1,710
4,235
1,481
3,293
4,817
3,913
2,750
4,175
3,525
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On average, a total of 1,250 (healthy), 850 (ICD), and 788 (CCD) proteins were
identified with MM database searches and 2,904 (healthy), 1,928 (ICD), and 2,241
(CCD) proteins using the HMRG database, thus represents the most extensive
metaproteome characterization of the human gut to date (Tables 8.2 and 8.3). Due to
the redundancy of homologous proteins, microbial proteins with >80% sequence identity
were clustered to generate a total of 5,692 and 3,101 orthologous clusters (OC) from
the HMRGs and MMs, respectively, across all 24 MS runs. Of the OCs that were
identified using the MM searches, 52 were identified across all subjects (core; Table
8.6) and included primarily general housekeeping functions (such as ribosomal
proteins); whereas 151, 3, and 88 OCs were unique to either the healthy, ICD, or CCD
core metaproteomes, respectively (Figure 8.1). Post-cluster analysis revealed that
1,017 proteins from the MM database searches were unique (i.e., they did not fall into a
protein cluster), in contrast, all identified proteins from the HMRGs did cluster,
suggesting that there is considerable diversity of genes within the human gut microbiota
that is not captured in reference genome sequences.
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Table 8.6: Common core microbial proteins identified in the metaproteomes of all
subjects included in the study (healthy, ileal CD and colonic CD).
Cluster
CLST000006
CLST000011
CLST000208
CLST000254
CLST000335
CLST000603
CLST000797
CLST000998
CLST001935
CLST005531
CLST005618
CLST005666
CLST005804
CLST005825
CLST005842
CLST005865
CLST005872
CLST005915
CLST005929
CLST005988
CLST005996
CLST006170
CLST006191
CLST006298
CLST006300
CLST006373
CLST006584
CLST006673
CLST006805
CLST006834
CLST006844
CLST006883
CLST006904
CLST006921
CLST007033
CLST007119
CLST007120
CLST007226
CLST007262
CLST007269
CLST007338
CLST007389
CLST007461
CLST007642
CLST007797
CLST008351
CLST008679
CLST014282
CLST017476
CLST018911
CLST020880
CLST022770

	
  

Protein
Ribosomal/protein/L14
Ribosomal/protein/S11
Annotation/not/available
Phosphoenolpyruvate/carboxykinase/(ATP)
NifU/homolog/involved/in/FeLS/cluster/formation
GlyceraldehydeL3Lphosphate/dehydrogenase/erythroseL4Lphosphate/dehydrogenase
GTPases/L/translation/elongation/factors
Ribosomal/protein/L11
Rubrerythrin
Fructose/tagatose/bisphosphate/aldolase
KetolLacid/reductoisomerase
Chaperonin/GroEL/(HSP60/family)
Ribosomal/protein/L5
Ribosomal/protein/L7/L12
DNALdirected/RNA/polymerase,/beta/subunit/140/kD/subunit
Ribosomal/protein/S7
Ribosomal/protein/S2
Molecular/chaperone
Ribosomal/protein/S19
Ribosomal/protein/L20
Ribosomal/protein/S8
Ribosomal/protein/S9
Translation/elongation/factors/(GTPases)
Ribosomal/protein/L1
Phosphoenolpyruvate/synthase/pyruvate/phosphate/dikinase
ABCLtype/sugar/transport/systems,/ATPase/components
IMP/dehydrogenase/GMP/reductase
Ribosomal/protein/S10
Ribosomal/protein/L29
3Lphosphoglycerate/kinase
Ribosomal/protein/L13
F0F1Ltype/ATP/synthase,/beta/subunit
Ribosomal/protein/L23
Protein/involved/in/phosphoenolpyruvateLdependent/sugar/phosphotransferase/system
PyruvateLformate/lyase
DNALdirected/RNA/polymerase,/beta/subunit/160/kD/subunit
Transaldolase
Ribosomal/protein/S4/and/related/proteins
Ribosomal/protein/S3
Ribosomal/protein/S5
Pyruvate/oxaloacetate/carboxyltransferase
Ribosomal/protein/L6P/L9E
CoLchaperonin/GroES/(HSP10)
Ribosomal/protein/L17
Ribosomal/protein/S15P/S13E
Pyruvate:ferredox/in/oxidoreductase/and/related/2Loxoacid:ferredoxin/oxidoreductases,/beta/subunit
Triosephosphate/isomerase
Penicillin/tolerance/protein
AcetylLCoA/acetyltransferase
Formyltetrahydrofolate/synthetase
Carbon/dioxide/concentrating/mechanism/carboxysome/shell/protein
AcylLCoA/dehydrogenases
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ICD

3

11

3
52

151

88

36

H

CCD

Figure 8.1: Venn diagram showing the number of protein clusters common or unique to
each disease category: H (healthy), ICD (ileal Crohn’s disease) and CCD (colonic
Crohn’s disease).
By broad comparison of the metagenomes and metaproteomes, two trends
emerged: (a) CD samples clustered separately from healthy (Figures 8.2a and 8.3)
and (b) the percent of expressed genes compared to the total gene repertoire is lower in
CD patients as compared to healthy subjects (Figure 8.2b), reflected by a significant
decrease in protein family richness in ICD and CCD that was particularly pronounced for
ICD (Figure 8.2c). The metaproteomes significantly differentiated by disease phenotype
(p<0.004) based on spectra matching to HMRGs (Figure 8.3a). This was also shown
with i) clustering based on function to MMs (Figure 8.3b) and ii) functional assignments
of genes from MMs by KEGG (Figure 8.3c), suggesting that disease phenotype was a
stronger discriminator than zygosity, similar to our previous analyses of the same
samples[201], [202]. Although healthy and CCD metaproteomes could be distinguished
from another, they clustered more closely together compared to the ICD
metaproteomes that were clearly distinct (Figure 8.2a). Therefore, we primarily focused
on functions that differentiated ICD from healthy, but included comparisons to the CCD
twin pair when relevant.
	
  

176	
  

Figure 8.2: (A) Non-metric multidimensional scaling (nMDS) of fecal metaproteomes. A
matrix of normalized spectral counts per protein from each duplicate gut metaproteome
was imported into PCORD v5 software. nMDS was performed using the Bray-Curtis
distance measure A three-dimensional solution was found after 119 iterations. The final
stress for the nMDS was 6.47458. (B) Fraction of proteins expressed as measured by
comparison to the metagenome (C) Functional richness as measured by the Chao1
richness estimate of KEGG orthologous groups (KOs).
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Figure 8.3: Clustering by Phenotype. (A) Non-metric multidimensional scaling (nMDS)
of fecal metaproteomes. A matrix of normalized spectral counts per protein from each
duplicate gut metaproteome was imported into PCORD v5 software. nMDS was
performed using the Bray-Curtis distance measure A three-dimensional solution was
found after 119 iterations. The final stress for the nMDS was 6.47458. (B) Heatmap of
Metaproteomes prediced from matched metagenomes by protein clusters. (C)
Hieractical Clustering of Metagenomes by KEGG KO relative abundances using
Manhattan distance calculation and the ‘average’ clustering method with an arcsin
square root transformation.
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While there were core microbial functions that were identified across all samples
in the metagenome (Figure 8.4a) and metaproteomes (Figure 8.4b), proteins involved
in translation, defense, organic metabolism, post-translational modification and
signaling, and genes involved in intracellular trafficking, translation and defense differed
in abundance between healthy and ICD subjects. To assess pathway abundance,
KEGG module analysis was performed on metagenome and metaproteome datasets.
Glycolysis, reductive pentose phosphate cycle and butyrate production were found to be
under-represented in ICD compared with healthy microbiota, in both the metagenomic
and metaproteomic datasets (data not shown). In the metagenomic analysis,
conjugated bile acid biosynthesis, urea cycle, phosphonate transport system and type
IV secretion system were found to be over-represented in ICD compared with healthy
microbiota.
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Figure 8.4: (A) Relative abundance of metagenomic reads assigned to COG
categories. (B) Relative abundance of metaproteomic spectra assigned to COG
categories. (C, D) Sugar utilization in the metagenome (C) and metaproteome (D) by
comparison to the CAZy database.
Each dataset contained a subset of genes and proteins of unknown function. For
example, ~17% of predicted ORFs were conserved with no known function or were not
homologous to any proteins. Approximately 31% of identified HMRG proteins and 29%
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of identified microbial OCs (including proteins that did not cluster in MMs) had no known
function. Interestingly, one OC comprising 11 unknown proteins was significantly
correlated with ICD, where five OCs (10-100s of unknown proteins) were significantly
correlated with healthy. These findings support the need for better coupling of
phenotypic assays with -omics strategies to aid in the characterization of important
functional but unknown genes and proteins.
8.3.3: Metabolic pathways differentiate CD and healthy phenotypes
We identified several examples in both the metagenome and metaproteome datasets
which suggested that functions related to carbohydrate transport and metabolism and
energy production are depleted in the ICD microbiota (Figure 8.4b). In addition to the
differential pathways identified by KEGG analysis, the abundance of genes for sucrose
and fructose degradation is higher in ICD, while genes and proteins involved in starch,
glycogen, and complex carbohydrate degradation are lower in abundance (Figure 8.4c
and d). These results, along with pathway analysis, suggest that the microbiota of ICD
subjects have a reduced capability to uptake complex carbohydrates and breakdown
nutrients.
Many proteins that were less abundant in ICD reflected a decreased abundance
of bacteria that contain metabolic pathways with relevance to the physiology of the
human gut (Figure 8.2a). Butyrate, a major energy source for colonocytes, is involved
in the maintenance of colonic mucosal health and can elicit anti-inflammatory
effects[208], thus its depletion could be one reason for the inflammation in CD.
Faecalibacterium prauznitzii is a major butyrate producer in the gut and the low
abundance of this species (as revealed by 16S rRNA and metagenomic analyses) and
proteins involved in the butyrate pathway (Figure 8.5) could contribute to the
inflammation associated with ICD. Reduced butyrate production correlates to the
depletion of known butyrate producers (e.g., Roseburia, Faecalibacterium and
Subdoligranulum) in our CD subjects (Figures 8.2a and 8.6). The increased
abundance of F. prausnitzii revealed abundant proteins central to butyrate production
and other short-chain fatty acid production (e.g., acetate and proprionate) exclusively in
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the healthy and CCD subjects but not in ICD (Figure 8.7a). Several other genes
associated with anti-inflammatory responses and properties, such as lactocepin
(EC3.4.21.96) and aspartate dehydrogenase (EC3.4.21.96), were significantly more
abundant in CD relative to healthy (Figure 8.5b).
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Figure 8.5: (A) Metabolic pathways differentiating by disease phenotype, as resulting from the metabolic module analysis
(p<0.05; 5% FDR). Highlighted areas discussed in the main text: (1) butyrate production; (2) membrane proteins (B)
Enzymes that were significantly different across Healthy, ICD, and CCD fecal metagenomes.
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Figure 8.6: Differences in Butyrate Production in ICD compared to Healthy. Cumulative
plots of fraction of total reads assigned to Faecalibacterium, Rosburia and
Subdoligranulum genera per sample.
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B
Figure 8.7: (A) Most significantly differential proteins from Healthy and CD subjects.
Presence-absence heatmap shows which of the 51 bacterial strains the proteins
matched to. (B) Enzymes that were significantly different across Healthy, ICD, and
CCD fecal metagenomes.
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Protein abundance measurements, based on MM searches, indicate an overrepresentation of bacterial TonB-dependent cell surface receptors, which are multifunctional but are involved in inorganic ion transport and metabolism, in the ICD
microbiota. These data are also consistent with metagenomic analysis which reveals a
greater abundance of genes involved in inorganic ion metabolism in the CD microbiota
(Figure 8.4a). If the gut ecosystem is deficient in inorganic ions in CD, the gut
microbiota may compensate by up-regulation of genes and proteins that are involved in
ion acquisition and transport.
8.3.4: Bacterial-host interactions and defense
Several proteins involved in bacterial-host interactions and defense were more
abundant in the ICD microbiota and included several bacterial outer membrane proteins
(e.g., OmpA, RagB, and SusC/D) that were differentially present in both the
metagenomes and metaproteomes (Figure 8.7a and b), supporting the current
hypothesis that CD is manifested by an aberrant mucosal response to otherwise
harmless bacterial antigens in genetically susceptible subjects[209,210,211]. OmpA, a
pore-forming protein in the outer membrane of many Gram-negative bacteria, harbors
diverse functions including maintenance of cell structure, binding various substances,
adhesion, and resistance to antimicrobials[212], and is suggested to be involved in gut
mucosal association[213]. One hypothesis is that because OmpA is highly represented
and highly conserved in many enteric bacteria, the immune system has acquired the
ability to recognize and to be activated by this class of protein[214]. Because these
proteins are more abundant in ICD, this suggests that the immune system is functioning
abnormally with respect to reduced levels of the corresponding bacteria expressing this
protein, and supports the current hypothesis that CD is manifested by an aberrant
mucosal response to otherwise harmless bacterial antigens in genetically susceptible
individuals[209,210,211].
Our study provides the first evidence of elevated abundance of other major
OMPs, such as RagB, SusC/D associated with CD (Figure 8.5a). An elevated IgG
response to RagB was previously reported in subgingival samples of patients with
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periodontitis[215] and virulence of the rag locus was demonstrated in Porphyromonas
gingivalis strains[216]. While the role of RagB/Sus in the etiology of CD warrants further
study, our data suggest that there is a shift from a healthy microbiota towards a
microbial consortium that can elicit an inflammatory immune response.
In addition, an integration host factor (IHF) protein, which is linked to virulence
gene regulation[217,218], was identified as being statistically more abundant in ICD
metaproteomes using MMs, but not HMRGs. This finding highlights the importance of
MMs to identify proteins that originate from bacteria not yet sequenced, or cultivated.
8.3.5: Broad Functional Comparisons of the Human Proteome
Because we are able to measure both bacterial and human proteins using
metaproteomics, a total of 1,646 human proteins were experimentally identified. Gene
ontology (GO) analysis revealed that human proteins found in all 3 subject groups
(core) are enriched in functions associated with the structural integrity of the mucosal
epithelium. Proteolysis, digestion, and carbohydrate catabolism were also among the
most abundant ‘core’ functions, as would be expected in the GI-tract (Figure 8.8a). For
human proteins that varied in healthy compared to CD, the majority were involved in
epithelial integrity and function, as detailed below. To our knowledge, this is the first
use of non-targeted shotgun proteomics to simultaneously assess both human and
microbial proteins from the same fecal samples to assess a disease state.
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Figure 8.8: Human proteins identified in the metaproteome data. (A) Human proteins’
“core” Gene Ontology terms across all subjects (healthy (H), ileal Crohn’s Disease
(ICD), and colonic Crohn’s Disease (CCD)). (B) Human proteins Gene Ontology terms
that are enriched according to disease.
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Figure 8.8 (B)
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8.3.6: Impaired epithelial integrity in ICD
The human proteins detected primarily in CD subjects support the hypothesis that
subjects with ICD, even in remission, have a defective epithelial barrier. A higher
abundance of proteins in GO categories for inflammatory and host defense, wounding
response, intracellular transport, and epithelial development and differentiation were
enriched in ICD subjects (Figure 8.8b). For example, mucin 2 (MUC-2), the most
prominent mucin secreted by intestinal epithelial cells, was also more abundant in ICD
subjects. Similarly, thiosulfate sulfurtransferase, important in sulfate reduction and
linked to mucin fermentation (PMID 3214155), was elevated in CD (p<0.001) based on
metagenome analysis (Figure 8.5b).
Other proteins that function in maintaining mucosal integrity were identified as
being statistically under-represented in ICD, including protocadherin LKC, a calcium
dependent mediator of cell-cell adhesion that associates with the mucosal actin
cytoskeleton[219] and type 1 collagen (alpha-2), the major collagen in the intestinal
extracellular matrix[220]. A depletion of these proteins might compromise host defense
at the mucosal interface.
A defective epithelial barrier is thought to result in an aberrant host response to
luminal antigens leading to an exaggerated adaptive immune response and chronic
inflammation[211]. Alpha defensin 5, a protein implicated in regulation of bacterial
concentrations in the ileal intestinal crypt[221,222,223] was statistically more abundant
in ICD, suggesting that the host may increase expression of defensins in response to
aberrant microbiota in these subjects, or that the products are leaking from the intestinal
site of action to feces.
8.3.7: Impaired intestinal absorption in ICD
The primary function of the small intestine is absorption and this appears to be impaired
in subjects with ICD. For example, several pancreatic enzymes: chymotrypsinogen B1
and B2, pancreatic carboxypeptidase A1 and B1 and pancreatic lipase were identified
with higher abundance in ICD. These enzymes are synthesized in the pancreas as
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inactive precursors that are activated in the intestine where they aid in digestion.
Relatively high amounts of pancreatic enzymes in feces may be indicative of
pancreatitis, which has been linked to CD[224], but remains to be confirmed since the
subjects in this study have not had active pancreatitis.
Several bile salts were previously found to be elevated in ICD fecal
samples[202], supporting the hypothesis that there is malabsorption of secreted
enzymes and metabolites by the gut epithelium in ICD. The reduced uptake of bile salts
and pancreatic enzymes could also be due to surgery since all ICD patients had
undergone resections of the ileum. Since uptake of bile salts occurs within the terminal
part of the ileum, patients that have undergone resections, leaving them with a shorter
ileum, might have a reduced uptake of bile salts. Bile salt malabsorption with secondary
diarrhea is a common clinical feature in patients undergoing extensive ileal resections.
8.4: Conclusions
Here we have used a combination of extensive and complementary “-omics” datasets to
provide a more comprehensive view of the role of the gut microbiota in CD than has
been previously possible. The value of this approach comes from the ability not only to
examine the structure and function of the microbiota from multiple perspectives, but also
from the ability to integrate data from the gut microbiota and the host. The validity of
our methods is supported by data at the species, gene, and protein levels that confirm
previous reports that ICD is associated with a loss of F. prauznitzii. New findings from
this study suggest several other malfunctions in CD, both with respect to the intestinal
microbiota and the host. Dysbiosis of the bacterial community in ICD results in a higher
abundance of bacterial surface proteins, many of which are antigenic and could
contribute to an exaggerated immune response, and that could cause or aggravate
inflammation associated with CD. This imbalance comes at the expense of loss of many
beneficial members of the microbiota, including those that produce butyrate. At the
same time, there are several indications that the host epithelial barrier is impaired, both
with respect to structural integrity of the mucosal boundary and with respect to its ability
to absorb secreted enzymes and metabolites. These functional changes may define the
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CD phenotype, even when patients are in remission. It will be of great value to extend
these studies to larger cohorts of CD patients and to also carry out longitudinal studies
to assess how the structure and function of the gut microbiota changes in a given
patient over time. We have also uncovered some interesting examples of where the
meta-omics data does not completely overlap, indicating the need to further explore the
fundamental differences and significance of genomic potential versus proteome
abundances. Together, these data point towards several new targets for further
investigation in the hunt for diagnostic targets and therapeutic treatments for CD.
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Chapter 9
Conclusions from the Metaproteomics Characterization of the Human GutAssociated Microbiome

9.1: Conclusions
The human microbiome, the collective set of microbes inhabiting the human body, is a
complex ecosystem that is poorly understood in both human health and disease.
Although the HMP has focused tremendous efforts and funds to understand the human
microbiota by sequencing the microbes present in and on the skin, oral and nasal
cavity, vagina and gastrointestinal tract by metagenomics, this approach will only reveal
the composition and ‘potential’ function. While genomics and metagenomics have laid
the groundwork for many microbial communities including the human microbiome,
proteomics and metaproteomics have evolved to provide an additional level of
information, ‘actual’ protein abundance that is not possible with metagenomics.
The research presented in this dissertation represents a detailed characterization
of the human gastrointestinal (gut) microbiome. Although not completely
comprehensive, a fairly deep level of detail regarding the identity and functional
signature of the host and gut microbial metaproteomes has been revealed through an
integrative approach consisting of both community genomics and proteomics. The
technology that enables high-throughput, unbiased, and highly reproducible community
proteomics is high throughput, high performance mass spectrometry. MS-based
proteomics can identify hundreds to thousands of proteins from a microbial community
sample. As discussed previously, genomics and metagenomics (predicted protein
database) is the foundation for MS-based proteomics. Therefore, the quality of DNA
sequencing (i.e., depth of coverage and sequencing errors), assembly, and gene-finding
has a tremendous effect on the ability of MS-based proteomics to assign all tandem
mass spectra using protein database searching. For example, if the final genomes or
metagenomes are not representative of the exact same samples used for proteomic
measurements or are not sequenced to a sufficient depth, fewer quality MS/MS will be
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assigned resulting in fewer peptide and protein identifications. Due to the
interdependence of both technologies and future of systems biology, it is the
development and advancement of genomic and proteomic technologies that will enable
and improve biological inference of the complex human microbiome.
The objective of this dissertation research is a detailed and mechanistic
understanding of the host and microbial functional signature in the human gut
microbiome. Initially, we used a less complex and defined human-derived microbial
community in gnotobiotic mice as a model system to study the human gut microbiome.
This model system is advantageous for several reasons, including the ability to control
the microbial membership in present in the gut. A defined human microbiota enables
the functional study of each of microbial member, their interactions, cooperation,
competition and adaptation in the gut. From the lower complexity binary and 12member consortia, we progressed to a representative and higher complex human gut
microbiome in human individuals. A non-targeted MS-based approach is ideal for
studying complex communities based on its ability to directly measure expressed
proteins from complex environmental matrices. This approach was applied to elucidate
the functional ‘core’ and differences in the commensal microbiota of human twins with
and without Crohn’s disease. Although challenges are present in both approaches,
both have provided different information that has contributed to a larger understanding
of how the human gut, health and disease, functions with our microbial counterparts.
9.2: Experimental optimization and biological inference in the human gut
microbiome
The experimental methodology and analytical technology originally developed on single
bacterial isolates has been extended to low- (AMD) and high-complexity (soil, ocean,
and the human microbiome) microbial communities, all of which with range in microbial
composition and diversity. Microbial communities have many challenges not
characteristic of single bacterial isolates including: environmental sample biomass
quantity, interfering matrices, species and protein dynamic range, and microbial
sequence redundancy. As revealed throughout this dissertation, experimental
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challenges associated with human gut microbiome related samples include efficient,
non-biased lysis and extraction of proteins from bacteria and host cells in complex
sample matrices (feces and cece) and dynamic range (detection of lower abundant
proteins and microbes). Informatics challenges are based on traditional database
filtering metrics and the ability to uniquely assign MS/MS to a protein and its’
corresponding microbial species within a large collection of closely related and diverse
microbes. Although these challenges initially had a significant impact on the ability to
perform deep proteome characterizations, we have identified new strategies that have
and will enhance community MS-based proteomic studies of the human microbiome.
For the two approaches described in this dissertation, liquid chromatography coupled
with tandem mass spectrometry has been successful to characterize the gut microbial
community proteomes of gnotobiotic mice and human twins.
9.2.1: Gnotobiotic mice
A defined human representative consortium of microbes has provided insight into how i)
distinct members of a larger consortium of microbes initially establish themselves
through cooperation and competition, and subsequently ii) compose the collective
functional community. Chapters 3-6 outlined experimental and computational
procedures used for proteomic assays of a model gut microbiota, and also illustrated
some of the benefits in obtaining this type of information. Experimental methods that
used a combination of pre-fractionation via ultracentrifugation and chemical
solubilization and physical homogenization have significantly improved peptidespectrum matching and protein identification of in situ extracted proteomes.
Computational methods that compare and use unique peptide (theoretical peptidome),
spectra, and protein counts enable the differentiation and assignment of proteins with
high sequence similarity to a distinct phylotype. The binary community proteomic
results revealed that the majority of identified proteins belonging to B. thetaiotaomicron
and E. rectale are true unique identifications, and that these species can be easily
differentiated by proteomics. Although this was a simplified two component human gut
microbiota of two evolutionary divergent species, the 12-member proteomic results
revealed similar conclusions with unique peptides as a preferred method for the relative
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estimation of species abundance with significant dynamic range. These analyses
suggested that the community structure is dictated by the host’s diet (i.e., diet is shaping
overall community structure), with many conserved hypothetical and pure hypothetical
proteins identified whose presence had not been predicted in the initial annotation of the
finished genome.
9.2.2: Human gut twin cohort
With a successful method to study the proteomes of lower-complexity microbiota in
gnotobiotic mice, we extended this methodology into higher complexity representative
human gut microbiomes in human feces. We have developed a novel non-targeted MS
approach to measure the identities of thousands of microbial and host proteins in
human feces using non-matched and/or matched metagenomes in addition to humanderived reference genomes for protein identification. Using this approach, we
established the role of an integrated platform using MS-based proteomics and
metagenomics in the human microbiome. Although these results presented the largest
coverage of the human gut metaproteome, to fully understand the functional role of the
gut microbiota and its interaction with the human host would require extensive efforts to
comprehensively define and characterize each microbial member in addition to the
community as a single collective entity in health and disease.
We have successfully demonstrated that whole community metaproteome
measurements were achievable in the human gut microbiome and provided the first
large-scale glimpse into the functional activities of the microbial community inhabiting a
healthy gut. These results also provided key insight into the challenges that we and
future studies will encounter as the omics’ field progresses and accumulates thousands
of metagenomic sequences, including extensive microbial sequence redundancy. In
order to advance and apply this methodology to higher complexity microbiota and
human subjects with disease, the field has to establish methods for how to tackle
microbial protein sequence redundancy in environmental samples. Although nonmatched metagenomic data may capture more sequence diversity, large protein
databases can create unreasonable sequence redundancy. Therefore, we applied a
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bioinformatics comparison and analysis of how to construct metagenomic sequence
databases for optimum metaproteome measurements. These results suggested that
proteomic data is twice as likely to match metagenomic data derived from the same
sample and protein databases derived from matched metagenomic sequenced reads
(RMPS), increased the number of MS/MS spectra, peptides, and protein identifications.
Using this novel approach, we were able to increase PSM and coverage of
metaproteomes collected from both healthy and individuals with Crohn’s disease and
revealed examples of where reference genomes and meta-omics data does not
correlate, indicating the need for future studies to explore the differences between
genomic potential versus proteome abundances.
9.3: Future directions
As this dissertation has demonstrated, biological advancements go hand in hand with
technological developments. We cannot improve our understanding of the human
microbiome unless the experimental and analytical tools are available and adapted for
complex environmental samples with higher complexity in microbial composition and
diversity (i.e., thousands of bacterial species with a wide range of abundances). These
analyses have and will advance the field of metaproteomics in the human gut
microbiome by providing novel experimental and bioinformatic strategies to identify and
characterize the metaproteomes of complex microbiomes extracted from feces and
ceca. Experimental comparisons and developments that lead to enhanced lysis and
protein extraction methods will enable future studies to build upon these methods to
increase protein identification and coverage of large-scale metaproteomes.
The future of metaproteomics in the human microbiome will likely focus on
several of the challenges discussed within this dissertation. Because we are only
sampling the surface with the identification of ~1-10% of the community proteome,
technological advancements will enable deeper measurements and wider coverage of
the entire community, but more importantly the lesser abundant microbes.
Improvements in chromatographic peptide separation and/or fractionation and mass
spectrometric measurements will provide better peptide separation and detection,
	
  

200	
  

through-put, and higher resolution and mass accuracies to resolve single amino acid
polymorphisms and post-translational modifications in the human microbiome which is
currently not possible.
The current bottleneck in microbial community metaproteomics hinges on the
available informatics algorithms and filtering metrics that were designed for single
microbial isolates and mixtures of proteins. Contrary to single bacterial genomes, when
faced with thousands of publically available metagenomes and reference genomes,
computational resources will be stretched to their practical limits, and traditional
database search algorithms will be ineffective and obsolete. New cost-effective
computational resources (i.e., to store and create substantial omic’ databases) and
informatics algorithms that are designed for microbial communities will lead the future
and enable the comprehensive and accurate assignment of all tandem mass spectra
within microbial communities for which a large portion of the are closely-related
microbes with high sequence similarity.
The future of the human microbiome, both in metagenomics and
metaproteomics, includes the development of tools to characterize large numbers of
proteins with unknown function. As evident throughout this dissertation in gnotobiotic
mice and human individuals, a large percentage of the collective microbial community
consists of proteins with unknown function that are not revealed by metagenomics. It is
obvious that these proteins are critical for microbial survival and carry out important
functions in the human gut. New experimental and biochemical assays focused on the
profiling and characterization of proteins with unknown functions will likely unravel new
microbial phylotypes and functions yet to be seen by traditional sequencing
technologies.
It is the field of systems biology and the combination of omic approaches, with
advancement in all areas of MS-based proteomics including technology and informatics
workflows that will serve as the future revolutionary tool to fully characterize microbial
community metaproteomes in the human microbiome.
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9.4: Perspective
Over the last five years, the research presented here has helped establish the field of
metaproteomics and its successfulness in the human gut microbiome, even though the
majority of current research efforts and funds are focused on metagenomics. We have
identified an experimental and analytical platform that supports an unbiased and deep
identification of the human gut metaproteome. This platform can be effectively scaled
from a less complex, controlled model microbiota to a highly complex gut microbiome
derived from human subjects. We have developed a novel bioinformatics workflow for
integrated omic studies that incorporates metagenomic sequence data and MS to
provide optimum identification and characterization of human host-gut metaproteomes.
In addition to designing and developing experimental, analytical, and informatics
workflows, we have provided a glimpse into whether a healthy ‘core’ gut metaproteome
exists and the metabolic functional differences between individual microbial species
(e.g., B. thetaiotaomicron and E. rectale) and communities as a whole (e.g., healthy
versus disease). These experiments and results represent substantial progress
towards the ultimate goal of a complete identification of the human gut microbiome.
The next 5 years will undoubtedly focus on implementing and continually
developing the platforms described herein to characterize human microbiomes collected
from higher complexity model communities (e.g., a 100-member microbial community in
gnotobioic mice) and other human body sites (e.g., oral cavity and vagina). The
establishment of metaproteomics in the human microbiome should drive an increase in
the funding and more extensive studies that focus on characterizing the actual
functional metaproteome. As a result, metagenomic-related research groups will
engage metaproteomics to not only enhance our understanding of the microbiome, but
also improve metagenomic sequencing with respect to its impact on metaproteomics.
With regards to mass spectrometry, new informatics workflows that combine traditional
protein database searching with novel de novo sequencing algorithms will be developed
and benefit integrated omic’ studies with the identification of unknown proteins that are
not sequenced and/or are missed in the assembly or gene-finding algorithms unique to
metagenomics. Finally, MS will be challenged to another level where efforts will likely
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begin to focus on designing new techniques and technologies in all omic’ fields that
permit the study of the ‘web of events’ rather than a static snapshot of the functional
activities in a microbial community. It is not apparent that there are any fundamental
inpenetratable roadblocks to this progress towards a comprehensive systems-biology
characterization of the human microbiome, but rather only experimental and informatics
hurdles that need to continue to be navigated. Since the ultimate goal is a gain in
biological insight, a focus on mining biological inferences from integrated metagenomicmetaproteomic datasets will advance mass spectrometry in the human microbiome.
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